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Thesis:
Hypoglycaemia is a common side effect of treatment with insulin in people with type 1 diabetes.
Because of its detrimental effects on the brain, acute hypoglycaemia is a major limiting factor in
achieving strict glycaemic control. Therefore, there is a need to study the effects of hypoglycaemia on
brain function so that clinical practice may be better informed, and to look for novel methods of
reducing hypoglycaemia. The initial chapters of this thesis describe the clinical and physiological
aspects of hypoglycaemia, followed by a review of the literature on the effects of acute hypoglycaemia
on cognitive function. The subsequent chapters describe original research studies in subjects with and
without diabetes, which examine the effects of acute hypoglycaemia on aspects of cognitive function
and the prevention ofhypoglycaemia.
In Studies 1 to 3, a hyperinsulinaemic glucose clamp was used to either maintain euglycaemia (blood
glucose 4.5 mmol/1) or induce hypoglycaemia (2.6 mmol/1) in both healthy adults (n=20), and subjects
with type 1 diabetes (n=16). A cognitive test battery was administered to examine aspects of attention,
intelligence, motivation, affect and subjective cognition. Hypoglycaemia induced a significant
deterioration in tests sensitive to both visual and auditory selective attention, and attentional flexibility
deteriorated (Studies 1 and 2). Intelligence scores did not deteriorate during hypoglycaemia (Studies 1
and 2). In Study 3, hypoglycaemia increased task-irrelevant interference and self-focus of attention,
but motivation declined to a similar extent during both study conditions. Hypoglycaemia produced a
negative mood state with a significant fall in energy levels and a concomitant rise in anxiety (Study 3).
Study 4 was an open-label, comparative study of the post-prandial glucodynamics of insulin lispro,
when administered either 5 minutes before or 20 minutes after a high fat/high solid phase meal, in
twelve subjects with type 1 diabetes. Administration of insulin lispro after the meal reduced the risk of
early postprandial hypoglycaemia, without compromising postprandial glycaemic control.
Therefore, the work in this thesis has demonstrated a differential deterioration of attentional function in
humans during hypoglycaemia with no effect on non-verbal reasoning skills. Furthermore, it would
appear that the brain is not only less cognitively competent and more dysphoric during hypoglycaemia,
it is also more self-aware and distracted when required to perform effortful processing.
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SUMMARY OF STUDY 1
Objective
Experimentally-induced hypoglycaemia in humans causes progressive, but
reversible cognitive dysfunction, but it is not known to what extent
neuropsychological tests index abilities of cognitive functioning that are
important in everyday life. This study sought to examine the effects of acute
insulin-induced hypoglycaemia on attention and intelligence in non-diabetic
humans.
Research Design and Methods
A hyperinsulinaemic glucose clamp was used to achieve controlled euglycaemia
(4.50 (0.22) mmol/1) and hypoglycaemia (blood glucose 2.59 (0.19) mmol/1) in
20 healthy volunteers. Subjects were studied on two occasions in a
counterbalanced order. During each study condition, subjects completed
parallel tests of cognitive function. Cognitive function was assessed by the Test
ofEveryday Attention and the Raven's Progressive Matrices.
Results
Hypoglycaemia induced a significant deterioration in tests sensitive to both
visual (p<0.01) and auditory selective attention (p<0.01). During
hypoglycaemia attentional flexibility deteriorated and speed of information
processing was delayed (p<0.0001). Sustained attention was preserved and
intelligence scores did not deteriorate during hypoglycaemia (p=0.1).
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Conclusions
During experimental hypoglycaemia in non-diabetic humans, a significant
deterioration occurs in attentional abilities, while fluid intelligence is preserved.
Furthermore, there is a differential sensitivity in attentional dysfunction during
hypoglycaemia, with some attentional abilities showing a marked deterioration,
whereas others are unaffected. On the basis of these results it can be surmised
that many complex attention tasks relevant to everyday life will be impaired
during moderate hypoglycaemia.
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SUMMARY OF STUDY 2
Objective
Acute hypoglycaemia leads to a rapid decline in mental abilities. A previous
study demonstrated impairment of attentional functioning in subjects without
diabetes. Therefore, the present study sought to determine whether acute
insulin-induced hypoglycaemia would cause a similar pattern and degree of
attentional dysfunction in people with type 1 diabetes. A further aim of the
present study was to assess if acute hypoglycaemia would have no effect on
non-verbal reasoning or whether a diagnosis of diabetes would act as a
moderator of this important cognitive modality.
Research Design and Methods
A hyperinsulinaemic glucose clamp was used to maintain euglycaemia (4.5
mmol/1) or induce hypoglycaemia (2.6 mmol/1) on separate occasions in sixteen
adults with type 1 diabetes each of whom were studied on two occasions in a
counterbalanced order. During each study condition, the subjects completed
parallel tests of cognitive function assessed by the Test of Everyday Attention
and the Raven's Progressive Matrices.
Results
Significant increments were noted in the autonomic (p=0.002), neuroglycopenic
(p=0.001), and general malaise symptom scores (p=0.01) during hypoglycaemia.
Sustained attention did not deteriorate during hypoglycaemia using either the
lottery ticket test (p=0.26) or the elevator counting test (p=0.15), and
intelligence scores, measured using the RPM, were preserved during
hypoglycaemia (p=0.24, r|2=0.12). Hypoglycaemia caused a significant
deterioration in tests sensitive to visual (the mean number of map symbols
circled was lower during hypoglycaemia at both one minute (p=0.032, r|2=0.29)
and at two minutes (p=0.042, r|2=0.26), and auditory selective attention




The present study has demonstrated that acute controlled hypoglycaemia causes
attentional dysfunction in adults with type 1 diabetes, while there was a non¬
significant decline in non-verbal reasoning. The severity of the attentional
deficit during acute moderate hypoglycaemia was dependent upon which
attentional system was being examined. It is likely therefore that many complex
cognitive tasks which involve attention will be impaired during moderate
hypoglycaemia during everyday life.
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SUMMARY OF STUDY 3
Objective
Although many aspects of cognitive function have been examined during acute
hypoglycaemia, other important areas have been neglected. In particular, little
information is available concerning the subjective feelings that are generated by
acute hypoglycaemia. Furthermore, the conative (motivation) aspect of mind
has not been explored during hypoglycaemia. Therefore, the present study
examined mood, motivation and cognition in adults with type 1 diabetes using a
validated measure, the Dundee Stress State Questionnaire (DSSQ).
Research Design and Methods
A hyperinsulinaemic glucose clamp was used to either maintain euglycaemia
(arterialised blood glucose 4.5 mmol/1) or induce hypoglycaemia (2.6 mmol/1)
in sixteen adults with type 1 diabetes, each of whom were studied on two
separate occasions in a counterbalanced order. During each study condition, the
subjects completed parallel tests of cognitive function. The Dundee Stress State
Questionnaire (DSSQ) was administered before, and after, the cognitive
function tests.
Results
Motivation declined to a similar extent during the euglycaemia and
hypoglycaemia conditions (p=0.07). Hypoglycaemia increased task-irrelevant
(p=0.02) interference. Self-focus of attention was much higher after
hypoglycaemia than euglycaemia (p=0.02). Hypoglycaemia produced a
negative mood state with a significant fall in energy levels (p=0.03) and a
concomitant rise in anxiety level (p=0.05). The subjective perception of
concentration was unaffected during hypoglycaemia (p=0.14), and the scores for
control and confidence did not fall (p=0.19).
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Conclusions
In people with type 1 diabetes, hypoglycaemia causes a state of heightened self-
awareness and distraction during active mental activity. This is likely to leave
fewer processing resources available to allow completion of cognitive tasks.
Acute hypoglycaemia induces a state of significant worry and anxiety which is
likely to have an impact on the social, personal and work activities of people
with diabetes.
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SUMMARY OF STUDY 4
Objective
Fast-acting insulin analogues have a more rapid onset and shorter duration of
action than human soluble insulin. Although these insulins are usually injected
immediately before meals, a delayed rise in postprandial blood glucose or a
reduced glycaemic response to a meal may increase the risk of early
postprandial hypoglycaemia. The aim of the present study was to examine the
effect of either pre- or post-prandial administration of insulin lispro on the
pharmacodynamics of blood glucose following the consumption of a high fat,
solid-phase meal, to determine which time of administration of insulin was less
likely to promote early post-prandial hypoglycaemia.
Research Design and Methods
12 subjects with type 1 diabetes were studied on two separate occasions. All
subjects ingested a high fat, solid-phase meal as a standardised (weighed)
portion of fried fish and chipped potatoes. Insulin lispro was administered 5
minutes before the meal on one occasion and 20 minutes postprandially on
another. The magnitude and temporal pattern of the postprandial glucose
excursions were measured.
Results
The glycaemic excursion over time was greater when insulin lispro was
administered after the test meal but failed to achieve statistical significance
(p=0.059). Pre-prandial lispro produced a cumulative decline in post-prandial
blood glucose (maximal decrement of blood glucose below baseline (mean (SD)
-1.7 (2.4) mmol/1), whereas blood glucose increased after the meal when lispro
was administered post-prandially (maximal increment of blood glucose above
baseline +2.2 (1.3) mmol/1). When lispro was administered before the meal,
post-prandial hypoglycaemia developed in three subjects. Hypoglycaemia did
not occur when lispro was administered post-prandially.
18
Conclusions
Administration of insulin lispro 20 minutes after a high fat, solid-phase meal did
not provoke a postprandial fall in blood glucose, and did not result in
pronounced postprandial hyperglycaemia. In conclusion, when a meal contains
a high content of fat in solid-phase, administration of insulin lispro after the
meal may reduce the risk of early postprandial hypoglycaemia, without






PATHOPHYSIOLOGICAL AND CLINICAL ASPECTS OF
HYPOGLYCAEMIA
1.1 BACKGROUND
The successful isolation of insulin by Frederick Banting and John Macleod, with
the collaboration of Charles Best and James Collip, in Toronto, was in the early
1920s. Thereafter, when insulin was introduced to treat human diabetes, the
symptoms of hypoglycaemia soon became apparent. A 'characteristic train of
symptoms' and signs were noted as the blood glucose was lowered below
normal, and this response was described as a 'hypoglycaemic reaction' [Fletcher
& Campbell, 1922, Banting et al, 1923]. As the blood glucose declined further
cognitive dysfunction became prominent, with a rapid deterioration in mental
functions, unless appropriate corrective action was taken [Fletcher & Campbell,
1922].
Since the discovery of insulin more than 80 years ago considerable advances in
insulin therapy have occurred: most recently analogues of human insulin have
been produced by manipulation of the amino acid sequence of the insulin
molecule; these have included rapid- and short-acting analogues (lispro and
aspart), and long-acting insulins (insulin glargine and insulin detemir) [McAulay
& Frier, 2003]. Despite these major advances that have occurred in the
treatments for diabetes, people who have type 1 diabetes still fail to achieve
recommended glycaemic targets. However, if the risk (and fear) of
hypoglycaemia was not always present, people with diabetes could achieve
normal blood glucose levels. Instead, they are often exposed to suboptimal
glucose concentrations, and are thus precluded from the full attainment of the
well-established benefits of strict glycaemic control [The DCCT, 1993]. A
fundamental problem with current treatment regimens is that they do not provide
insulin replacement that is blood glucose-regulated; whereas the glucose
lowering action of endogenous insulin occurs in minutes, even the shortest
acting insulin analogues used to treat diabetes, have a duration of action that is
measured in hours. Therefore, hypoglycaemia causes recurrent symptomatic
and often disruptive episodes in most people with type 1 diabetes, and remains
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the limiting factor in achieving normal glucose levels in the treatment of
diabetes [Cryer, 1993a].
1.2 DEFINITION OF HYPOGLYCAEMIA
It is not possible to study hypoglycaemia without actually determining what
'hypoglycaemia' means for the individual with diabetes. Hypoglycaemia can be
defined as an arbitrary biochemical level, e.g. blood glucose of 3.5 mmol/1 or
below, or on the basis of symptoms of hypoglycaemia. The latter can be classed
into degrees of severity depending on the physical effects and the need for help
from another person to restore a normal glucose. Hence, hypoglycaemia can be
mild, and self-treated by the patient (mild symptomatic hypoglycaemia), or
severe, requiring the help of others for recovery (severe hypoglycaemia). The
latter does not necessitate whether the patient is conscious, in a coma or
convulsing, nor the mode of treatment, whether it be food, intravenous glucose
or glucagon. Hypoglycaemia can also be asymptomatic and detected on
biochemical testing (biochemical hypoglycaemia). The latter poses particular
problems because it can only be identified by measuring the blood glucose so
will often go undetected, especially during sleep (usually nocturnal
hypoglycaemia).
These definitions of hypoglycaemia, especially the numerical biochemical level,
may appear to be straightforward, but they present numerous problems in both
clinical and research practice. For example, in many people with insulin-treated
diabetes the perception of symptoms becomes altered or diminished, either with
increasing duration of diabetes, or relating to periods of recent metabolic
change, and they develop the syndrome of impaired awareness of
hypoglycaemia [Frier & Fischer, 1999]. By contrast, people with poor
glycaemic control and an elevated HbAlc may experience symptoms of
hypoglycaemia when blood glucose declines within the hyperglycaemic range
[Maddock & Krall, 1953, Boyle et al, 1988, Jones et al, 1991, Kinsley et al,
1995].
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In clinical practice, the most important definition of hypoglycaemia is that
which the patient understands. Some patients assume that they have not
suffered hypoglycaemia unless they have been in coma. Therefore, it is
important to be clear what is meant by hypoglycaemia when discussing this with
people with diabetes. Diabetes UK has recommended that individuals with
diabetes should maintain a blood glucose above 4.0 mmol/1 wherever possible
[www.diabetes.org.uk]. In the clinic, a useful question may be, "How often do
you experience symptoms of a low blood glucose during an average week?"
Some patients consider that only severe hypoglycaemia, i.e. the need for
external assistance, or even loss of consciousness, to represent a 'hypo'. To
clarify the frequency of these episodes the patient could be asked, "How many
times in the last year have you had a low blood glucose when you have required
help for treatment?" If an individual is experiencing frequent symptomatic
hypoglycaemia, it is important to seek biochemical verification in view of the
non-specific nature of symptoms.
1.3 FREQUENCY OF HYPOGLYCAEMIA
1.3.1 Frequency of mild hypoglycaemia
People with type 1 diabetes suffer an average of two episodes of symptomatic
hypoglycaemia per week, amounting to thousands of such episodes over a
lifetime of diabetes treatment [Pramming et al, 1991]. However, many episodes
ofmild hypoglycaemia that occur in the community go unrecognised so that this
figure is likely to be a significant underestimate. This may well be a particular
problem during the night, and it is unsurprising that the frequency of nocturnal
hypoglycaemia is high. In one of the first overnight studies, Gale & Tattersall
[1979] found at least one blood glucose value below 2.0 mmol/1 in half of 39
patients with diabetes treated with insulin, and in three-quarters of these
episodes the hypoglycaemia lasted for three or more hours. These results were
confirmed by subsequent investigators, where nocturnal hypoglycaemia
occurred in 10-56% of overnight profiles [Dornan et al, 1981, Pramming et al,
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1985, Whincup & Milner, 1987, Bendtson et al, 1988, Shalwitz et al, 1990,
Vervoort et al, 1996], Rather worryingly, this nocturnal hypoglycaemia was
asymptomatic in 25-70% of episodes and lasted for up to 6 hours in some.
Few large-scale studies have recorded the frequency of hypoglycaemic episodes
in people with type 2 diabetes treated with insulin over a protracted period of
treatment. The proportion of patients experiencing hypoglycaemia during the
first 10 years of the UKPDS [1998] is shown in table 1.1.
Table 1.1 Proportion of patients with type 2 diabetes experiencing hypoglycaemia
per year in UK Prospective Diabetes Study over 10 years of the study by
principal treatment regimen (mean figures are shown) (derived from
UKPDS, 1998). Reproduced from Diabetes in Old Age 2nd edition, 2001
(eds AJ Sinclair and P Finucane). Copyright 2001, John Wiley & Sons
Limited, reproduced with permission
One or more major3 episodes of
hypoglycaemia (%)






"major hypoglycaemia required third-party help or medical intervention
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1.3.2 Frequency of severe hypoglycaemia
Edwin Gale proposed the 'Rule of Thirds' to hypoglycaemic coma; this states
that one in three patients will have a hypoglycaemic coma at some point in their
life, that one in three of these (10% of the total) will have had a coma in the
previous year, and that one in three of these (i.e. 2-3% of the total) have a
significant disruption of their lives from recurrent hypoglycaemia coma [Gale,
1986]. However, severe hypoglycaemia can occur without coma and, therefore,
around one third of people with type 1 diabetes will experience an episode of
severe hypoglycaemia per annum [The Diabetes and Complications Trial
Research Group, 1993, Reichard et al, 1991, MacLeod et al, 1993].
Representative event rates for severe hypoglycaemia during aggressive insulin
therapy in type 1 diabetes range from 62 [The DCCT, 1991] to 170 [MacLeod et
al, 1993] episodes per 100 patient-years. This contrasts with aggressive insulin
therapy for type 2 diabetes, which range from 3 [Abraira et al, 1995] to 73
[MacLeod et al, 1993] episodes per 100 patient-years, although a recent, short
prospective survey in Dundee demonstrated a rate of severe hypoglycaemia of
0.35 events per patient per year [Donnelly et al, 2005]. In that study, a history
of previous hypoglycaemia and long duration of diabetes was highly predictive
of further events [Donnelly et al, 2005]. However, in a local series, the
frequencies of severe hypoglycaemia were similar in type 1 and type 2 diabetes
matched for duration of insulin therapy [Hepburn et al, 1993a]. Therefore,
given the progressive insulin deficiency that occurs in type 2 diabetes [UKPDS,
1998], iatrogenic hypoglycaemia becomes a more frequent clinical problem for
people with type 2 diabetes as they approach the insulin-deficient end of the
spectrum.
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1.4 PHYSIOLOGICAL RESPONSES TO HYPOGLYCAEMIA
1.4.1 Effects of glucose deprivation on CNS metabolism
Glucose is an obligate metabolic fuel for the brain under normal physiological
conditions. Because the brain cannot synthesise glucose or store more than a
few minutes supply as glycogen, it is critically dependent on a continuous
supply of glucose from the blood. Although the brain constitutes only 2% of
body weight, it consumes 20% of the body's oxygen and receives 15% of its
cardiac output [Sokaloff, 1989], Under normal circumstances with intact
glucose homeostasis, counterregulatory responses are usually very effective so
that hypoglycaemia rarely occurs in healthy individuals, even after prolonged
fasting. Therefore, blood glucose concentrations are maintained within a narrow
range despite wide variability in carbohydrate intake and physical activity. To
maintain this balance, acute hypoglycaemia induces a series of hormonal,
neurophysiological, symptomatic and cognitive changes that occur at different
and defined blood glucose concentrations.
1.4.2 Counterregulation
In humans, several mechanisms have evolved to maintain glucose homeostasis
and so protect the integrity and function of the brain [Cryer, 1993a]. Falling
arterial glucose concentrations activates a characteristic hierarchy of responses,
commencing with the suppression of endogenous insulin secretion, the release
of several counterregulatory hormones, and the subsequent development of
characteristic symptoms (figure 1.1). These alert the individual to the
development of hypoglycaemia, so allowing them to take early and appropriate
action to assist recovery. Such protective responses are usually very effective in
maintaining the arterial blood glucose concentration within the normal range,
which protects the brain from exposure to neuroglycopenia caused by protracted
glucose deprivation. Glucose counterregulation is controlled from centres
within the brain (mainly the ventromedial hypothalamus) assisted by activation
of central autonomic nervous centres within the hypothalamus with subsequent
stimulation of the peripheral sympatho-adrenal system. This contributes to
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glucose counterregulation through the peripheral actions of catecholamines and
also by the generation of characteristic autonomic warning symptoms [Cryer
1993a].
Although glucagon (secreted by pancreatic alpha cells independently of control
by the brain) is the most potent counterregulatory hormone, the role of
adrenaline release from the adrenal medullae, becomes paramount if the
secretory response of glucagon is deficient [Gerich, 1988]. Other
counterregulatory hormones, released through activation of the hypothalamic-
28
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pituitary axis, such as Cortisol and growth hormone have greater importance in
promoting recovery from prolonged hypoglycaemia [Cryer 1993b]. Glucagon
stimulates hepatic glycogenolysis, releasing glucose from glycogen stored in the
liver, and also promotes gluconeogenesis from three-carbon precursors such as
alanine, lactate and glycerol [Frizell et al, 1988], The energy for this process is
provided by the hepatic oxidation of free fatty acids that are released by
lipolysis. Catecholamines inhibit insulin secretion, diminish the peripheral
uptake of glucose, stimulate lipolysis and proteolysis and promote
glycogenolysis in peripheral muscle to provide lactate, which is utilised for
gluconeogenesis in the liver and kidney [Frizell et al, 1988].
1.4.3 Symptoms of hypogiycaemia
Most symptoms experienced during hypoglycaemia are generated either by the
direct effects of a low blood glucose on the brain (neuroglycopenia) or through
activation of the autonomic nervous system. Common autonomic symptoms are
sweating, tremor, pounding heart, anxiety and hunger, whereas neuroglycopenic
symptoms include drowsiness, poor concentration, confusion, difficulty
speaking and incoordination [Deary, 1999]. Non-specific symptoms are nausea
and headache [Deary, 1999]. The symptoms of hypoglycaemia are discussed in
more detail in section 1.5.
1.4.4 Glycaemic thresholds
Different physiological responses occur when the declining blood glucose
reaches specific concentrations. Although these glycaemic thresholds are
readily reproducible in non-diabetic humans [Vea et al, 1992], they are dynamic
and can be modified in people with diabetes. In non-diabetic humans the
glycaemic threshold at which the secretion ofmost counterregulatory hormones
is triggered is an arterialised blood glucose of approximately 3.8 mmol/1, so that
counterregulation is usually activated when blood glucose falls below the
normal range. Counterregulation therefore occurs at a higher blood glucose than
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that at which the symptomatic response to hypoglycaemia occurs (3.0 mmol/1)
and before the onset of cognitive dysfunction (2.8 mmol/1) (figure 1.1). It is
important to be clear on the semantics used to describe these alterations in
glycaemic threshold. When the blood glucose required to initiate a given
response is lower than usual, the glycaemic threshold is said to be raised or
elevated. Therefore, a more profound hypoglycaemic stimulus is required to
trigger a response.
1.5 SYMPTOMS OF HYPOGLYCAEMIA
When the brain is deprived of glucose various symptoms are generated.
Awareness of the symptoms of hypoglycaemia provides the patient with
diabetes with an early warning of a progressive decline in blood glucose,
therefore perception of their onset usually allows appropriate action to be taken
before the effects of neuroglycopenia become disabling.
1.5.1 Classification of symptoms
Symptoms have been categorised using two principal approaches: (1)
physiological studies in which symptoms are recorded and measured during
experimentally-induced hypoglycaemia, often using pharmacological blockade
and (2) multivariate statistical analyses of symptoms described in field studies or
during experimentally-induced hypoglycaemia.
Physiological methods
Autonomic symptoms: In addition to observations in people with diabetes, studies
have been performed in non-diabetic subjects and in people with various forms
of autonomic denervation. People who have suffered cervical cord transection
develop tetraplegia and a pre-ganglionic sympathectomy. They experience
neuroglycopenic symptoms during acute hypoglycaemia but autonomic warning
symptoms are absent [Corrall et al, 1979, Mathias et al, 1979, Frier, 1981].
However, patients who have undergone bilateral adrenalectomy [Ginsburg &
Paton, 1956, Altorfer et al, 1981] or splanchnicectomy [French & Kilpatrick,
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1955] do not secrete adrenaline in response to hypoglycaemia, and retain
autonomic symptoms. Their autonomic neural pathways are otherwise intact,
allowing normal stimulation of end-organs, thus demonstrating that the secretion
of adrenaline is not vital to generate most autonomic symptoms. The autonomic
origin of the symptoms of 'feeling shaky/tremulous', 'pounding heart' and
'feeling nervous/anxious' was also confirmed during glucose clamp studies
using non-selective adrenoceptor blockade [Kerr et al, 1990a, Towler et al,
1993],
By contrast, the sweating response to hypoglycaemia [French & Kilpatrick,
1955, Ginsburg & Paton, 1956, Altorfer et al, 1981, Frier, 1981, Corrall et al,
1983, Towler et al, 1993] is mediated via cholinergic sympathetic fibres. The
perception of hunger is generated through an incompletely understood
behavioural mechanism involving hypothalamic control and the autonomic
nervous system [Leibowitz, 1975, Frances et al, 1983, Bray, 1984, Krauchi et al,
1984] and, during experimental hypoglycaemia, the symptom of hunger was
mediated largely by cholinergic neural mechanisms [Towler et al, 1993],
Neuroglycopenic symptoms: Neuroglycopenia causes a rapid impairment of brain
function through direct effects on neurones, and induces various symptoms.
Symptoms of difficulty thinking, warmth, weakness, confusion, tiredness and
drowsiness occur during hypoglycaemia, are not reduced by pan-autonomic or
adrenoceptor blockade and have been classified as neuroglycopenic in type
[Hepburn et al, 1993b, Towler et al, 1993]. The symptoms of faintness,
dizziness, difficulty speaking and blurring of vision were not affected by
pharmacological blockade [Towler et al, 1993] and are also considered to be
neuroglycopenic.
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Statistical approaches: Factor analysis
The set of statistical procedures known as factor analysis has been utilised to
classify the symptoms produced during acute experimental hypoglycaemia into
autonomic or neuroglycopenic groups [Berlin et al, 1987, Egger et al, 1991]. A
retrospective study of 295 ambulant subjects with insulin-treated diabetes
demonstrated five discrete groups of symptoms of hypoglycaemia [Hepburn et
al, 1992], whereas a further study of 598 people using confirmatory factor
analysis suggested a three factor model [Deaiy et al, 1993a]. These three groups
of symptoms were described as 'neuroglycopenic', 'autonomic' and 'general
malaise'. This validated three-factor model contains 11 common symptoms
(referred to as the 'Edinburgh Hypoglycaemia Scale'), and application of these
statistical techniques has revealed age-specific differences in the classification
and frequency of common hypoglycaemic symptoms.
1.5.2 Symptoms in different age groups
The symptoms of hypoglycaemia vary depending on the age of the individual
(table 1.2). This observation is of relevance both to clinical practice and to the
interpretation and design of research studies.
Children
In very young children, neuroglycopenic and non-specific symptoms are more
common and autonomic symptoms are reported less frequently, if at all [Tupola
& Rajantie, 1998]. In a prospective study of 161 children and adolescents with
type I diabetes, the most commonly reported symptoms of hypoglycaemia were
weakness, tremor, hunger and drowsiness [Tupola & Rajantie, 1998]. In studies
of hypoglycaemia symptoms in children using a modified hyperinsulinaemic
glucose clamp, hunger, sleepiness, "feeling low", sweating and shakiness were
reported with the greatest frequency [Ryan et al, 1990, Jones et al, 1991,
Bjorgass et al, 1997].
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Table 1.2 Features of hypoglycaemia in children and the elderly










































Data derived from Japp et al [1998], McCrimmon et al [1995], Ross et al [1998],
Deary et al [1993a]
Using principal components analysis it was observed that weakness was the
symptom most commonly reported by children (81%) [McCrimmon et al, 1995]
and the sign most frequently observed by parents was pallor (88%). Both the
children and their parents reported a cluster of symptoms relating to behavioural
change, which included irritability, being argumentative and becoming naughty.
In keeping with other studies [McCrimmon et al, 1995, Ross et al, 1998] there
was close agreement between children and their parents concerning the relative
frequency and intensity of each symptom reported. Similar behavioural
symptoms in children have been described previously [Macfarlane et al, 1989,
Macfarlane & Smith, 1988].
Elderly people
In studies of experimental hypoglycaemia in elderly non-diabetic subjects, fewer
individual symptoms were documented, the intensity of hypoglycaemic
symptoms was diminished and subjective awareness of hypoglycaemia was
reduced [Brierley et al, 1995, Matyka et al, 1997]. Elderly people with type 2
diabetes also have a more limited perception of autonomic symptoms of
hypoglycaemia which have a lower intensity than those reported by non-diabetic
elderly subjects [Meneilly et al, 1994]. Limited recognition of symptoms may
partly be a consequence of inadequate education in elderly people with diabetes,
whose relatives have also been shown to lack knowledge of the symptoms of
hypoglycaemia [Mutch & Dingwall-Fordyce, 1985, Thomson et al, 1991],
Factor Analysis of the hypoglycaemia symptoms of elderly people have
revealed distinct neuroglycopenic and autonomic groupings while headache and
nausea, typical symptoms of the 'general malaise' factor experienced by
younger adults, were rare [Japp et al, 1998]. This is of relevance in the clinical
situation because neurological symptoms of hypoglycaemia in elderly people
may be misinterpreted as representing transient cerebral ischaemia, vasovagal
syncope or even the effects of a cardiac arrhythmia. Hypoglycaemia may not
therefore be recognised and the cause of the symptoms not addressed.
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Therefore, the frequency of hypoglycaemia is probably underestimated in this
age group.
1.5.3 Variability of symptoms
A few general statements concerning symptoms of hypoglycaemia can be made:
• The symptom profile provoked by hypoglycaemia is idiosyncratic and varies
in character and intensity between individuals [Pennebaker et al, 1981, Cox
etal, 1983, 1985].
• Although no single symptom is present consistently during hypoglycaemia
in all people with diabetes, some symptoms are more common than others
[Cox etal, 1983],
• People with insulin-treated diabetes should be familiar with their own
symptom profile, thus enabling them to perceive the early onset of
hypoglycaemia.
Unfortunately, no single symptom has been shown to correlate significantly with
a specific blood glucose concentration in humans [Pennebaker et al, 1981].
Thus, the idiosyncratic nature of symptoms of hypoglycaemia is important when
educating people with newly diagnosed diabetes or those commencing insulin
treatment, ensuring that symptoms are highlighted that are of personal
relevance. However, reliance on symptom reporting can be misleading as some
seemingly discriminatory symptoms of hypoglycaemia can also occur during
hyperglycaemia. For example, in one study of symptoms in people with insulin-
treated diabetes, 'weakness' was significantly associated with hypoglycaemia in
27% of respondents, but in 7% was also a dependable symptom of
hyperglycaemia [Pennebaker et al, 1981]. Indeed, all of the recorded symptoms
of hypoglycaemia may occur in other circumstances and can therefore be
considered as 'non-specific'. Examples of this are 'sweating' and 'pounding
heart' which are normal physiological responses to exercise, but in a person with
insulin-treated diabetes, may be indicative of exercise-induced hypoglycaemia.
The potential for misinterpretation of the symptoms of hypoglycaemia in such
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situations is significant, and the only reliable way of ascertaining the cause is to
measure blood glucose.
Although the intensity of individual symptoms is fundamental to detecting the
onset of hypoglycaemia, the number of warning symptoms that are experienced
is also important. People who had one to three reliable symptom(s) of
hypoglycaemia correctly recognised about one half of their episodes of
hypoglycaemia (arbitrarily defined as a capillary blood glucose below 3.9
mmol/1), while those who had four or more reliable symptoms recognised
hypoglycaemia in more than 70% of episodes [Cox et al, 1993a].
1.5.4 Autonomic or neuroglycopenic symptoms to detect hypoglycaemia?
It is a widely held view, both among health professionals [Cox et al, 1994a] and
some people with diabetes, that the detection of hypoglycaemia is based
principally on autonomic symptoms. Some investigators have firmly stated that
awareness of hypoglycaemia is almost entirely the result of perception of
autonomic, as opposed to neuroglycopenic, symptoms [Towler et al, 1993].
Even in the earliest clinical descriptions of hypoglycaemia, autonomic
symptoms were associated with "mild reactions" whereas "severe reactions"
were affiliated with neuroglycopenic symptoms, suggesting that autonomic
symptoms are generated at an earlier stage in the development of hypoglycaemia
[Maddock & Krall, 1953],
In studies of non-diabetic subjects that have used the stepped glucose clamp to
induce experimental hypoglycaemia, autonomic symptoms were generated
before neuroglycopenic symptoms, the mean difference in blood glucose
concentrations being of the order of 0.5 mmol/1 [Schwartz et al, 1987, Mitrakou
et al, 1991]. This small difference between the glycaemic thresholds for the
onset of autonomic and neuroglycopenic symptoms is unlikely to be detectable
in a real life situation when the blood glucose of a person with diabetes may be
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declining rapidly, and when people may not be focusing on symptoms.
Therefore, when ambulant people with insulin-treated diabetes were asked about
their routine experience of warning symptoms of hypoglycaemia they reported
that autonomic and neuroglycopenic symptoms occurred with equal frequency
[Hepburn et al, 1991]. This observation has also been made during
experimentally-induced hypoglycaemia in insulin-treated diabetic subjects [Cox
et al, 1993]. In contrast to autonomic symptoms, the generation of
neuroglycopenic symptoms is not affected by counterregulatory hormonal
failure or by preceding episodes of hypoglycaemia [Frier & Fisher, 1999].
Therefore, it would seem that autonomic and neuroglycopenic symptoms are of
equal value in warning individuals of the onset of hypoglycaemia, provided that
the symptoms typical to the individual are identified by them and interpreted
correctly. However, with increasing duration of diabetes, autonomic symptoms
may diminish in intensity and number, requiring greater reliance on
neuroglycopenic cues, but the importance of the latter as valuable warning
symptoms should not be underestimated [Frier & Fisher, 1999],
1.5.5 Factors affecting symptom generation and perception
Modulation ofphysiological responses
In non-diabetic subjects glycaemic thresholds are reproducible and stable within
individuals [Vea et al, 1992], Neither gender [Cox et al, 1996], nor obesity [Vea
et al, 1994], affects the glycaemic thresholds for symptoms. Potential factors
that may affect the magnitude of the physiological responses to hypoglycaemia
include the depth and duration of hypoglycaemia, the rate of decline of blood
glucose, and, in a person with diabetes, the duration of diabetes, the quality of
prevailing glycaemic control (HbAlc) and recent exposure to hypoglycaemia.
Glycaemic control
With strict glycaemic control the threshold for onset of symptoms is raised so
that a more profound hypoglycaemic stimulus is required to trigger the
symptomatic response for autonomic symptoms [Clarke et al, 1991, Kinsley et
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al, 1995, Boyle et al, 1995, Lager et al, 1986, Amiel et al, 1988, Maran et al,
1995, Davis & Shamoon, 1991] and probably also for neuroglycopenic
symptoms [Clarke et al, 1991, Maran et al, 1995]. This effect becomes evident
when the HbAlc is within the non-diabetic range [Boyle et al, 1995, Kinsley et
al, 1995]. The converse is true in people who have poor glycaemic control with
an elevated HbAlc in whom symptoms typical of hypoglycaemia may be
experienced when blood glucose declines within a hyperglycaemic range [Jones
et al, 1991, Kinsley et al, 1995, Maddock & Krall, 1953, Mokan et al, 1994,
Boyle et al, 1988]. These observations help to explain why many subjects with
strict glycaemic control do not experience symptomatic hypoglycaemia until
their blood glucose is very low, and conversely why subjects with poor
glycaemic control may report experiencing symptoms of hypoglycaemia when
their blood glucose is normal or elevated.
Antecedent hypoglycaemia
Fluctuations in blood glucose concentrations can influence the glycaemic
threshold at which symptoms are initiated. Exposure to antecedent
hypoglycaemia can diminish the degree of hormonal counterregulatory
responses and symptoms to a subsequent episode of hypoglycaemia in non-
diabetic subjects [Heller & Cryer, 1991, Davis & Shamoon, 1991, Widom and
Simonson, 1992, Veneman et al, 1993, Mellman et al, 1994] and in people with
type 1 diabetes [Lingenfelser et al, 1993, Dagogo-Jack et al, 1993, Ovalle et al,
1998]. Although the relevant studies differ considerably in design and methods
of inducing hypoglycaemia, it appears that exposure to antecedent
hypoglycaemia for at least 60 minutes is necessary before this exerts a
significant influence on the magnitude of the symptomatic and neuroendocrine
responses to a subsequent episode of hypoglycaemia occurring within the
following 24 to 48 hours [Frier & Fisher, 1999]. Thus, the antecedent
hypoglycaemia has to be prolonged, as exposure to repeated episodes of short¬
lived (15-30 minute episodes) hypoglycaemia did not demonstrate this effect
[Peters et al, 1995, Davis et al, 2000], This effect of antecedent hypoglycaemia
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on the symptomatic response is probably a manifestation of cerebral adaptation
to changes in prevailing blood glucose which operates through a shift of the
glycaemic threshold (similar to the effect of strict glycaemic control).
Nocturnal hypoglycaemia
The effect of recurrent exposure to hypoglycaemia is one potential mechanism
underlying the pathogenesis of impaired awareness of hypoglycaemia. The
effects of asymptomatic nocturnal hypoglycaemia lasting for two or more hours
may be of particular relevance, with two studies demonstrating a reduction in
the magnitude of the symptomatic response to hypoglycaemia the following day
[Veneman et al, 1993, Fanelli et al, 1998]. This is an important observation as
nocturnal hypoglycaemia has been demonstrated in up to 50% of people treated
with insulin, is asymptomatic in 25-75 % of episodes and may last up to 6 hours
[Gale & Tattersall, 1979, Pramming et al, 1985, Bendtson et al, 1988].
Although most people treated with insulin are at risk of experiencing nocturnal
hypoglycaemia, those taking fixed mixtures with their evening meal, and
patients taking short-acting insulin in the late evening, may be at greater risk
because of the relative hyperinsulinaemia that these insulin regimens produce in
the early part of the night.
1.5.6 Alteration of physical symptoms
The physical symptoms of hypoglycaemia may be modified in several ways.
Posture
The intensity of autonomic symptoms are greater in the erect position compared
to a supine posture in people with type 1 diabetes [Hirsch et al, 1991a] and in
non-diabetic subjects [Maggs & Macdonald, 1994]. Hence, this facilitates
understanding why some individuals do not recognise subtle symptoms of
hypoglycaemia while they are lying in bed, but the symptoms become apparent
soon after rising. In addition, this is of importance in interpreting studies of
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experimentally-induced hypoglycaemia, most of which are performed with
subjects in a supine position.
Medications
Hypnotic medications and alcohol may impair the ability to perceive and
interpret symptoms of hypoglycaemia [Kerr et al, 1990b]. By contrast, the prior
consumption of caffeine has been shown to augment the magnitude of the
symptomatic response to moderate hypoglycaemia in non-diabetic [Kerr et al,
1993a] and in diabetic subjects [Debrah et al, 1996]. Although it has been
claimed that the frequent ingestion of caffeine may have a therapeutic
application to improve symptomatic awareness in people with impaired
awareness of hypoglycaemia, this would require further study before widespread
application in people with diabetes [Watson et al, 2000],
Beta-adrenoceptor antagonists have been shown to blunt specific autonomic
symptoms of hypoglycaemia, though sweating is either unaltered [Macdonald et
al, 1982] or may even be increased [Molnar & Read, 1974, Clausen Sjobom et
al, 1987, Kerr et al, 1990a, Hirsch et al, 1991b]. The peripheral vasoconstriction
caused by beta-adrenoceptor antagonists may diminish the sensation of warmth
[Kerr et al, 1990a]. When these medications are prescribed to people with
insulin-treated diabetes, they should be made aware of this potential change in
symptomatology, but should not preclude their use. Although the beta agonist,
terbutaline, [Saleh & Cryer, 1997] and the methylyxanthine, theophylline
[Hvidberg et al, 1994] augment counterregulation and speed recovery from
hypoglycaemia, their effects on the symptomatic response to hypoglycaemia
have not been evaluated.
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1.5.7 Altered ability to detect symptoms
Anticipation
People with diabetes who anticipate the possible development of hypoglycaemia
because of a missed meal or strenuous exercise usually focus their attention on
the development of symptoms and are therefore more likely to detect the onset
of hypoglycaemia [Cox et al, 1993a], Knowledge of the imminence of
experimentally-induced hypoglycaemia in non-diabetic subjects enhanced the
intensity of neuroglycopenic, but not autonomic, symptoms [Pohl et al, 1997],
demonstrating the effect of anticipation on the perception of symptoms.
Circumstances
Circumstances and activities are also important. For example, individuals
requiring manual dexterity for their work, such as an artist, may be more
sensitive to noticing tremor. Neuroglycopenic symptoms such as difficulty in
concentrating may be recognised more readily by individuals who are occupied
with active mental activity. The converse applies to the effects of distraction
reducing the perception (or awareness) of hypoglycaemia. An activity
associated with similar symptoms may alter their perception or interpretation in
the context of simultaneously occurring hypoglycaemia. For example, while
sweating is an appropriate response during physical activity, on a hot day it may
be ignored, and be of less benefit to alert the individual developing
hypoglycaemia.
Altered ability to detect low blood glucose
Because many of the common symptoms of hypoglycaemia can be attributed to
alternative physiological causes, some of which may also promote a fall in blood
glucose (such as exercise-induced sweating, pounding heart and fatigue), people
with diabetes must be familiar with the symptoms of hypoglycaemia that are
peculiar to themselves. Previous experience of hypoglycaemia symptoms is
necessary to permit their early detection and correct interpretation. Flowever,
asymptomatic biochemical hypoglycaemia is common in people treated with
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insulin [Dornan et al, 1981, Arias et al, 1985], and a lack of correlation has been
observed between actual blood glucose concentration and the subjective
symptomatic response [Pramming et al, 1990]. This reinforces the need for
frequent measurement of blood glucose using an accurate blood glucose meter.
1.5.8 Plasma insulin concentration and method of delivery
At comparable levels of hypoglycaemia, plasma catecholamine concentrations
appear to be higher with greater levels of hyperinsulinaemia. Therefore, it could
be assumed that the higher plasma catecholamine concentrations indicated more
intense stimulation of the autonomic nervous system. Two studies, both in
people with type 1 diabetes, have examined this effect on hypoglycaemia
symptoms.
Using the glucose clamp technique and different concentrations of plasma
insulin, the symptoms of trembling, sweating, facial flushing and hunger during
hypoglycaemia (arterialised blood glucose 2.8 mmol/1) were found to be
attenuated when plasma insulin concentrations were high [Kerr et al, 1991a].
Only hunger was affected during more profound hypoglycaemia (blood glucose
2.2 mmol/1), suggesting that this effect of hyperinsulinaemia may be manifest
only during moderate degrees of hypoglycaemia. By contrast, during higher
plasma insulin concentrations, Lingenfelser and colleagues (1996) observed an
increased magnitude of autonomic and neuroglycopenic symptoms. The
relevance of these discordant results to clinical practice is difficult to assess, but
the suggestion that hyperinsulinaemia may provoke more profound
hypoglycaemic symptoms during an equivalent hypoglycaemic stimulus is of
interest and may be relevant to the lower frequencies of hypoglycaemia that
have been described with the use of fast-acting insulin analogues, with which a
higher post-injection peak of plasma insulin is achieved.
Insulin species (animal versus human) has been proposed to be a modifier of the
symptoms of hypoglycaemia. A small number of patients reported a change in
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their ability to perceive the onset of hypoglycaemia and in the nature of their
symptoms of hypoglycaemia after changing from animal to human species of
insulin in the 1980s. However, despite extensive investigation little scientific
evidence has emerged to support these claims other than a few subjective and
anecdotal reports, and most comparative, controlled trials have produced
negative results [Nelleman Jorgensen et al, 1994, Airey et al, 2000]. Some of
the patients' observations may be explained by the altered pharmacokinetics of
human insulin and by advancing knowledge about the mechanisms of impaired
awareness of hypoglycaemia. However, human insulin does not suit some
people who do not find this a satisfactory form of therapy, and animal insulin
species should remain available indefinitely.
1.5.9 Recommended clinical assessment of symptoms
Because of the effects of time and extraneous factors on hypoglycaemia
symptomatology, the symptoms experienced by patients with insulin-treated
diabetes should be reviewed at least annually and should certainly be discussed
at the diabetes clinic visit. The diabetes team may find value in having a
proforma sheet of the questions to ask about symptoms of hypoglycaemia so
enabling a comprehensive review with some degree of standardisation, which
could allow for effective audit. A detailed documentation of symptoms is also
useful when advising people on medical fitness to drive, to track changes in
awareness of hypoglycaemia, in situations with medico-legal import, and for
clinical research.
If biochemical hypoglycaemia is a frequent occurence, patients should be
advised to make a note of the concomitant symptoms that they have
experienced. Similarly, patients should try to identify whether these symptoms
occur when their blood glucose is not low. Through these measures they will
identify their relevant sensitive and specific symptoms of hypoglycaemia.
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1.6 ACQUIRED HYPOGLYCAEMIA SYNDROMES IN TYPE 1 DIABETES
In people with diabetes, glycaemic thresholds can be modified by the prevailing
glycaemic state, particularly by strict control and can also be influenced by
metabolic change such as antecedent hypoglycaemia. Many studies in people
with insulin-treated diabetes who have strict glycaemic control have
demonstrated that the counterregulatoiy hormonal and symptomatic responses to
hypoglycaemia do not occur until a much lower blood glucose concentration is
reached, particularly when the glycated haemoglobin concentration is within the
non-diabetic range [Amiel, 1999]. Similarly, antecedent hypoglycaemia
persisting for one hour or more has been shown to diminish the magnitude of the
symptomatic and neuroendocrine responses to any subsequent episode of
hypoglycaemia occurring within the subsequent 24 to 48 hours [Frier & Fisher,
1999]. During periods of strict glycaemic control the cerebral uptake of glucose
is maintained during hypoglycaemia so preserving cognitive function despite a
low blood glucose [Boyle et al, 1995]. This is a manifestation of cerebral
adaptation to prolonged exposure to neuroglycopenia, but it is maladaptive as
the early symptomatic warning to hypoglycaemia is absent, risking progression
to severe neuroglycopenia.
1.6.1 Counterregulatory deficiencies
In many people with type 1 diabetes, the glucagon secretory response to
hypoglycaemia becomes diminished or absent within a few years of the onset of
insulin-deficient diabetes. With glucagon deficiency alone, blood glucose
recovery from hypoglycaemia is relatively unaffected because counterregulation
is maintained by the actions of adrenaline. However, in up to 45% of people
who have type 1 diabetes of long duration there is impairment of the secretion of
glucagon and adrenaline [Gerich & Bolli, 1993], predisposing them to serious
deficiencies of glucose counterregulation when exposed to hypoglycaemia,
delaying the recovery of blood glucose and allowing progression to more severe
hypoglycaemia. The dual impairment of glucagon and adrenaline responses
results in the syndrome of defective glucose counterregulation. People with
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type 1 diabetes of long duration are therefore at increased risk of developing
severe and prolonged hypoglycaemia, particularly when intensive insulin
therapy is used [White et al, 1983]. Indeed, people with type 1 diabetes and
combined deficiencies of their glucagon and adrenaline responses to
hypoglycaemia have been shown to be at 25-fold or even higher increased risk
for severe iatrogenic hypoglycaemia during intensive insulin therapy compared
with those with absent glucagon but retention of adrenaline responses [White et
al, 1983, Bolli et al, 1984].
1.6.2 Impaired awareness of hypoglycaemia
This occurs when the symptomatic warning is diminished or inadequate in
people with diabetes. Several mechanisms underlying this problem have been
proposed (table 1.3). Impaired awareness of hypoglycaemia is generally
thought to be due to reduced sympathoadrenal responses and the resultant
reduced, largely adrenergic symptom response, to a given level of
hypoglycaemia [Cryer, 2002, Grimaldi et al, 1990, Clarke et al, 1991, Hepburn
et al, 1991],
Impaired awareness of hypoglycaemia is common, affecting almost 25% of all
insulin-treated patients, and becomes more prevalent with increasing duration of
diabetes [Frier & Fisher, 1999], Because it compromises behavioural defences
against developing hypoglycaemia, e.g. food ingestion, impaired awareness of
hypoglycaemia predisposes the patient to a high risk of developing severe
hypoglycaemia [Gold et al, 1994], In some patients, impaired awareness may be
reversible, being attributable to an elevated glycaemic threshold during intensive
insulin therapy or has followed recurrent severe hypoglycaemia [Cryer et al,
1994] but, in patients with type 1 diabetes of long duration, it may be
permanent.
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1.6.3 Central autonomic failure
Because hormonal counterregulatory deficiencies and impaired awareness of
hypoglycaemia co-segregate and are associated with an increased frequency of
severe hypoglycaemia, the concept of a "hypoglycaemia-associated autonomic
failure", or HAAF, has been proposed by Cryer [1992] who has speculated that
recurrent severe hypoglycaemia may be the primary problem which causes these
abnormalities and by establishing a vicious circle has maintained this state. This
concept deems that recent antecedent hypoglycaemia, in those with type 1
diabetes and advanced type 2 diabetes, causes defective glucose
counterregulation through a reduced adrenaline response to subsequent
hypoglycaemia in the setting of an absent glucagon response, and impaired
awareness of hypoglycaemia by reducing the sympatho-adrenal response and
thus resulting autonomic symptom response to subsequent hypoglycaemia.
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Table 1.3 Possible mechanisms of impaired awareness of hypoglycaemia
Study
Clarke et al, 1991
Kinsley et al, 1995
Boyle et al, 1995
Lager et al, 1986
Amiel et al, 1988
Maran et al, 1995
Davis & Shamoon, 1991
Mitrakou et al 1993
Davis et al, 1992
Dagago-Jack et al, 1993
Lingenfelser et al, 1993
George et al, 1995
Ovalle et al, 1998
Fanelli et al, 1998
Gerich et al, 1973
White et al, 1983
Bolli et al, 1988
Hirsch & Shamoon, 1987
Dagago-Jack et al, 1993
Cryer, 1992
Davis et al, 1996
Davis et al, 1997
McGregor et al, 2002
Mechanism
Strict glycaemic control






1.7 RISK FACTORS FOR SEVERE HYPOGLYCAEMIA
An essential prerequisite for hypoglycaemia is hyperinsulinaemia. Absolute or
relative insulin excess occurs when:
a. Insulin or an insulin secretagogue dose is excessive, badly timed or of
the wrong type.
b. Exogenous glucose delivery is decreased, e.g. a missed meal or
overnight fast.
c. Endogenous glucose production is decreased, e.g. following alcohol.
d. Glucose utilisation is increased, e.g. during and after exercise.
e. Insulin sensitivity is increased, e.g. late after exercise, following weight
loss, improved fitness.
f. Insulin clearance is decreased, e.g. in renal failure.
However, by relying on the above factors alone, it is often difficult to account
for an episode of hypoglycaemia. To understand this requires an appreciation of
the limitations of existing treatments for type 1 diabetes in combination with the
acquired syndromes of hypoglycaemia. As previously noted, the insulin
preparations in current use do not replicate the physiological changes in plasma
insulin concentrations that occur in non-diabetic individuals. Therefore, it is
likely that most people with type 1 diabetes will encounter significant
hyperinsulinaemia at many points during the day and night, but they do not
always experience hypoglycaemia at these points, especially towards the start of
their diabetes career. This is because the integrity of the physiological and
behavioural defences against a falling plasma glucose concentration determines
if less marked hyperinsulinaemia causes an episode of hypoglycaemia. Thus, it
is easier to account for hypoglycaemia in the setting of absolute or relative
insulin excess plus compromised glucose counterregulation [Cryer et al, 1994],
Risk factors relevant to compromised glucose counterregulation are outlined in
table 1.4. These factors are markers of the key features of the pathophysiology
of glucose counterregulation discussed earlier. For example, by successfully
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achieving strict glycaemic control, with a glycated haemoglobin within the
normal range, people with type 1 diabetes have a higher chance of developing
low blood glucose concentrations. Recovery from subsequent hypoglycaemia
may be compromised by the effect on modifying glycaemic thresholds for
counterregulatory hormone secretion, so causing more hypoglycaemia.
Similarly, a history of severe hypoglycaemia indicates recent antecedent
hypoglycaemia, and an increase in the glycaemic threshold for the symptomatic
and neuroendocrine responses to a low, and falling, plasma glucose
concentration [Cryer et al, 1994],
1.8 MORBIDITY AND MORTALITY OF SEVERE HYPOGLYCAEMIA
An episode of acute hypoglycaemia is, at the very least, a nuisance and a
distraction. However, for the person with type 1 diabetes, hypoglycaemia can
exert a profound social, psychological and physical burden and, in its most
extreme form, can result in death.
1.8.1 Morbidity of hypoglycaemia
In a group of 60 people with type 1 diabetes, 11 described severe
hypoglycaemia as being the most frightening event in their lives [Sanders et al,
1975], Pramming et al [1991] found that although most people with diabetes
were unconcerned about episodes of mild hypoglycaemia, they expressed an
equal degree of anxiety about exposure to severe hypoglycaemia as to the
development of late diabetic complications, such as blindness or renal failure.
Perhaps unsurprisingly, some people with diabetes avoid the attainment of good
glycaemic control to prevent hypoglycaemia [Cox et al, 1987].
Physical injury can occur and is sometimes serious. Fractures of long bones,
joint dislocations, soft tissue injuries, head injuries and occasionally burns have
been described as a direct consequence of accidents associated with
hypoglycaemia [Hepburn et al, 1989]. Hypothermia may also be a direct
consequence ofhypoglycaemic coma. In a report of 102 cases of
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Table 1.4 Risk factors for severe hypoglycaemia
Risk factor Study
Intensive insulin therapy
Strict glycaemic control/low HbAlc
Long duration of diabetes
Younger age
Male
History of severe hypoglycaemia
History of impaired awareness of hypoglycaemia
C-peptide negative









Allen et al, 2001
The DCCT, 1991
Bott et al, 1997
The DCCT, 1991
Bott et al, 1997
The DCCT, 1991
The DCCT, 1991
Bott et al, 1997
Muhlhauser et al, 1998
Gold et al, 1994
MacLeod et al, 1994a
Clarke et al, 1995
Muhlhauser et al, 1998
The DCCT, 1991
Bottetal, 1997
Muhlhauser et al, 1998
The DCCT, 1991
Bott et al, 1997
ter Braak et al, 2000
The DCCT, 1991
Jones et al, 1998
Banarer and Cryer, 2003
Galassetti et al, 2001
McGregor et al, 2002
Arky et al, 1968
Feher et al, 1989
ter Braak et al, 2000
Muhlhauser et al, 1998
Muhlhauser et al, 1991
Pedersen-Bjorgaard U et al, 2001
Pedersen-Bjorgaard U et al, 2003
Nordfeldt S et al, 2003
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hypoglycaemic coma induced either by insulin or by glibenclamide, physical
injury was reported in seven patients, myocardial ischaemia in two and stroke in
one patient [Ben-Ami et al, 1999]. In addition to the unpleasant symptoms of
hypoglycaemia such as palpitations, anxiety, shaking and sweating, acute
hypoglycaemia triggers a profound haemodynamic response secondary to
sympatho-adrenal activation and the secretion of adrenaline, causing an increase
in the workload of the heart and a widening of pulse pressure [Fisher & Heller,
1999]. Although this degree of haemodynamic stress is unlikely to cause any
difficulties in the young person with normal cardiac function, in the older
individual with diabetes who may have underlying cardiovascular disease,
hypoglycaemia may have serious consequences. In diabetic patients who have
ischaemic heart disease, cardiac arrhythmias may be induced. These have been
described during experimentally-induced hypoglycaemia and in anecdotal case
reports, with atrial fibrillation and premature atrial and ventricular contractions
all being observed during hypoglycaemia in diabetic patients who had no overt
clinical evidence of heart disease [Lindstrom et al, 1992, Fisher & Heller, 1999].
Sudden death during hypoglycaemia-induced cardiac arrhythmia has been
described in individual case reports [Frier et al, 1995, Burke & Kearney, 1999].
Transient ventricular tachycardia has been observed during experimental
hypoglycaemia in a non-diabetic subject with coronary heart disease and
myocardial infarction has also been reported in association with acute
hypoglycaemia [Fisher & Heller, 1999], Acute hypoglycaemia can lengthen the
QT interval on the electrocardiogram both in non-diabetic humans and people
with diabetes [Marques et al, 1997]. When combined with the effects of
catecholamine-mediated hypokalemia and the profound haemodynamic
changes associated with acute hypoglycaemia, the potential for inducing a
serious cardiac arrhythmia may be increased.
An array of psychological and neurological manifestations of acute
hypoglycaemia can cause loss of sensory and motor functions. Transient
ischaemic attacks and transient hemiplegia may be a feature of neuroglycopenia
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and supports the justification for blood glucose testing of patients in coma or
with suspected stroke. Less commonly, permanent neurological deficits have
been described, especially in elderly patients. These are probably caused by
mechanisms such as direct focal cerebral damage from glucopenia, acute
thrombotic occlusion secondary to the haemodynamic and haematological
effects of hypoglycaemia or by cerebral ischaemia provoked by changes in
regional blood flow in the brain [Perros & Deary, 1999]. It is unusual for severe
hypoglycaemia to cause permanent brain damage but this may arise if the
episode is protracted and often occurs in the context of excessive insulin dosage,
deliberate or accidental, and with excessive alcohol consumption [Agardh et al,
1983],
1.8.2 Mortality of hypoglycaemia
Hypoglycaemia is a relatively rare cause of death in people with type 1 diabetes.
In a study by the British Diabetic Association (now Diabetes UK), an estimated
4% of deaths in men with type 1 diabetes aged 20 to 49 years and 1% of deaths
in women in the same age group were attributed to hypoglycaemia [Laing et al,
1999]. Occasional deaths in otherwise healthy young people have been referred
to as the 'dead in bed syndrome' with the most likely cause being
hypoglycaemic-induced cardiac arrhythmias [Tattersall & Gill, 1991].
1.9 REDUCING THE FREQUENCY OF SEVERE HYPOGLYCAEMIA
Reducing the risk of hypoglycaemia, while maintaining good glycaemic control
is difficult but can be achieved. Firstly, the issue of hypoglycaemia has to be
addressed frequently, preferably at every contact with the diabetes team.
Unfortunately, this first principle is often neglected in the modern diabetes care
setting, which increasingly concentrates on the cardiovascular risk profile of
patients with type 2 diabetes. Secondly, the principles of good diabetes care
need to be applied, including patient education and empowerment, frequent
home blood glucose monitoring, appropriate use of insulin, the setting of
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individual glycaemic goals, and ongoing guidance and support. Finally, the
conventional risk factors for hypoglycaemia have to be taken into consideration
in addition to those indicative of counterregulatory failure in the individual with
diabetes.
1.9.1 Raising the issue of hypoglycaemia
Hypoglycaemia cannot be dealt with if it remains unrecognised, so the person
with diabetes should always be asked if hypoglycaemia is occurring. Are they
aware of hypoglycaemia and at what blood glucose concentration do they
experience symptoms? Do they have asymptomatic biochemical hypoglycaemia
and have there been any severe episodes? What is the temporal relation to
meals and snacks, alcohol ingestion and exercise? Is nocturnal hypoglycaemia a
problem? It is particularly important to ensure that both the doctor and the
patient understand what is meant by hypoglycaemia (see section 1.2).
1.9.2 Principles of good diabetes care
A well informed patient will understand the pharmacokinetics of the insulin that
they are using and the impact of food, alcohol and exercise on their home blood
glucose monitoring. They will be competent in responding to the latter, whether
it is a high or a low blood glucose reading, and will take appropriate remedial
action. Although no trials have demonstrated that the use of home blood
glucose monitoring (HBGM) reduces the risk of severe hypoglycaemia, patients
will recognise patterns of HBGM, which can predict who is at increased risk of
severe hypoglycaemia [Cox et al, 1994b], allowing appropriate adjustment of
therapy.
If frequent or troublesome hypoglycaemia is problematical, the insulin regimen
may require adjustment. For example, a fixed mixture of insulin often causes
unwanted nocturnal hyperinsulinaemia, predisposing to unrecognised
hypoglycaemia. When isophane insulin is administered before the evening
meal, nocturnal hypoglycaemia often occurs around 3.00-4.00 am [Pramming et
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al, 1985], while soluble insulin before a late evening meal can cause
hypoglycaemia in the early hours of the night [Vervoort et al, 1996], Therefore,
nocturnal hypoglycaemia may induce impaired awareness of hypoglycaemia
through the pathogenetic mechanism of antecedent hypoglycaemia [Veneman et
al, 1993, Fanelli et al, 1998]. To avoid nocturnal hypoglycaemia useful
therapeutic manoeuvres include the use of a rapid-acting insulin analogue before
the evening meal [Brunelle et al, 1998, Home et al, 1998, Heller et al, 1999] or
the evening dose of isophane insulin can be deferred at bedtime.
If impaired awareness of symptoms is related to strict glycaemic control, the
glycaemic control can be relaxed by reducing the total prescribed dose of
insulin. Three studies have demonstrated an improvement in symptoms of
hypoglycaemia following scrupulous avoidance of hypoglycaemia in a small
number of patients over periods of three weeks to one year [Cranston et al,
1994, Fanelli et al, 1994a, Dagogo-Jack et al, 1994], In two of the studies
[Cranston et al, 1994, Fanelli et al, 1994a,], the definition of impaired awareness
of hypoglycaemia was based upon an increased frequency of asymptomatic
biochemical hypoglycaemia, as opposed to a history of loss of awareness of
hypoglycaemia. A small rise in HbAlc occurred in all three studies, so that part
of the response may have been confounded by relaxation of glycaemic control.
In another study, avoidance of hypoglycaemia restored some of the
counterregulatory deficiencies, but not the symptomatic response to
hypoglycaemia [Davis et al, 1994], When continuous subcutaneous insulin
infusion was used to deliver insulin overnight instead of bedtime isophane
insulin, the intensity of the warning symptoms of hypoglycaemia was enhanced,
perhaps as a result of reducing the frequency of asymptomatic nocturnal
hypoglycaemia [Kane et al, 1998]. Although avoidance of hypoglycaemia is
clearly desirable, it requires intensive efforts on behalf of both the patient and
their healthcare providers, and is often difficult to achieve.
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In a patient treated with a basal-bolus regimen, morning fasting hypoglycaemia
indicates that the basal insulin requires adjustment; daytime hypoglycaemia
requires modification of the bolus insulin. Substitution of a long-acting insulin
analogue (insulin glargine or insulin detemir) for isophane insulin, may also
reduce the frequency of hypoglycaemia, both nocturnal [Vague et al, 2003,
Ratner et al, 2000] and severe hypoglycaemia [Ratner et al, 2000]. Blood
Glucose Awareness Training (BGAT) has been developed in the USA as a
method of teaching people who have type 1 diabetes with impaired awareness of
hypoglycaemia how to recognise, and distinguish between, high and low blood
glucose concentrations by detecting and interpreting subtle symptomatic
changes [Cox et al, 1989]. BGAT does appear to improve the accuracy of blood
glucose estimation in people with type 1 diabetes and may reduce the frequency
of undetected hypoglycaemia [Cox et al, 1995]. Although potentially valuable,
this programme has significant resource and cost implications.
1.9.3 Risk factors for hypoglycaemia and compromised glucose counterregulation
It is important to consider the risk factors that lead to absolute or relative insulin
excess discussed earlier. These include excessive insulin dose, inappropriate
timing of insulin, and the wrong insulin being administered. The effects of food
and alcohol need taken into account and patients educated about the need for
regular meals and snacks and about the adjustment of carbohydrate intake and
insulin dose before and after exercise. In addition, risk factors for compromised
glucose counterregulation should be sought. Therefore, a diagnosis of impaired
awareness of hypoglycaemia, which is usually evident from the history, implies
defective counterregulation and a history of recurrent hypoglycaemia. If the
latter is not apparent to the patient or their family, and is not reflected in the
patient's HBGM, then it is most likely occurring during the night.
As noted earlier, nocturnal hypoglycaemia is common and is likely due to a
combination of the imperfect pharmacokinetics of the available insulins in
current use and the effects of sleep on the recognition ofwarning symptoms and
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reduced adrenaline response to hypoglycaemia [Jones et al, 1998]. The
frequency of nocturnal hypoglycaemia may be reduced by the ingestion of a
bedtime snack, but the efficacy of this is limited to the first half of the night
[Saleh & Cryer, 1997]. Other experimental approaches have included the
bedtime administration of the amino acid alanine, which stimulates glucagon
release, and the beta2 adrenergic agonist, terbutaline [Saleh & Cryer, 1997].
Furthermore, uncooked cornstarch is slowly digested and may maintain blood
glucose concentrations for several hours [Kaufman & Devgan, 1996]. Finally,
the frequency of nocturnal hypoglycaemia can be reduced by adjustment of the
insulin regimen as noted earlier, e.g. the use of a rapid acting analogue with the
evening meal or a long-acting basal analogue at bedtime. The evidence for the
reduction in the frequency of hypoglycaemia with the rapid-acting analogue,
insulin lispro, will now be examined.
1.9.4 Insulin analogues
When insulin exists as a dilute solution and is in the circulation, it is in the form
of a monomer. In concentrated solution and in crystalline form as in
pharmaceutical preparations prepared for parenteral administration, six
monomers self-associate with two zinc ions to form a hexamer. This structure
affects the pharmacokinetics of insulin because its absorption into the
circulation from subcutaneous injection sites requires the monomeric form, and
the slow absorption of insulin from subcutaneous tissue is partly caused by the
time taken for the dissociation and dispersal of insulin.
The introduction of recombinant DNA technology for protein synthesis which
permitted the development of human insulin in the 1980s was followed by the
ability to manipulate various amino acid sequences of the A and B chains of the
insulin molecule, and so modify the absorption characteristics of the hormone.
This led to the development of insulin analogues which have differing durations
of action and rapidity of onset.
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Insulin lispro
The first monomeric insulin to be introduced for clinical use was insulin lispro
(Humalog, Eli Lilly & Co), which is formed by reversal of the amino acids
lysine and proline, at positions 28 and 29 on the insulin B chain. This reversal
weakens the binding of dimers and hexamers, allowing rapid dissociation into
the monomeric form following subcutaneous injection. Insulin lispro is
therefore absorbed quickly, has a rapid onset of action (10 to 20 mins), an earlier
peak effect (1 to 2 hours), and a shorter duration of activity (3 to 5 hours), than
soluble (regular) insulin. The rapid absorption of insulin lispro allows this
insulin to be administered immediately before a meal. The overall
bioavailability (~ 99%) of insulin lispro is similar to human soluble insulin
[Radziuk et al, 1997],
Insulin lispro and hypoglycaemia
Lower frequencies of mild (self-treated) symptomatic, biochemical, nocturnal
and severe (requiring assistance) hypoglycaemia have been recorded in people
with diabetes treated with insulin lispro, compared with human soluble insulin.
For example, in a prospective six-month, multicentre study of 1008 adults with
type 1 diabetes, the administration of insulin lispro immediately before meals
was compared with human soluble (regular) insulin, injected 30 to 45 minutes
before meals [Anderson et al, 1997]. The frequency of symptomatic and
biochemical hypoglycaemia was 12% lower with insulin lispro and this effect
was particularly beneficial overnight. A cumulative meta-analysis of eight
studies, comprising 2576 patients with type 1 diabetes, demonstrated that severe
hypoglycaemia (defined as coma or an episode requiring treatment with
parenteral glucose or glucagon) was 30% lower with insulin lispro than with
soluble (regular) insulin [Brunelle et al, 1998].
In a multicentre study in the UK of 135 subjects with type 1 diabetes, insulin
lispro was compared with human soluble (regular) insulin given before meals,
with isophane (NPH) being administered at bedtime in both regimens. Over a
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four month period, strict glycaemic control was achieved with both treatments,
with mean glycated haemoglobin concentrations of around 6.0% [Heller et al,
1999]. Episodes ofmild symptomatic and biochemical hypoglycaemia occurred
less frequently with insulin lispro, although the main beneficial effect in
minimising hypoglycaemia was predominantly during the night.
The potential benefit of using insulin lispro before the evening meal to reduce
the risk of nocturnal hypoglycaemia is based on the short duration of action of
this insulin, in that its hypoglycaemic action wanes by bedtime, so reducing the
level of nocturnal hyperinsulinaemia. This was demonstrated in a double-blind,
crossover study comparing insulin lispro with human soluble (regular) insulin in
a group of 14 adolescents with type 1 diabetes [Mohn et al, 1999], and in adults
with type 1 diabetes [Ahmed et al, 1998]. In both studies the overnight profiles
showed that insulin lispro was associated with lower plasma insulin and higher
blood glucose concentrations, and in the adult group a lower frequency of
nocturnal hypoglycaemia was observed [Ahmed et al, 1998].
Impaired awareness of hypoglycaemia is a common acquired complication of
insulin therapy in type 1 diabetes, and is associated with a sixfold higher
frequency of severe hypoglycaemia than in individuals with normal awareness
[Gold et al, 1994], In a study in Edinburgh, 33 subjects with type 1 diabetes of
long duration and co-existing impaired awareness of hypoglycaemia,
participated in a prospective crossover trial for 12 months, in which the use of
insulin lispro was compared with human soluble (regular) insulin [Ferguson et al
2001]. No difference in glycaemic control was observed between the two
groups but a trend to a lower incidence of severe hypoglycaemia was evident in
the group treated with insulin lispro (55 versus 88 episodes; p=0.087). This was
also associated with a lower incidence predominantly of nocturnal
hypoglycaemia (25 versus 47 episodes) [Ferguson et al 2001].
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The recommended time of administration of insulin lispro is immediately before
a meal, to restrict the postprandial rise in blood glucose. However, when a meal
has a high fat content (particularly fat in the solid-phase), the rate of gastric
emptying is reduced [Horowitz et al, 1991] and the absorption of glucose is
slower. In addition, gastric emptying is attenuated in many people with type 1
diabetes of long duration, in whom it may be preferable to administer insulin
lispro after the meal to provide a closer match between the time-action profile of
the fast-acting insulin and the slower postprandial rise in blood glucose. This
modification does minimise the risk of postprandial hypoglycaemia [Burge et al,
1997, Schernthaner et al, 1998, Strachan & Frier, 1998], Fast-acting insulin
analogues should be used with caution in people with overt autonomic
neuropathy, particularly those with a history of gastroparesis, where delayed
gastric emptying enhances the risk of postprandial hypoglycaemia. The
flexibility in time of injection of insulin lispro may be of benefit during
intercurrent illness and in situations where the quantity of food to be ingested
may be unpredictable, as in the routine management of very young children with
diabetes, or where the content and timing ofmeals may be unknown in advance,
e.g. meals on airline flights. Because of the rapid onset of action of insulin
lispro, the risk of early postprandial hypoglycaemia is increased by exercise;
appropriate reduction of the pre-meal dose of insulin lispro may have to be made
if postprandial exercise is contemplated [Tuominen et al, 1995],
1.10 Summary
Iatrogenic hypoglycaemia is a common problem for people with type 1 diabetes.
Despite the efforts of healthcare staff and patients to minimise the frequency of
hypoglycaemia, the problem persists because, in general, the aim of treatment is
strict glycaemic control. Even with optimal insulin therapy, some people with
diabetes will suffer from recurrent severe hypoglycaemia which leads to
significant disruption of their lives. Because of this, hypoglycaemia precludes
the maintenance of euglycaemia in people with type 1 diabetes and exposes
them to the risks of hyperglycaemia.
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CHAPTER 2




The function of the human brain depends upon the adequate delivery of glucose
as a metabolic fuel. Consequently, when the glucose concentration of the blood
is insufficient to meet the metabolic requirements of the brain, its function
deteriorates. Therefore, in addition to the study of the neuroendocrine responses
to hypoglycaemia, several investigators have examined the effect of low blood
glucose concentration on brain function. This has been done in various ways; in
addition to administering tests of cognitive function, some have examined the
neuroglycopenic symptoms generated during hypoglycaemia, whereas others
have applied electrophysiological measures such as brain-evoked potentials.
2.1.2 Studies of cognitive function during acute hypoglycaemia
Although the dramatic effects of severe hypoglycaemia were recognised soon
after the discovery of insulin [Banting et al, 1923], it was not until much later
that there was a systematic study with the use of neuropsychological testing. In
one of the first studies, Russell & Rix-Trot [1975] examined cognitive function
during insulin-induced hypoglycaemia in thirteen subjects with suspected
pituitary disease. An intravenous bolus of insulin was administered to lower the
mean blood glucose to 1.6 mmol/1 and tests of cognitive function were
compared with those found during euglycaemia. This indicated that fine motor
coordination, word recall and concentration were impaired during
hypoglycaemia [Russell & Rix- Trot, 1975],
A subsequent study by Flender & Lifshitz [1976] utilised the glucose tolerance
test in eight children, both with and without diabetes. In that study, fine motor
coordination, memory and concentration were impaired at blood glucose
concentrations between 2.9 and 3.6 mmol/1. However, these studies were not
controlled and involved a rapid change and instability in the blood glucose, thus
making it difficult to reach any firm conclusions other than that cognitive
disruption was evident.
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These difficulties were overcome by Holmes and her colleagues in a series of
studies in the 1980s. They utilised a glucose-controlled insulin infusion system
as a crude artificial pancreas to maintain blood glucose concentrations at low,
normal or high levels in subjects with type 1 diabetes. This permitted an
examination of various aspects of cognitive function during hypoglycaemia.
The level of hypoglycaemia achieved in these studies was mild, ranging from
3.1 to 3.3 mmol/1. Visual and auditory reaction times were prolonged during
hypoglycaemia [Holmes et al, 1983], there was a slowing of mental arithmetic
tests [Holmes et al, 1983], verbal fluency was impaired [Holmes et al, 1984],
and there was impaired generation of colour-name associations [Holmes et al,
1984], In a further study by Holmes and her colleagues, it was demonstrated
that simple motor and sensory skills were not affected by hypoglycaemia in
contrast to more complicated discrimination tests and choice reaction time
where a decision had to be made [Holmes et al, 1986].
Pramming et al [1986] infused insulin intravenously in 16 subjects with type 1
diabetes to progressively lower the blood glucose concentration from 6.0 to 3.0
mmol/1, and then 2.0 mmol/1 followed by a return of the blood glucose to 6.0
mmol/1, with a stable blood glucose plateau between each level. They
administered a variety of psychological tests including trail making B, finger
tapping, digit span, story recall and serial events, thus covering a wide range of
cognitive modalities. When the tests were scored, the results were presented as
a summation of all the cognitive tests administered. Three quarters of the
subjects deteriorated when the blood glucose was lowered from 6.0 mmol/1 to
3.0 mmol/1. Most of the participants deteriorated in performance between 3.0
and 2.0 mmol/1 and they all improved when the blood glucose was returned to
6.0 mmol/1 [Pramming et al, 1986].
Therefore, it was clear from these early studies that cognitive function is
impaired during acute hypoglycaemia. Since then a large number of studies
have demonstrated that moderate hypoglycaemia (2.0-3.0 mmol/1) impairs brain
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function, and the data from these studies has allowed reviewers to reach a
number of conclusions.
Firstly, many aspects of cognitive function, such as the performance of tests that
require attention, concentration, psychomotor skill, the accessing of longterm
memory and the ability to ignore distracting information, decline as the blood
glucose concentration drops below around 3.0 mmol/1 [Deary, 1993b]. It has
been noted that more profound hypoglycaemia causes a greater cognitive
impairment and that in health, a protective hierarchy exists whereby the
counterregulatory responses and symptoms of hypoglycaemia occur before the
onset of cognitive dysfunction [Schwartz et al, 1987, Mitrakou et al, 1991,
Fanelli et al, 1994],
Secondly, cognitive tasks are more likely to be disrupted at a given level of
neuroglycopenia than are simpler motor tasks. Pramming et al [1986]
demonstrated that moderate hypoglycaemia of 2.0 mmol/1 had no effect on a
simple motor task (finger tapping), whereas more complex tests, like trail
making B became impaired. In the study by Cox et al [1993b], 10 subjects with
type 1 diabetes were administered the Paced Auditory Serial Addition Test
(PASAT) to assess cognitive function, and the Finger Tapping Test (FTT) to
assess motor function, during euglycaemia and hypoglycaemia. At a blood
glucose nadir of 2.6 mmol/1 only the PASAT was disrupted [Cox et al, 1993b],
Thirdly, there is considerable inter-individual variability in the blood glucose
concentration at which brain function becomes disrupted. Widom and
Simonson [1990] demonstrated that some individuals had significant decline in
performance at blood glucose concentrations of 4.0 mmol/1, whereas others were
functioning normally at 2.2 mmol/1. In the study of reaction time by Flerold et al
[1985], 14 non-diabetic volunteers and 12 subjects with type 1 diabetes were
examined at a blood glucose concentration of 2.5 mmol/1. Whereas some
subjects showed marked prolongation of reaction times, others had small
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increases, a few showed no change, and some even improved during
hypoglycaemia.
Other investigators have observed that accuracy is often spared at the expense of
speed during hypoglycaemia. Many tests that involve speeded responses and
are more cognitively complex become impaired during hypoglycaemia. In the
study of 17 subjects with type 1 diabetes by Widom and Simonson [1990],
demanding tasks like letter cancellation, Digit Symbol Substitution Test (DSST)
and trail making were impaired at arterialised blood glucose concentrations of
2.4 to 2.8 mmol/1, whereas digit span and word recall remained unaffected.
Lastly, an important practical point for the person with diabetes is that the
recovery of cognitive function does not occur immediately on restoration of
euglycaemia. Several studies have reported delays of 45 to 90 minutes for
mental performance or electrophysiological parameters to return to normal after
a period of hypoglycaemia [Blackman et al, 1992, Lindgren et al 1996]. Recent
studies with a more robust methodology have demonstrated residual cognitive
impairment at 20 minutes [Evans et al, 2000] and 60 minutes [Fanelli et al,
2003] following restoration of euglycaemia. In a clinical study, Strachan and
colleagues examined 20 subjects with insulin-treated diabetes who had
experienced an episode of severe hypoglycaemia, and administered cognitive
tests at 1.5, 9 and 30 days after the event, comparing them with a group of
matched controls. Only one test from a large battery showed continuing
dysfunction after 1.5 days, therefore it is unlikely that severe hypoglycaemia
impairs acute mental capacity by more than 36 hours [Strachan et al, 2000].
Table 2.1 summarises the key facts that are evident regarding cognitive
disruption during acute insulin-induced hypoglycaemia.
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2.1.3 Limitations of cognitive function testing in studies of hypogiycaemia
Various authors have reviewed the main effects of acute hypogiycaemia on
cognitive performance [Deary, 1993b, Deary, 1999, Heller & Macdonald, 1996].
They have alluded to the problems of experimental design inherent in many of
these studies. In the earlier experiments, different methods of induction of
hypogiycaemia were used, with some investigators using an insulin infusion
[Russell & Rix-Trot, 1975], and others using a hyperinsulinaemic glucose clamp
[Holmes et al, 1983]. This meant that subjects in the infusion studies were
exposed to a rapid change in blood glucose and insulin concentrations, both
representing confounding variables that may have impacted on
neuropsychological testing. By contrast, the clamp studies apply a constant rate
of insulin infusion achieving high concentrations of insulin and are now the
methodology of choice in such studies. It is pertinent to note that although the
higher rates of insulin infusion have been shown to attenuate the symptomatic
and neuroendocrine responses to hypogiycaemia, they do not appear to influence
the cognitive response to comparable levels of hypogiycaemia (Kerr et al,
1991a, Fanelli et al, 1994).
One other problem with the earlier studies of hypogiycaemia was that different
methods of blood sampling were used, with some investigators reporting plasma
whereas others used whole blood glucose values. This is important for
comparison because plasma produces a glucose value around 10-20% higher
than the equivalent whole blood glucose concentration [Foster et al, 1978],
Furthermore, in studies of cognitive function, it is important to assess the arterial
blood glucose concentration, so it is now accepted practice to incorporate
sampling from a hand vein which has been warmed, either in a heated blanket or
box, to closely approximate arterialised blood [McGuire et al, 1976]. However,
many previous studies have used standard venous samples drawn from the
antecubital fossa [Heller & Macdonald, 1996],
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Concerns have also been raised regarding the different ability levels of subjects
used in studies of cognitive function [Deary, 1999] with the suggestion that
subjects with a higher intelligence may be more susceptible to the effects of
neuroglycopenia [Gold et al, 1995a]. Furthermore, other factors may affect the
cognitive response to hypoglycaemia such as age and sex and glycaemic
exposure (see later). Therefore, studies may report different results simply
because different subjects were examined.
In addition, it is often difficult to precisely identify the cognitive processes that
are being measured with neuropsychological testing, and the heterogeneity of
many of the test batteries employed make it difficult to extrapolate the results to
everyday tasks. Because of this, a lack of consensus remains as to the
appropriate tests for measurement of cognitive function [Strachan et al, 1997,
Amiel, 1998]. There remains a wide selection of tests to measure speed of
information processing, but there is considerable overlap with other cognitive
processes such as reaction time, visual sensory processing and motor
coordination. Because many of the commonly used tests of cognitive function
in hypoglycaemia are timed, and the major effect of hypoglycaemia during these
tests is on speed rather than ability, the effects of hypoglycaemia may be
overstated. Finally, because many studies have been underpowered, negative
results may have been due to type 2 statistical errors, adding a further difficulty
when trying to compare studies.
The following section will examine the evidence for deterioration of attentional
abilities, intelligence and motivation, which form the basis of this thesis, during
controlled insulin-induced hypoglycaemia.
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2.2 SPECIFIC COGNITIVE DOMAINS
2.2.1 Attention
Many investigators have used their results from experimental glucose clamp
studies to assert that attentional abilities in adults with type 1 diabetes [Holmes
et al, 1983, 1984, Harrad et al, 1985, Pramming et al, 1986, Hoffman et al, 1989,
Widom & Simonson, 1990] and in healthy volunteers [Harrad et al, 1985, Ipp
and Forster, 1987, Stevens et al, 1989, Mitrakou et al, 1991, McCrimmon et al,
1996, McCrimmon et al, 1999a, Strachan et al, 2001] are sensitive to
hypoglycaemia. However, although these studies claim to examine attention,
many have used a range of neuropsychological tests that involve attention.
Therefore, a fundamental problem with the examination of attention is that all
tests are 'contaminated' to some extent by attentional processes. Hence, because
attention is a fundamental cognitive process that is integral to many
neuropsychological tests, the isolated identification of attentional dysfunction is
a difficult undertaking.
In the study of 12 volunteers with type 1 diabetes by Holmes et al [1983], the
Matching Familiar Figures Test (MFFT) and delayed reaction time were used to
index attentional abilities. The attention to, and the performance on a reaction
time task, was slowed during hypoglycaemia. By contrast, there was no effect
of hypoglycaemia on the MFFT [Holmes et al, 1983]. Deterioration in simple
reaction time has been detected in non-diabetic subjects at blood glucose
concentrations of 2.0, 2.4 and 2.7 mmol/1 [HeroId et al, 1985, Mitrakou et al,
1991, Wirsen et al, 1992]. However, to effect this change, the degree of
hypoglycaemia has to be quite severe because Stevens and colleagues showed
no effect on a simple reaction time test at a blood glucose concentration of 3.4
mmol/1 [Stevens et al, 1989].
In a later study by Holmes and her colleagues [1984], the Stroop test [Trenerry
et al, 1989], which measures several cognitive processes including selective
attention, was administered to 12 young male subjects, aged 18 to 35 years, with
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type 1 diabetes. In that study, the Stroop task of naming dot colours and ink
colours was significantly slowed at a blood glucose concentration of 3.3 mmol/1.
In the study of 10 non-diabetic volunteers by Mitrakou et al [1991], the Stroop
test was impaired at an arterialised blood glucose concentration of 2.4 mmol/1,
but not at 3.1 or 3.7 mmol/1.
Hoffman et al [1989] administered a variety of cognitive tests to 18 subjects
with type 1 diabetes at blood glucose concentrations of 2.7, 5.6 and 16.6 mmol/1.
The Trail making B (TMB) test, in which subjects connect numbered and
labelled points in sequence, measures selective attention and divided attention in
addition to working memory, deteriorated significantly during hypoglycaemia.
This finding with the Trail making B test has been replicated by other
investigators during hypoglycaemia in non-diabetic volunteers [Stevens et al,
1989, Widom and Simonson, 1990, Mitrakou et al, 1991, McCrimmon et al,
1996, McCrimmon et al, 1999a, Strachan et al, 2001] and in subjects with type 1
diabetes [Pramming et al, 1986, Widom & Simonson, 1990]. In the study by
Ipp and Forster [1987], although TMB failed to deteriorate in seven non-
diabetics at a blood glucose concentration of 3.6 mmol/1, it was markedly
affected at a plasma glucose concentration of 2.1 mmol/1 in a substudy of four
volunteers (p<0.01).
Harrad et al [1985] administered the Farnsworth test, a measure of sustained
attention and concentration over a long period, to six control subjects and five
subjects with type 1 diabetes at blood glucose concentrations of 2.5 and 1.5
mmol/1 and at blood glucose concentrations greater than 4.0 mmol/1. In that
study, the Farnsworth test deteriorated significantly during hypoglycaemia. In a
large study of 42 subjects with type 1 diabetes, Draelos et al employed the digit
vigilance test as a measure of sustained attention and reported this to be
profoundly affected by hypoglycaemia [Draelos et al, 1995]. In this test,
subjects are given a page containing rows of digits and instructed to cancel
target digits (either the number 6 or 9). The number of targets located in 2
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minutes as well as the percentage of targets erroneously missed are scored,
providing measures of speed and accuracy. However, it is highly likely that this
test is measuring speeded processing, and this may account for the significant
deterioration in this subtest in the study by Draelos et al [1995]. Digit
vigilance has also been included in the test batteries used by others [Mitrakou et
al, 1991, Mokan et al, 1994, Fanelli et al, 1993, 1994, Veneman & Van Haeften,
1994] where overall z scores have deteriorated at plasma glucose concentrations
ranging between 2.4 and 3.0 mmol/1.
Therefore, there is a considerable weight of evidence to back the assertion that
attention-demanding tasks are impaired during moderate insulin-induced
hypoglycaemia.
2.2.2 Fluid intelligence
Very few studies of acute hypoglycaemia have included subtests specifically
designed to measure aspects of intelligence. One of the first studies to attempt
an examination of this modality administered simple arithmetic problems to
twelve people with type 1 diabetes [Holmes et al, 1983]. This demonstrated that
fewer mathematical computations were correctly completed at a blood glucose
level of 3.3 mmol/1 compared to normal and high blood glucose concentrations.
However, Holmes and her colleagues noted in their discussion that the
percentage of correct math problems to the number of problems attempted
showed no treatment or glucose effects, suggesting that the subjects had
preserved accuracy at the expense of speed during the tests as discussed earlier.
The Digit Symbol Task (DSST), a subtest of the Performance IQ scale of the
Wechsler battery of intelligence tests [Weschler & Stone, 1981] was included in
a battery of tests administered to 12 non-diabetic volunteers [Stevens et al,
1989]. In that study, the DSST showed significant impairment at an arterialised
blood glucose concentration of 3.4 mmol/1. In a further study of 20 non-diabetic
volunteers, the DSST was disrupted at arterialised blood glucose levels of 2.5
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mmol/1 [McCrimmon et al, 1996]. Similar findings were reported in the study
of 16 non-diabetic subjects by Strachan et al [2001] during moderate
hypoglycaemia (2.6 mmol/1), and in 20 healthy volunteers exposed to an
arterialised blood glucose concentration of 2.5 mmol/1 [Gold et al, 1995a].
Kerr and colleagues [1991b] examined a range of cognitive processes in nine
subjects with type 1 diabetes. There was a significant decline in scores for the
DSST at a mean arterialised blood glucose of 2.8 mmol/1. Similar findings were
described in a further two studies of subjects with type 1 diabetes at blood
glucose concentrations of 1.98 [Wirsen et al, 1992] and 2.5 mmol/1 [Gold et al,
1995a],
2.2.3 Motivation and workload
The tests of cognitive function utilised during studies of hypoglycaemia have
been criticised as being imperfect because of the perceived practice effect that
may take place, i.e. repetition of the test will improve performance [Heller &
Macdonald, 1996]. The resulting improvement results from practice and will
diminish the impairment caused by hypoglycaemia, leading to the incorrect
conclusion that cognitive function is unaffected or only modestly impaired.
Furthermore, fatigue may increase the sensitivity of cognitive tests, in that those
tests attempted at the end of a test period may be more sensitive to the effects of
hypoglycaemia [Heller & Macdonald, 1996]. It may also be difficult to
discriminate the effects of affect, or mood, from those of its cognitive and
motivational concomitants. For example, the effects of anxiety on behaviour
might be mediated by affect (e.g. tension) or by cognitions (e.g. intrusive
thoughts and worries), or by motivations, such as the urge to withdraw from the
threatening situation. Another variable is that the motivation to perform a task
may decline over the cognitive function testing period and between test days,
thereby influencing the results. Effort reduction is a common response to tasks
that have little perceived value [Hockey, 1997]. Therefore, it is surprising that
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In view of the unpleasant symptoms that are generated by hypoglycaemia, it is
surprising that the effects of acute hypoglycaemia on emotions did not receive a
rigorous research effort until the 1990s. However, early reports did suggest a
deleterious effect of hypoglycaemia on behaviour and personality [Fischer &
Dolger, 1946, Jones, 1947], and in a more recent study by Gonder-Frederick et
al [1989], low blood glucose concentrations were associated with negative mood
states such as nervousness.
In the study by Hepburn and colleagues, an insulin infusion was used to induce
hypoglycaemia in 12 non-diabetic subjects and 15 subjects with type 1 diabetes
[Hepburn et al, 1995]. A significant increase in tense arousal and a decline in
energetic arousal occurred during hypoglycaemia. In other words,
hypoglycaemia provoked a state of increased anxiety and lethargy. However, a
significant limitation of this study was the lack of a control arm, so it is possible
that the stress and fatigue associated with the tests per se may have led to the
observed changes in mood.
In two subsequent studies, a hyperinsulinaemic glucose clamp technique was
used to induce controlled hypoglycaemia, and a euglycaemic control limb was
incorporated [Gold et al, 1995c, McCrimmon et al, 1999a]. In one study, a
hyperinsulinaemic glucose clamp was used to induce hypoglycaemia in 24 non-
diabetic adults [Gold et al, 1995c]. Hypoglycaemia induced significant
increments in the scores for tense arousal with a simultaneous decrement in the
score for energetic arousal [Gold et al, 1995c]. In a further report of healthy
adult volunteers McCrimmon and colleagues used an identical study design to
demonstrate a rise in anxiety levels during hypoglycaemia. Furthermore, in both
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these studies of non-diabetic subjects, subjects became less happy (hedonic
tone) during hypoglycaemia [Gold et al, 1995c, McCrimmon et al, 1999a], In a
subsequent study, McCrimmon and colleagues demonstrated an increase in
anger scores during controlled hypoglycaemia, a finding that is compatible with
the symptom of aggression, or even frustration, that is occasionally manifest as
an expression ofhypoglycaemia in some individuals [McCrimmon et al, 1999b],
2.4 INFLUENCES ON COGNITIVE FUNCTION DURING ACUTE HYPOGLYCAEMIA
At the beginning of this chapter the substantial inter-individual differences in
mental disruption during hypoglycaemia were highlighted. A number of factors
are associated with susceptibility to cognitive disruption during hypoglycaemia
including age, gender, IQ, the diagnosis of diabetes per se, with the effects of
glycaemic control and antecedent hypoglycaemia, and a history of impaired
awareness of hypoglycaemia (table 2.2).









Impaired awareness of hypoglycaemia
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2.4.1 Age
The hierarchy of the cognitive changes in response to hypoglycaemia may
change with age. In the study of non-diabetic subjects by Matyka et al [1997]
the responses to moderate hypoglycaemia of seven elderly men were compared
with those of seven young men. The four-choice reaction time, a measure of
psychomotor coordination, deteriorated in the older men at a mean (SD) plasma
glucose of 3.0 (0.1) mmol/1 compared to 2.6 (0.1) mmol/1 in the young group,
and the abnormality was more profound (figure 2.1). Because the symptomatic
response to hypoglycaemia commenced at a lower blood glucose concentration
in the older men than in the young adults (3.0 (0.2) vs. 3.6 (0.1) mmol/1), in the
older subjects the glycaemic threshold for subjective symptomatic awareness of
hypoglycaemia and that for the onset of cognitive dysfunction was coincidental.
A similar problem has been observed in patients with type 1 diabetes who have
developed impaired awareness of hypoglycaemia, in whom the onset of the
cognitive dysfunction induced by hypoglycaemia either preceded or was
coincidental with the onset of a symptomatic response [Frier & Fisher, 1999],
This observation suggests that the elderly may be at an intrinsically greater risk
of developing neuroglycopenia because the onset of warning symptoms and
cognitive impairment occur simultaneously, so interfering with their ability to
recognise and take action to self-treat a low blood glucose.
2.4.2 Gender
In a study by Draelos et al [1995] of 20 men and 22 women with type 1
diabetes, aged 18 to 44 years, significant gender differences on two cognitive
tests during hypoglycaemia were reported. At a mean blood glucose
concentration of 2.2 mmol/1, women performed better than men on the trail
making test (p=0.02) and on the percentage of errors component of the digit
vigilance test (p=0.03). Interestingly, these tests also measure selective and
sustained attention as well as mental flexibility. No other significant gender

















The difference between the glycaemic threshold for subjective
awareness of hypoglycaemia and that for the onset of cognitive
dysfunction may be absent in the elderly. Reproduced from Diabetes in
Old Age 2nd edition, 2001 (eds AJ Sinclair and P Finucane). Copyright
2001, John Wiley & Sons Limited, reproduced with permission
2.4.3 Intelligence Quotient
It has been suggested that people with very high IQs may have a greater
disruption to mental function during hypoglycaemia than people with average
IQs. This was based on the mooted assertion that a higher intelligence might
offer protection against cerebral insult because of increased 'brain reserve
capacity' during brain processing [Maylor et al, 1990, Saltz, 1993].
In a study of 24 non-diabetic subjects, Gold et al [1995a] lowered the
arterialised blood glucose from 4.5 mmol/1 to 2.5 mmol/1. The subjects were
divided into a high IQ group (equivalent to top 30% of University students) and
average IQ group (bottom 12% of University students) on the basis of the
National Adult Reading Test (NART) and Alice 4 Heim tests. In a univariate
analysis, the average IQ group deteriorated significantly less than the higher IQ
group during hypoglycaemia in only one of 4 tasks administered (p=0.03), and
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may have been a type 1 statistical error. This was supported by the study of
Draelos and colleagues, where a higher IQ did not affect the cognitive disruption
during hypoglycaemia [Draelos et al, 1995],
2.4.4 Diagnosis of diabetes
Some investigators have suggested that a diagnosis of diabetes confers
susceptibility to cognitive dysfunction during hypoglycaemia [Wirsen et al,
1992]. In that study a battery of neuropsychological tests were administered to
ten male subjects with type 1 diabetes (median age 25 years) and 12 non-
diabetic volunteers (median age 25 years). Blood glucose concentrations were
lowered to approximately 2.0 mmol/1 in both groups. The investigators found
that the diabetic subjects performed less well in areas such as perceptual speed
and reaction times [Wirsen et al, 1992], However, the subjects with diabetes
started at a higher blood glucose concentration (5.85 vs 4.56 mmol/1) and so had
a proportionately greater fall in blood glucose, which may have affected the
results. Furthermore, both groups were from different occupational
backgrounds (the diabetics were white collar workers and the non-diabetic
subjects were medical students), and there was poor matching of pre-morbid
cognitive ability [Deary, 1993b], In two other studies, no significant
differences in cognitive dysfunction were noted between groups of diabetic and
non-diabetic subjects [Herold et al, 1985, Widom & Simonson, 1990]. Finally,
although Heller and colleagues demonstrated reaction time testing to be
significantly faster in non-diabetic volunteers compared to diabetic subjects, the
non-diabetic subjects were younger and more intelligent, two important
variables known to affect reaction time [Heller et al, 1987]. Therefore, the issue
of whether diabetes is a factor that moderates an individual's susceptibility to
cognitive dysfunction during hypoglycaemia remains unresolved.
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2.4.5 Glycaemic control, antecedent hypogiycaemia and impaired awareness
Glycaemic control
Due to the dynamic response of the glycaemic thresholds for the neurohumoral
and symptomatic response to changes in glycaemic control, it is not
unreasonable to propose that similar changes may occur with cognitive
disruption. However, there is considerable interaction between these three
areas, making it difficult to study them in isolation. Nonetheless, in the study by
Amiel and colleagues, subjects with good glycaemic control developed
electroencephalographic (EEG) changes at higher blood glucose levels than
subjects with poor glycaemic control, suggesting a dissociation between
neuroglycopenic symptoms and cognitive disruption [Amiel et al, 1991],
In a study by Widom and Simonson [1990], eight subjects with good glycaemic
control (HbAl 8.0% (0.2%)) were compared with nine subjects with poor
glycaemic control (HbAl 11.8% (0.4%)), and ten non-diabetic volunteers. A
hyperinsulinaemic glucose clamp was used to lower the plasma glucose from
5.0 mmol/1 to 2.2 mmol/1. Although an increase in the glycaemic threshold for
the symptomatic and neuroendocrine response to hypogiycaemia was observed,
there was no difference in the median glucose threshold for cognitive
dysfunction in any of the tests administered.
Maran and colleagues examined subjects with well-controlled diabetes who
reported the onset of autonomic and neuroglycopenic symptoms at blood
glucose concentrations of 2.4 and 2.3 mmol/1, whereas subjects with less strict
glycaemic control and non-diabetic individuals' responses began at significantly
higher levels, between 2.8 and 3.0 mmol/1. However, for all three groups, the
reaction time test deteriorated at blood glucose concentrations between 2.8 and
3.0 mmol/1, thus seriously disadvantaging the intensively treated group who had
the onset of cognitive deterioration before the warning symptoms of
hypogiycaemia [Maran et al, 1995]. However, in another study by Zeigler and
colleagues, seven diabetic subjects with strict glycaemic control (mean HbAlc
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6.3%) were compared with 11 with less good control (HbAlc 9.1%). In that
study, an intravenous insulin infusion was used to lower the blood glucose
concentration over a 50 minute period. The threshold for the P300 wave
occurred at a lower blood glucose concentration than the latter (1.6 mmol/1 vs
3.5 mmol/1, p<0.05) [Zeigler et al, 1992], contrary to the findings of Amiel et al
[1991]. Equivalent results were found in the study by Jones et al [1997].
Antecedent hypoglycaemia
We know that the reduced adrenaline response to hypoglycaemia following a
recent episode of hypoglycaemia lasts about 6 days (see section 1.6.5) and is
specific to that stimulus. However, does a history of antecedent hypoglycaemia
affect the cognitive response to subsequent hypoglycaemia? The available
published studies give conflicting results. Whereas Mellman et al [1994] found
that scores on the Logical Memory test in non-diabetic subjects during
hypoglycaemia were attenuated by a prior two hour period of antecedent
hypoglycaemia, Hvidberg and colleagues [1996] found no effect of antecedent
hypoglycaemia (arterialised plasma glucose of 2.6 mmol/1 for two hours) on
overall cognitive performance during a stepped hypoglycaemic clamp.
Freuhwald-Schultes and colleagues examined cognitive function during a
stepped hypoglycaemic clamp at 4.1, 3.6, 3.1 and 2.6 mmol/1 in 30 non-diabetic
volunteers over a 6 hour period [Freuhwald-Schultes et al, 2000]. 15 of the
volunteers received an additional 150 minute antecedent hypoglycaemic clamp
on the preceding day. In that study, following antecedent hypoglycaemia, there
was attenuation not only of the amplitude of the P3 of the auditory-evoked brain
potential, but also in a test of short term memory and reaction time.
The findings in three studies of subjects with type 1 diabetes are also
conflicting. In the study of 15 subjects with type 1 diabetes, Dagago-Jack
[1993] found that scores for attention were actually worse during moderate
hypoglycaemia following a period of antecedent hypoglycaemia the day before.
In a further study of eight diabetic subjects, George et al [1995] confirmed no
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effect of antecedent hypoglycaemia on the glycaemic threshold for impairment
of four-choice reaction time during hypoglycaemia, despite a blunted
catecholamine response. Ovalle et al [1998] induced twice weekly
hypoglycaemia (plasma glucose of 2.8 mmol/1 for two hours) in six diabetic
subjects for one month. In a subsequent stepped hypoglycaemic clamp, there
was less deterioration in cognitive function despite an expected blunting of the
symptomatic and neurohumoral responses to antecedent hypoglycaemia.
Most insulin regimens cause nocturnal hyperinsulinaemia and predispose to
nocturnal hypoglycaemia which occurs in up to 50% of people treated with
insulin, is asymptomatic in 25-75% of episodes and may last for up to six hours
[Tattersall, 1999]. Two studies have examined the cognitive effects of
antecedent nocturnal hypoglycaemia [Veneman et al, 1993, Fanelli et al, 1998].
In the first study of 10 non-diabetic subjects, a lowering of the plasma glucose to
2.4 mmol/1 for two hours on the day prior to study, lessened the degree of
cognitive disruption during subsequent hypoglycaemia the following day. In a
study of 15 subjects with type 1 diabetes, Fanelli and colleagues found that
antecedent hypoglycaemia of 2.8 mmol/1 for 3.5 hours reduced overall cognitive
function during subsequent hypoglycaemia the following day [Fanelli et al,
1998].
This important topic would not be complete without reference to the
extraordinary experiment by Boyle and colleagues where brain glucose uptake
(BGU), the neuroendocrine response and cognition were examined in 12 non-
diabetic humans during two stepped glucose clamps, at glucose concentrations
of 4.2, 3.6, 3.1 and 2.5 mmol/1 [Boyle et al, 1994]. Between the two clamps, the
blood glucose was maintained at 2.9 mmol/1. Although BGU was impaired at a
blood glucose concentration of 3.6 mmol/1 on the first clamp, it was not
impaired at any level after 56 hours of hypoglycaemia. As expected, the onset
of the neuroendocrine and symptomatic response occurred at lower levels of
blood glucose in the second clamp. However, decrements in two out of four
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cognitive tests were delayed following 54 hours of hypoglycaemia [Boyle et al,
1994]. Although these results suggest a comprehensive cerebral response to
antecedent fuel supply, this alteration in cognitive threshold did not occur after a
shorter period of sustained hypoglycaemia [Gold et al, 1995d]. Furthermore,
there was no control for practice effects and there were no statistical interaction
analyses between clamps, thus making it easier to find a sham effect in line with
the experimental hypothesis.
Impaired awareness of hypoglycaemia
Few studies have evaluated how a diagnosis of impaired awareness of
hypoglycaemia impacts on cognitive disruption during hypoglycaemia.
Furthermore, the study of this important area is hindered by a lack of consensus
definition of impaired awareness of hypoglycaemia, by the aforementioned
considerable interrelation with strict glycaemic control and antecedent
hypoglycaemia, and by the lack of a consensus agreement on a validated battery
of cognitive tests for use in hypoglycaemia.
In the study by Gold et al [1995b], a self-rating scale was used to measure
impaired awareness in which subjects scored how often they had symptoms
during spontaneous hypoglycaemia. In that study, the subjects with impaired
awareness appeared to show more profound cognitive disruption during acute
hypoglycaemia, which persisted for longer following blood glucose recovery.
By contrast, in an earlier study of 11 subjects type 1 diabetes with impaired
awareness of hypoglycaemia and four with normal awareness, there was no
difference in cognitive performance as assessed by four-choice reaction time
[Heller et al, 1987],
An alternative mode of examining this process is by testing cognitive function
following restoration of awareness of hypoglycaemia, by avoidance of
hypoglycaemia. In the study by Fanelli et al [1993], this was associated with a
rise in the blood glucose threshold for cognitive dysfunction from 2.5 to 3.0
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mmol/1. However, in another study of 12 subjects with type 1 diabetes, half
with good control and half with poor control, hypoglycaemia was avoided for a
period of three weeks. Although the glycaemic thresholds for hormonal and
symptomatic responses to hypoglycaemia were raised during a stepped
hypoglycaemic clamp, the threshold for cognitive disruption remained
unchanged at 2.8 mmol/1 [Cranston et al, 1994],
2.4.6 Adaptation to hypoglycaemia
Patients who have impaired awareness of hypoglycaemia frequently record
biochemical hypoglycaemia, which is asymptomatic, suggesting the
development of an adaptation to neuroglycopenia. Therefore, the impact of the
duration of hypoglycaemia on cognitive function has been examined in a
number of studies. In the study of 24 non-diabetic subjects by Gold et al
[1995d], short term exposure (40-60 minutes) to moderate hypoglycaemia (2.5
mmol/1) led to no improvement in cognitive function and no reduction in
symptom scores. By contrast, two earlier studies in subjects with [Kerr et al,
1991b] and without diabetes [Kerr et al, 1989], showed an improvement in tests
of cognitive function after a period of 60-90 minutes. However, in these two
studies, no direct statistical comparisons were made between euglycaemia and
hypoglycaemia, and there was evidence of a practice effect on the reaction time
task used, whereas the Edinburgh study controlled for both of these variables
[Gold et al, 1995d]. In a more recent study, cognitive function was assessed
(using four-choice reaction time, Stroop word and colour-word test) repeatedly
using a hyperinsulinaemic glucose clamp in eight non-diabetic volunteers.
During moderate hypoglycaemia (arterialised plasma glucose of 2.6 mmol/1) for
90 minutes, there was no attenuation of the hormonal, symptomatic or cognitive
responses during sustained hypoglycaemia [Evans et al, 2000], thus supporting
the earlier results found by Gold and colleagues [Gold et al, 1995d],
The possibility that a longer duration of hypoglycaemia would lead to cerebral
adaptation was suggested in the study by Bendtson and colleagues, where no
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cognitive impairment was identified after severe nocturnal hypoglycaemia
[Bendtson et al, 1992]. In the experiment by Boyle and colleagues of non-
diabetic volunteers who were subjected to a prolonged period of hypoglycaemia
for 56 hours, BGU was prolonged after chronic hypoglycaemia, and the
glycaemic thresholds for the neuroendocrine, symptomatic and cognitive
responses to hypoglycaemia were increased, suggesting an effect of cerebral
adaptation during chronic neuroglycopenia [Boyle et al, 1994], However, in
that study the degree of hyperinsulinaemia was uncontrolled and may have had a
direct effect on cerebral function [Kerr et al, 1991a].
2.5 Summary and clinical importance of cognitive disruption during
hypoglycaemia
Acute hypoglycaemia, of the depth and duration often experienced by patients
with type 1 diabetes, causes cognitive dysfunction. This develops at around 3.0
mmol/1 and affects many aspects of cognition including attention-demanding
tasks, mental flexibility, psychomotor skill and long-term memory. Non-
cognitive disruption during hypoglycaemia promotes an expression of negative
mood states including diminished energetic arousal, decreased happiness,
increased anxiety and increased anger. A hierarchy exists in the sensitivity of
different aspects of cognition, with complex tasks being more severely impaired
than simpler cognitive tasks. Accuracy of tasks is often preserved at the
expense of speed.
Although a pronounced inter-subject variability is apparent for the blood
glucose thresholds at which impairment of particular cognitive tasks commence,
the precise moderators of cognitive dysfunction remain unclear. While older
people and men may be more susceptible to cognitive disruption during
hypoglycaemia, the available evidence suggests that current intelligence and the
diagnosis of diabetes per se do not moderate the response. The complex
interrelation of glycaemic control, antecedent hypoglycaemia and impaired
awareness is a highly contentious area and remains unresolved. Whereas some
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commentators hold the view that cognitive dysfunction is not affected by
antecedent hypoglycaemia, an increasing number of studies suggest that the
glycaemic threshold is indeed raised, similar to the neuroendocrine and
autonomic symptom response [Veneman et al, 1993, Ovalle et al, 1998, Fanelli
et al, 1998, Freuhwald-Schultes, 2000]. Much of the controversy is related to
methodical differences between studies pertaining to the heterogeneity of the
subjects, sample sizes and the neuropsychological tests used.
Short-term cerebral adaptation to hypoglycaemia does not occur but is a
maladaptive response to more prolonged hypoglycaemia, predisposing the
individual to severe hypoglycaemia. During prolonged hypoglycaemia, brain
glucose uptake is promoted through the upregulation of GLUT1 and GLUT3
molecules [Kumagai et al, 1995]. This enhanced central glucose uptake during
hypoglycaemia may prevent neuroglycopenia, thereby reducing cognitive
dysfunction during hypoglycaemia. Alternatively, the weakened
neuroendocrine response after antecedent hypoglycaemia, through the effects of
Cortisol release, may contribute to the attenuation of cognitive disruption.
Importance and validity of cognitive dysfunction during hypoglycaemia
Are the cognitive changes during acute hypoglycaemia of consequence and
valid? It is widely recognised that there is a need to study the effects of
hypoglycaemia on brain function so that clinical practice may be better
informed. Although various general psychometric tests and tests of reaction
time have confirmed the existence of cognitive dysfunction during acute
hypoglycaemia, in terms of specificity, they are analogous to the erythrocyte
sedimentation rate used in general medicine. Further research is required to
elucidate the specific psychological processes affected by hypoglycaemia.
Understanding these processes provides information that will be useful to
diabetes educators and policy makers. Moreover, further research needs to
demonstrate that impairments in laboratory cognitive tasks have a bearing on
mental performance in important practical and work-related abilities.
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Driving simulator studies have demonstrated impairment of driving skills during
moderate hypoglycaemia (2.6 mmol/1) [Cox et al, 1993c] and mild
hypoglycaemia (3.4-4.0 mmol/1) [Cox et al, 2000]. In the earlier study by Cox
et al [1993c], during hypoglycaemia, more than one third of individuals with
type 1 diabetes demonstrated more spinning, swerving, time off the midline and
the road. In keeping with earlier observations about accuracy preservation at the
expense of speed, there was more very slow driving. In the later study, it was
worrying that subjects were generally unaware of their poor driving skills and
that the mean glucose level at which they took corrective action was 2.7 mmol/1
[Cox et al, 2000]. Although these studies are useful, they have been criticised
for not being relevant to real driving experience.
An alternative strategy to assess the importance of cognitive dysfunction during
hypoglycaemia is the investigation of the more basic brain processes and human
information processing. A preliminary examination of language function was
carried out by Holmes and colleagues who demonstrated impairment of verbal
fluency [Holmes et al, 1984], More recent studies have shown that although
acute hypoglycaemia has no effect on visual acuity or stereoscopic vision in
non-diabetic subjects [McCrimmon et al, 1996], it does disrupt visual
information processing using measures of visual inspection time, simple visual
discrimination and the speed of transfer of visual information to decision¬
making processes [Ewing et al, 1998]. In a further study of 15 adults with type
1 diabetes, the same investigators found that moderate hypoglycaemia
(arterialised blood glucose of 2.6 mmol/1) caused deterioration in single tone
loudness and in auditory temporal processing [Strachan et al, 2003].
In Chapters 6 and 7 of this thesis the results of original research will be
presented that used a batch of tests specifically designed to assess attentional
processes and intelligence. In Chapter 8, new data will be reported on tests of
workload and subjective cognition both of which are two important areas that
have not been studied previously in hypoglycaemia.
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CHAPTER 3
ATTENTION, MOTIVATION AND INTELLIGENCE
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3.1.1 The concept of attention
The concept that attention is central to human performance has been recognised
in experimental psychology for more than a century [James, 1890]. However, it
was not until relatively recently that developments in neuroscience revealed a
system of anatomical areas that appear to be basic to the selection of information
for focal, or conscious, processing [Wurtz et al, 1980, Raichle, 1983]. Although
knowledge of the precise neural mechanisms responsible for these operations is
still incomplete, many of the brain areas and networks involved have been
identified. Furthermore, there is evidence that damage to some of these
networks produces similar symptoms regardless of whether the cause is
cerebrovascular disease, psychopathology or developmental [Posner & Cohen,
1994]. Therefore, it is now recognised that attention is a complex mental ability
involving multiple subcomponent processes [Posner and Peterson, 1990], and
several independent attention systems in the brain serve different functions.
Although all neurons are selective in the range of activation to which they will
respond, the role of the attention system is to modulate this selection for those
types of stimuli that might be most important at a given moment. Three
fundamental findings can be attributable to attention. Firstly, the attention
system of the brain is anatomically separate from the data processing systems
that perform operations on specific inputs even when attention is directed
elsewhere. Therefore, although the attention system interacts with other parts of
the brain, it maintains its own individuality. Secondly, attention is not the
property of a single centre in the brain, nor a general function of the brain in its
entirety, i.e. attention is carried out by a network of anatomical areas [Mesulam,
1981, Rizzolatti et al, 1985], Finally, the areas involved in attention carry out
different functions [Posner et al, 1988],
The attentional processes that have been studied most frequently involve
focusing, selecting, dividing, sustaining, suppressing, and inhibiting attention.
Although no dominant theory can integrate all of these components within a
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unifying framework, several models have been proposed that support the
concept of fractionation of attention into different supramodal systems each of
which has a distinct neuroanatomical basis [Posner & Peterson, 1990]. Using
the concept that attention is fractionated into different supramodal systems, it
has been proposed that attention consists of at least three separate systems
[Posner & Peterson, 1990]. A selection system is responsible for selecting
relevant stimuli/processes and inhibiting irrelevant ones, a vigilance system
maintains readiness to respond in the absence of external cues and an orientation
system is responsible for engaging, moving and disengaging attention in space.
3.1.2 Attentional systems
Orientation system
The sensory responses of neurons in several areas of the brain have been shown
to discharge at a greater rate when the orientation system is engaged. For
example, when a monkey is directed to a specific location, as opposed to some
other random spatial location, three areas of enhancement occur within the
brain; the posterior parietal lobe [Mountcastle, 1978, Wurtz et al, 1980], the
lateral pulvinar nucleus of the postereolateral thalamus [Petersen et al, 1987],
and the superior colliculus. Similar effects in the parietal cortex have been
shown in normal humans using positron emission topography [Petersen et al,
1988a]. Likewise, when people are asked to move their eyes towards a specific
target, an improvement in efficiency at the target location occurs well before the
eyes move [Remington, 1980], and it is thought that this covert shift of attention
functions as a way of guiding the eye to an appropriate area within the visual
field [Fischer & Breitmeyer, 1987, Posner & Cohen, 1984],
As you might expect, brain injury to any of the mentioned three areas in humans
causes a reduction in the ability to shift attention covertly [Posner, 1988],
although the deficit produced varies between areas. For example, damage to the
posterior parietal lobe has its greatest effect on the ability to disengage from an
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attentional focus [Posner & Cohen, 1984], whereas a lesion of the superior
colliculus results in an inability to shift attention.
Selection system
Studies of attention have shown that detecting a target produces widespread
interference with most other cognitive processes [Posner, 1978]. However,
monitoring many spatial locations or modalities produces little or no
interference over monitoring a single modality, unless a target occurs [Duncan,
1980]. This finding supports the distinction between a general alert state and
one in which attention is clearly orientated and engaged in processing
information. Petersen et al [1988b] have shown that the anterior cingulate gyrus
and the supplementary motor area are active during the processing of words.
Further evidence to support the concept that the anterior cingulate is involved in
target detection comes from Posner et al [1988] who demonstrated that the
degree of blood flow in the anterior cingulate increases as the number of targets
to be detected increases.
Vigilance system
An important attentional function is the ability to prepare and sustain alertness
to process high priority signals. Anatomical evidence has accumulated on the
nature of the systems producing a change in the alert state. A consistent finding
is that the ability to develop and maintain the alert state depends heavily upon
the integrity of the right cerebral hemisphere [Heilman et al, 1985]. This fits
very well with the observation that patients with right hemispheric lesions show
signs of neglect, and that performance in vigilance tasks is more impaired with
right rather than left lesions [Coslett et al, 1987, Wilkins et al, 1987],
Furthermore, it has been noted in split-brain patients that vigilance is poor when
information is presented to the isolated left hemisphere, but is relatively good
when presented to the isolated right hemisphere [Diamond & Beaumont, 1973].
In addition, cerebral blood flow and metabolic studies also argue for a link
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between the right cerebral hemisphere and the vigilance system [Cohen et al,
1988, Deutsch et al, 1987],
Neuropathological observations have indicated that the brain is susceptible to
neuroglycopenia in a rostrocaudal direction with the cerebral cortex and
hippocampus being most sensitive [Auer et al, 1984], Acute insulin-induced
hypoglycaemia promotes a redistribution of regional cerebral blood flow and
radioisotope labelled neuroimaging has shown that the blood flow to the frontal
and parietal lobes increases during acute hypoglycaemia in non-diabetic adults
[Tallroth et al, 1992]. Similarly, MacLeod et al [1994] reported increments in
relative cerebral blood flow to both superior frontal cortices and the right
thalamus, and significant decrements to the right posterior cingulate cortex and
the right putamen in subjects with type 1 diabetes. The susceptibility of the
frontal areas of the brain to hypoglycaemia has been shown by other tests,
including electroencephalography [Harrad et al, 1985, Pramming et al, 1988,
Tamburrano et al, 1988, Tallroth et al, 1990, Bendtson et al, 1991], and
neuropsychological tests. The vulnerability of the frontal lobes to acute
hypoglycaemia is important, as this part of the brain has been implicated in the
performance of tasks requiring attention. Neuroimaging with Positron Emission
Tomography (PET) in normal humans has provided evidence of neuro-
anatomical localisation for these attentional processes. The blood flow to the
frontal lobes is increased during the performance of many different tasks that
require sustained attention [Deutsch et al, 1987, Cohen et al, 1988, Pardo et al,
1991]. Furthermore, adults who have sustained damage to their frontal lobes
exhibit deficits on tasks that require sustained attention [Salmaso & Denes,
1982, Wilkins et al, 1987, Richer et al, 1993, Rueckert & Grafman, 1996]. With
respect to selective attention, activation of the anterior cingulate gyrus of the
frontal cortex has been demonstrated during performance of the Stroop Test
[Pardo et al, 1990, Bench et al, 1993],
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3.1.3 The Test of Everyday Attention
The Test of Everyday Attention (TEA) is a cognitive test battery that gives a
broad-based measure of the most important clinical and theoretical aspects of
attention. It consists of eight subtests and can be used analytically to identify
patterns of attentional breakdown. The TEA was devised from the evidence on
separable attention systems in the brain [Posner & Peterson, 1990] and it was
developed to improve existing methods of assessing attentional problems. The
TEA attempts to measure aspects of the selection and vigilance systems of
attention and correlates significantly with existing measures of attention
[Robertson et al, 1994], It gives a broad-based measure of the most important
clinical and theoretical aspects of attention and can be used analytically to
identify patterns of attentional breakdown. Moreover, it is the only test of
attention based largely on everyday materials and the real-life scenario means
that most patients enjoy the test and find it relevant. It yields standardised and
reliable scores that allow valid comparisons in terms of selective attention,
sustained attention and attentional switching.
During the standardisation and validation of the TEA, an age-, sex-, and IQ-
stratified sample of 154 normal participants were given these tests, along with a
number of existing tests of attention [Robertson et al, 1996]. The factor
structure revealed by these data matched well contemporary evidence for a set
of functionally independent attentional circuits in the brain, and included factors
for sustained attention, attentional switching, selective attention and auditory-
verbal working memory. The TEA was developed and standardised on the basis
of these subtests, was shown to have high test-retest reliability, and correlated
significantly with existing measures of attention [Robertson et al, 1996]. The
discriminative validity of the TEA subtests has been confirmed in closed head
injury patients [Chan et al, 2000].
The individual TEA subtests are described in detail in section 5.2.2.
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3.2 INTELLIGENCE
3.2.1 General cognitive ability
Individuals differ from one another in their ability to understand complex ideas,
to learn from experience, and to engage in various forms of reasoning. It is well
recognised that differences in mental abilities have a hierarchical structure at the
top of which rests g, or general cognitive ability [Carroll, 1993], g is often the
best practical predictor obtainable from a battery of mental tests accounting for
up to half of the variance in test scores [Deary, 1998]. Spearman [1927a,
1927b], a British psychologist, in 1904, first noted that although a person may
do relatively better on one subtest than another, those who score highly on one
such subtest will likely be above average on others as well. Using factor
analysis, these complex patterns can be clarified and a correlation coefficient - r
- defined. The value of r measures the degree of relationship between two sets
of scores, by assessing how well one of them could be used to predict the value
of another. Spearman inferred that these correlations could be explained if there
were some underlying common, or 'general' factor - g - in mental ability.
Therefore, g refers to a statistical correlation, or a broad general factor that
accounts for a portion of the variance of scores over a great variety of
intellectual tasks.
However, while tests of general intelligence and g have high predictive values
within the academic arena, their predictive validity becomes much smaller in
other areas much more difficult to measure such as initiative, leadership and the
ability to communicate effectively [Taylor, 1976, Guilford, 1977]. For example,
tests of g have a predictive validity of around .3 in occupational performance,
thus accounting for only about 10% of the variance [Cook, 1998, Hunter &
Hunter, 1984],
Although the former discussion is relatively easy to grasp, there has been
considerable debate among psychologists as to the true meaning of g.
Therefore, Thomson in 1939 described it as a mere statistical regularity
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[Thomson, 1939], Spearman as a 'kind of mental energy' [Spearman, 1927a,
1927b], and others as a generalised abstract reasoning ability [Gustafsson, 1984]
or an index measure of neural processing speed [Reed & Jensen, 1992]. While
alternative theories of intelligence exist, e.g. Gardner's theory of 'multiple
intelligences' [Gardner, 1983] or Robert Steinberg's [1985] triarchic theory
which proposes three fundamental aspects of intelligence - analytic, creative,
and practical - the g based factor hierarchy is the most widely accepted current
view of the structure of abilities, with g at the apex and various more specialised
abilities arrayed beneath [Jensen, 1980].
Tests that correlate highly with g are complex, and require problem-solving
analysis and rule inferring, such as Raven's Progressive Matrices [Raven, 1958].
The two main components of general cognitive ability that Raven sought to
measure directly were previously identified by Spearman in 1923. These are
eductive ability and reproductive ability. The Raven's Progressive Matrices are
made up of a series of designs with a part missing, and measure eductive ability.
The subjects taking the tests select the correct part to complete the designs from
a number of options that are printed beneath. The Mill Hill Vocabulary Scale
was designed to discriminate between people's knowledge of, and ability to
replicate, verbal knowledge and concepts, and is a measure of reproductive
ability.
Eductive ability
The term eductive is derived from the Latin educere, which means 'to draw out'
and refers to the ability to make meaning out of confusion, and to generate high-
level, usually non-verbal, paradigms, which make it easier to handle complex
situations and events. This is also known as 'fluid intelligence' and reflects the
capacity to solve unfamiliar problems, i.e. the individual must approach a new
problem (which more often than not is non-verbal in nature) in a novel way, and
reach a solution quickly, analogous to thinking under pressure. These reflect the
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abilities required by children in developing a sense of the unwritten rule of
language.
To understand the concept of eductive ability, it is useful to examine how
Spearman viewed this. Spearman noted that the initial detection of any problem
requires a contextual perception. Therefore, when we approach a problem, we
form a perceptual pattern or structure in our minds. This does not only apply to
pictorial material because the immediate recollection after reading a piece of
material is often only a concentrated awareness of its essence, rather than any of
its parts. Next, if we are interested in the material, we may develop a sense of
its implications in excess of its actual content. Following this we move on to
analyse the condition, which may reveal a problem that needs to be solved, e.g.
a part missing in the RPM. This analysis needs more than an overall perception
of the problem; one has to be able to investigate and decide what is important to
attend to within the problem as a whole. The RPM also measure the ability to
educe relationships, so that as each set of problems are presented the
relationship of the past with the present has to be recognised to obtain the
correct answer. Thus, eductive behaviour demands a perceptive process which
involves problem solving after examining all the available preceding evidence.
Importantly, such processes are often non-verbal, depending on flashes of
insight which are often too rapid for assimilation into language. For example,
Broadbent & Aston [1978] showed that the ability to manage a complex
computer simulation of the British Economy was unrelated to the ability to
answer questions on it.
Reproductive ability
Reproductive ability, also known as crystallised intelligence, is the capacity to
absorb, recall, and reproduce information that has been made clear and
expressed between people. In other words, it replicates education- and
experience-based knowledge; it tends to be a well-practised, highly learned
knowledge, and is also likely to be largely verbal in nature.
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However, although reproductive and eductive abilities are very different, they
do interact considerably; perception and thought are generally dependent on
acquired constructs, and the ability to absorb information is often dependent on
being able to make meaning out of a confused area of discourse. In other words,
eductive ability enables us to develop understanding, whereas the verbal
competence of reproductive ability is needed to translate the understanding into
words. Unsurprisingly, diffuse brain damage is far more likely to affect 'fluid
intelligence' or eductive ability, than other aspects of cognition. By contrast,
abilities that are concerned with stored information and knowledge, or
reproductive ability, are more resistant to the effects ofmild brain damage.
It is important to clarify a major point. Although the RPM are generally
regarded as an excellent measure of g, this does not necessarily reflect general
academic ability. The latter is defined by tests that assess the ability to recall
factual information, i.e. tests of reproductive ability, rather than tests that
measure critical thinking, judgement, or a readiness to find and sift through
evidence. Therefore, people who can generate new insights and ideas may have
difficulty verbalising these thoughts and concepts and hence struggle with
standard tests of academic ability. Consequently, using the RPM to select
students for academic subjects may not be appropriate because the chosen
students may not excel in that type of subject. The next section briefly outlines
the large body of research that has been performed on the Standard Raven's
Progressive Matrices over the last 70 years.
3.2.1 The Standard Raven's Progressive Matrices
Standardisation of the RPM
Following the introduction of the Standard RPM in the mid-1930s, it was
revised and standardised in 1938 [Raven, 1941], Extensive adult norms were
collected during the Second World War, and the test was standardised on
schoolchildren in 1943 [Raven & Walshaw, 1944], Further data accrued on old
people in the 1940s [Raven, 1948] and, during the Fifties and Sixties, checks
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were run on the accuracy of norms [Adams, 1952], Since then, local norming
studies have been carried out in schoolchildren in various countries including
Britain and Ireland, North America, Germany, New Zealand and Australia.
Additional, new adult norms were collected in China and Belgium in the mid
Eighties, and in Scotland and Iowa in the early Nineties. Therefore, the
Standard RPM are an extensively studied and standardised test of cognitive
ability [Raven et al, 1996],
Reliability of the RPM
Over forty studies dealing with the reliability of the RPM have been reported.
In addition to studying normal populations, they cover a wide age-range, many
cultural groups and clinical populations. Overall, the general picture is of good
reliability, in terms of internal consistency and retest reliability. For example, in
the 1979 British Standardisation of the RPM, the correlations between the item
difficulties established separately for eight socio-economic groups ranged from
.97 to .99 [Raven et al, 1996]. The correlations between the item difficulties
established separately in the UK, US, Germany, New Zealand, and Chinese
standardisations range from .98 to 1.00. Therefore, the RPM are extremely
robust and measures the same factor in a wide range of cultural, socio¬
economic, and ethnic groups [Raven et al, 1996].
Validity of the RPM
The Standard RPM have shown reliable correlations with concurrent
intelligence measures for English speaking children. For example, correlations
of SPM with the Binet and Wechsler Scales, traditional measures of general
intelligence, range from .54 to .86 [Raven et al, 1996], Inter-test correlations for
adult subjects are similar in magnitude and pattern to those outlined for children
[Raven et al, 1996],
As previously noted, correlations between SPM and performance on
achievement tests or academic achievement are generally lower than
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correlations with intelligence tests, ranging from negligible to very high [Raven
et al, 1996]. The Standard RPM are described in detail in section 5.2.3.
3.3 MOOD, CONATION (MOTIVATION) AND COGNITION
3.3.1 The Trilogy of Mind
Psychology has traditionally identified and studied three components of mind;
cognition, affect (mood) and conation (motivation). However, the distinction
between cognition, conation and affection in psychology is regarded as a matter
of emphasis rather than a true division because all human behaviour, especially
learning and achievement, involves some mixture of all three aspects [Hilgard,
1980], The interaction between these domains can be problematical because it
may be difficult to differentiate the effects ofmood from those of its cognitive
and emotional components. For example, the effects of state anxiety on
behaviour may be mediated by mood, e.g. tension, or by cognitions, e.g.
intrusive thoughts and worries [Zeidner, 1998], or by motivations, such as the
urge to withdraw from the threatening situation [Geen, 1987].
Briefly, cognition refers to the process of how we acquire and understand
concepts, including encoding, storing, processing and retrieving that
information. Affect refers to the emotional interpretation of perceptions,
information or knowledge, and is generally associated with attachment, positive
or negative, to people, objects or ideas. In the affective domain, mood states
provide a background context for psychological functioning, and impinge on
different functions such as memory and attention [Matthews, 1992]. In terms of
an organisational structure within the trilogy of mind, conation is placed
'between' the cognitive and affective domains, with motivation and volition
forming a continuum within the conative category [Kuhl & Beckman, 1994].
Traditionally, conation had received limited research attention because it is
entwined within the study of other cognitive domains so it is difficult to separate
[Snow, 1989], For example, the Wechsler scales of intelligence include a
conative component [Cooper, 1997, Gregory, 1998]. Generally, conation
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reflects the motivational and volitional aspects of human behaviour. Motivation
is an internal state or condition that serves to activate or strengthen behaviour
and give it direction and refers to the intentional and personal motivation of
behaviour [English & English, 1958]. Therefore, it is planned, deliberate and
goal-oriented. It is a proactive, as opposed to reactive or habitual, aspect of
behaviour [Emmons, 1986], Conation is closely associated with the concept of
volition, defined as the use of will, or the freedom to make choices about what
to do [Kane, 1985]. For that reason, conation is absolutely critical if an
individual is to successfully engage in self-direction and self-regulation.
3.3.4 The Dundee Stress State Questionnaire
The Dundee Stress State Questionnaire (DSSQ) was developed as a
comprehensive assessment of subjective states in performance contexts
[Matthews et al, 1999]. It consists of 77 items that yield 10 factor-analytically
determined scales under the headings of energetic arousal, tense arousal,
hedonic tone, intrinsic task motivation, self-focused attention, self-esteem,
concentration, confidence and control, task-relevant interference and task-
irrelevant interference. The affective items within the DSSQ refer to diffuse
moods, the motivation items to the pressures that instigate performance-related
behaviour, and the cognitive items refer to self-referent beliefs and styles of
thought. The instructions for the DSSQ emphasise the rating of immediate
rather than typical subjective experience, thus ensuring reporting of states rather
than traits [Matthews et al, 1999]. The main motivation dimension measured by
the DSSQ relates to intrinsic motivation, which is the extent to which the person
is motivated by interest and engagement in task content. Regarding the
application of the DSSQ, the scales appear to have a variety of desirable
psychometric properties including a sound factor-analytic basis, high internal
consistency, moderate test-retest stability, and generality of properties across
two Western cultures [Matthews et al, 1999].





4.1 Acute hypoglycaemia and attentional dysfunction
As described in Chapter 2, the effects of acute neuroglycopenia on cognitive
function are well documented. However, the cognitive tests employed during
these studies have been criticised for a lack of specificity and applicability to the
activities of daily life undertaken by people with type 1 diabetes. Although it is
well known that cognitive tests typically engage several putative mental
processes, very little detailed information is available on the effects of
controlled hypoglycaemia upon the specific information processing abilities of
the brain. Therefore, it is recognised that further research needs to demonstrate
that impairments in laboratory cognitive tasks have a bearing on mental
performance in real life.
In study 1, 20 healthy volunteers were studied whereas in study 2, 16 subjects
with type 1 diabetes were examined. A within subjects, counterbalanced test
design examined the effects of acute hypoglycaemia on sustained attention,
attentional switching, visual and auditory selective attention and auditory-verbal
working memory. Although previous investigators have attempted to
demonstrate attentional problems during acute hypoglycaemia using
psychological tests, the data derived from these studies is the first to assess
dysfunction of subdivisions of attention during hypoglycaemia using a test
battery designed specifically to measure attention. The study hypothesis was
that complex attentional tasks would deteriorate during hypoglycaemia, while
simple tasks e.g. sustained attention, would be preserved.
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4.2 Does acute hypoglycaemia impair non-verbal reasoning?
General intelligence is a key finding and theoretical construct in the
psychometric structure of human abilities and is an important influence on many
everyday activities. Although a deterioration in aspects of intelligence has been
observed during acute hypoglycaemia, both in non-diabetic subjects [Stevens et
al, 1989, McCrimmon et al, 1996] and in people with diabetes [Kerr et al,
1991b, Holmes et al, 1983, Ewing et al, 1998], few studies of non-diabetic or
diabetic adults have included subtests that were designed specifically to measure
aspects of non-verbal reasoning.
20 healthy volunteers (study 1) and 16 subjects with type 1 diabetes (study 2)
are described. An identical study design examined the effects of acute
hypoglycaemia on general fluid intelligence (non-verbal intelligence). An
acknowledged key test of this ability (RPM) was used with the hypothesis that
acute hypoglycaemia would lead to a significant deterioration in this important
modality.
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4.3 Does motivation and subjective emotion moderate the degree of cognitive
dysfunction during hypoglycaemia?
Although many aspects of cognitive function have been examined during acute
hypoglycemia, the subjective feelings that are generated by acute hypoglycemia
experienced during task performance have not been studied. For example, style
of thinking and beliefs, such as self-esteem, concentration, and control and
confidence, in relation to tasks has not been examined (i.e. subjective cognition).
Similarly, few studies have examined the non-cognitive changes in cerebral
function that occur during acute hypoglycaemia including the influence on
emotions (affect, mood). The conative aspect of mind has not been explored
during hypoglycemia and no studies have examined either the role of motivation
on the performance and outcomes of controlled studies of hypoglycemia, or the
perception ofworkload during the tasks administered.
16 subjects with type 1 diabetes are described in study 3. Using a within
subjects, counterbalanced test design, a validated test (DSSQ) measured mood,
motivation and cognition before and after the transient stress of acute
hypoglycaemia. This provided original data with the hypothesis that acute
hypoglycaemia would have a negative impact on mood and motivation during
these tests, thus allowing interpretation of the results of other such studies more
broadly. In addition, it was surmised that acute hypoglycaemia would lead to a
deterioration on subjective aspects of cognition.
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4.4 Post-prandial hypoglycaemia - effect of timing of insulin administration
Insulin lispro is a fast-acting analogue of human insulin which is usually
injected immediately before meals to avoid inducing preprandial
hypoglycaemia. However, a delayed rise in postprandial blood glucose or a
reduced magnitude of the glycaemic response to food may increase the risk of
early postprandial hypoglycaemia.
12 subjects with type 1 diabetes were examined in study 4. The design was an
open-label, randomised comparative study of the post-prandial glucodynamics
of the insulin analogue, lispro, when administered either 5 minutes pre-
prandially or 20 minutes after the commencement of a high fat/high solid phase
meal. The aim of the study was to examine the effect of either pre- or post¬
prandial administration of insulin lispro on the pharmacodynamics of blood
glucose following the consumption of a high fat, solid-phase meal, which is
popular in the UK and is often consumed by many people with type 1 diabetes.
The principal objective was to determine the optimal time of administration of








5.1 GLUCOSE CLAMP STUDIES
5.1.1 Subjects
The details of criteria for selection of subjects for each study are explained in
the individual chapters.
5.1.2 Ethical permission
The Lothian Medicine Ethical Advisory Committee for Medicine and Clinical
Oncology gave ethical permission for the studies. All subjects gave their written
informed consent following a detailed explanation of the nature of the studies.
5.1.3 The hyperinsulinaemic glucose clamp technique
In studies 1-3 hypoglycaemia was induced and maintained using a modified
hyperinsulinaemic glucose clamp [DeFronzo et al, 1979]. This technique
involves the continuous intravenous infusion of insulin at a fixed rate and a
simultaneous 20% dextrose infusion at a variable rate. Insulin is initially
• 2 • • •infused at a rate of 150 mU/m /min before being reduced over a period of 10
minutes to a rate of 60 mU/m2/min, at which it is maintained. This loading dose
ensures saturation of the insulin receptors to facilitate subsequent manipulation
of blood glucose. The infusion of 20% dextrose is commenced approximately 5
minutes after the insulin infusion is started, initially at a rate of about 1 ml/kg/hr.
The subsequent rate of dextrose infusion is determined by the arterialised blood
glucose concentration measured at the bedside every 5 minutes. In all the
experiments, stable euglycaemia was achieved and then maintained at an
arterialised blood glucose of 4.5 mmol/1 for 30 minutes. Depending on the arm
of the study being conducted, the dextrose infusion was then either maintained
or altered to achieve euglycaemia or hypoglycaemia. To induce hypoglycaemia,
the dextrose infusion was stopped for 5 minutes, then recommenced at half the
rate required to maintain euglycaemia. This allowed the arterialised blood
glucose concentration to decline smoothly over a 20-minute period to a level of
2.6 mmol/1. The dextrose infusion was then adjusted regularly for the duration
of the experiment to maintain the predetermined level of hypoglycaemia. Blood
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glucose was then maintained at the predetermined level for the duration of
cognitive function testing, following which blood glucose was restored to
normal.
5.1.4 Experimental procedure
Each session commenced at 0800 hrs after an overnight fast. The subjects with
diabetes omitted their morning dose of insulin. Intradermal lignocaine (1%) was
used for local anesthesia, and two cannulae were placed in the non-dominant
arm, one being inserted retrogradely in a distal hand vein. This hand was used
for blood sampling, having been placed in a warm blanket to 'arterialise' venous
blood. A second intravenous cannula was placed in the antecubital fossa for
infusion of 20% dextrose and human soluble insulin (Humulin S; Eli Lilly).
After a brief priming regimen, insulin in supraphysiological concentrations was
infused at a constant rate of 60 mU/m2/min into a peripheral vein using an
IMED Gemini PCI pump. A variable infusion of 20% dextrose was given
simultaneously via an IMED Gemini PCI pump and adjusted according to the
blood glucose concentration measured at the bedside (Yellow Springs
Instrument 2300 Stat, Yellow Springs, Ohio, USA). Samples of arterialised
venous blood were obtained for glucose estimation initially at three-minute
intervals, and then at five-minute intervals once a stable blood glucose
concentration had been achieved.
In each study condition, the arterialised blood glucose concentration was
stabilised at 4.5 mmol/1 (baseline) for a period of 30 minutes, following which it
was either maintained at 4.5 mmol/1 (euglycaemia) or lowered to 2.6 mmol/1
(hypoglycaemia). An arterialised blood glucose concentration of 2.6 mmol/1
was chosen for the degree of hypoglycaemia to be tested because several
previous studies have demonstrated significant impairment of various domains
of cognitive function at this level [Deary et al, 1993a]. A period of 20 to 30
minutes elapsed between the baseline plateau and the attainment of
hypoglycaemia to allow the blood glucose concentration to stabilise. The target
107
blood glucose concentration was maintained for a further 10 minutes before the
tests were administered. Blood glucose was maintained at the study level for 90
minutes, during which the cognitive function tests and a questionnaire on the
symptoms of hypoglycaemia were administered. Subjects were blinded as to the
order of the studies and to their prevailing blood glucose concentration at all
times throughout the procedure.
In the subjects with diabetes, HbAlc was measured by high-performance liquid
chromatography (Variant II Hemoglobin Testing System; Biorad Diagnostics,
Hercules, CA) (local DCCT-aligned non-diabetic reference range: 4.3-6.5%).
5.1.5 Methodological limitations during studies of hypoglycaemia
Despite the importance of studies designed to assess cognitive function and
symptoms associated with experimentally induced hypoglycaemia, there are
methodological limitations that need to considered when interpreting the results
of such studies. The supraphysiological levels of plasma insulin achieved using
the hyperinsulinaemic glucose clamp technique do not readily mimic the
pharmacological insulin concentrations that cause hypoglycaemia in patients
with diabetes. Although glucose uptake into cerebral tissue was previously
regarded as insulin-independent under physiological insulin concentrations
[McCall, 1993], it is now known that the insulin-responsive glucose transporter,
GLUT-4, is found in brain endothelial tissue [McCall, 1992]. Furthermore,
insulin receptors have been identified in the brains of animals [Hill et al, 1986,
Unger et al, 1989] and of humans [Hopkins & Williams 1997], especially in the
hippocampus, hypothalamus and olfactory bulb. Therefore it is possible that the
high concentrations of insulin, which prevail during the glucose clamp, could
cause an artifactual rise in cerebral blood glucose uptake, and the physiological
response including cognitive function during experimental hypoglycaemia may
be different from the changes that occur during insulin therapy. However, it is
hoped that the inclusion of a hyperinsulinaemic euglycaemia control arm in all
the studies will control for any variables incurred. Although higher rates of
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insulin infusion have been shown to attenuate the symptomatic and
neuroendocrine responses to hypoglycaemia, it is reassuring that two human
studies, in which differing concentrations of insulin were infused, did not affect
the cognitive response to comparable levels of hypoglycaemia [Kerr et al,
1991a, Fanelli et al, 1994b].
Furthermore, such studies cannot be expected to reproduce exactly the
conditions of clinical hypoglycaemia and the many extraneous modifying
factors such as situation, activity and time of day. In addition, the perception of
symptoms that patients have in a clinical situation is likely to differ from the
perception that they report in response to probing questions during
experimentally-induced hypoglycaemia. For example, knowledge of the
imminence of experimentally-induced hypoglycaemia in non-diabetic subjects
enhanced the intensity of neuroglycopenic symptoms, demonstrating the effect
of anticipation on the perception of symptoms [Pohl et al, 1997].
One other important caveat should be recognised in studies of hypoglycaemia.
When assessing the effects of hypoglycaemia on cognitive function it is
important to ensure that 'arterialised' blood is sampled, reflecting the cerebral
arterial glucose concentration. Warming the hand allows shunting of the blood
from the arterial to the venous system and this arterialised venous blood has
been shown to approximate very closely with true arterial blood glucose
concentrations [Liu et al, 1992]. Knowledge of whether blood samples are
plasma or whole blood, venous or arterialised are also important, both for
comparing studies of hypoglycaemia and in the interpretation of the results,
since glucose measurement of plasma gives a value around 10-20% higher than
the equivalent concentration in whole blood [Foster et al, 1978].
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5.2 COGNITIVE FUNCTION TESTS
5.2.1 National Adult Reading Test (NART)
The NART is widely used to estimate a person's premorbid level of intellectual
ability, which is the peak level of mental ability achieved by an individual prior
to any cognitive decline [Nelson, 1982], The test requires subjects to read out
loud a set of 50 words which are irregular in terms of their grapheme-phoneme
correspondences, e.g. courteous, subtle. The responses are individually scored
as correct or incorrect according to their pronunciation. This score can then be
used to derive a premorbid IQ estimate. The NART has been validated against
the Wechsler Adult Intelligence Scale and has been shown to correlate closely
with this test in subjects without reason for cognitive decline [Crawford, 1992].
Furthermore, a recent retrospective validity study followed up 179 individuals
that had been administered an IQ test at age 11. A comparison of these scores
with the NART scores at age 77 lent strong support to the claim that NART
estimates premorbid, rather than current intelligence [Crawford et al, 2001].
5.2.2 The Test of Everyday Attention (TEA)
The absence of readily available paper and pencil tests for measures of sub¬
types of attention meant that relatively little was known about the clinical
correlates of attention problems. The TEA was devised from the evidence on
separable attention systems in the brain [Posner & Peterson, 1990] and it was
developed to improve existing methods of assessing attentional problems. The
TEA attempts to measure aspects of the selection and vigilance systems of
attention and correlates significantly with existing measures of attention
[Robertson et al, 1994]. It gives a broad-based measure of the most important
clinical and theoretical aspects of attention and can be used analytically to
identify patterns of attentional breakdown. Moreover, it is the only test of
attention based largely on everyday materials and the real-life scenario means
that most patients enjoy the test and find it relevant. It yields standardised and
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reliable scores that allow valid comparisons in terms of selective attention,
sustained attention and attentional switching.
The TEA is divided into eight subtests and has parallel forms [Robertson et al,
1994], Subjects were asked to pretend that they were on holiday in Philadelphia
in the USA, and were told that they would be asked to perform various tasks
such as looking for symbols on maps and consulting telephone directories.
1. Map Search
This is a test of selective attention. The subjects had to search for a particular
symbol such as a sign that represented a garage, on a colour map - in this case
of the Philadelphia area. The score is the number of symbols circled out of a
possible maximum of 80 in two minutes. After the first minute had elapsed, the
subjects were given a different coloured pen to circle the map signs, to enable
the number of targets located in the first minute to be identified and compared to
the final total achieved. This subtest loads on the same factor as the Stroop Test
[Robertson et al, 1994]. A small proportion of subjects may have difficulty with
this test because of visual acuity problems, but this can easily be assessed in
preliminary fashion using the subtest map itself prior to embarking on the full
test.
2. Elevator Counting
This subtest was presented on audio-tape, and consisted of a simple counting
procedure. Subjects were asked to pretend that they were in an elevator whose
floor-indicator was not functioning. They had to ascertain at which 'floor' they
had arrived by counting a series of tape-presented tones. Two practice items
were provided at the beginning of the tape, so that the subjects were familiarised
with the tones. This subtest is based on the procedure devised by Wilkins and
colleagues that has been validated as a measure of right frontal lobe-based
sustained attention [Wilkins et al, 1987]. The version used in the TEA is a
variation of Wilkins' task as devised by Broks et al [1988] and loads on the
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sustained attention factor of the factor analysis of data obtained from normal
subjects.
3. Elevator Counting with Distraction
This subtest is similar to Elevator Counting, and was also presented on audio¬
tape. It differed in that subjects had to count the same tone that had been heard
previously, while ignoring a distracting tone which had a higher note. The task
commenced with two examples to demonstrate the difference between the two
tones and to give the subject practice in counting.
4. Visual Elevator
In this subtest, the subject was asked to imagine that they were travelling up and
down in an elevator, which in this case was represented by a series of pictures of
elevator doors. Large arrows showed the direction of counting between
pictures. This reversal task is a measure of attentional switching, and hence of
cognitive flexibility. It is self-paced and the 'number correct' score loads on the
same factor as the number of categories on the Wisconsin Card Sorting Test
[Nelson, 1976].
5. Elevator Counting with Reversal
This subtest was the same as the visual elevator subtest except that it was
presented at a fixed speed on audio-tape. It loads on the auditory-verbal
working memory factor.
6. Telephone Search
In this test the subjects had to look for key symbols while searching through
pages in a telephone directory. This subtest loads on the selective attention
factor.
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7. Telephone Search while Counting
In this task, the subject had again to search for key symbols in a (different)
telephone directory while simultaneously counting a series of strings of tones
presented on audio-tape. By combining the scores for this subtest, and the time
per target score for the previous telephone search, this test aims to provide a
measure of divided attention, a 'dual task decrement'. In the factor analysis of
normal data, this task loads on the sustained attention factor.
8. Lottery
In this final subtest of sustained attention, subjects had to listen for their
(predetermined) winning lottery numbers. To do this, they had to listen to a 10
minute series of audio-tape-presented numbers of the form 'BC143', i.e. two
letters followed by three numbers. The task was to write down the two letters
preceding all lottery numbers ending in certain numbers, e.g. '55'.
The ability to select target stimuli, while not selecting powerfully competing
distractors, seems to be the common factor uniting the different tests of selective
attention (table 5.1). Subjects who have a visual selective attention deficit may
have difficulty filling out forms, looking up transport timetables/TV schedules,
or finding what they are looking for on supermarket shelves. The visual
elevator subtest measures attentional switching and this test is sensitive to
problems of flexibility of thought and would reflect difficulties in changing from
one topic to another, e.g. during a meeting. Subtests loading on the sustained
attention factor involve the ability to sustain attention to repetitive stimuli in the
absence of external cues to attend (lottery counting and elevator counting).
People who do poorly on these tasks find it difficult to keep their mind on a
relatively dull, unchanging task. They may also lose concentration while
reading or watching television, and even while talking with friends and family.
The telephone search while counting subtest involves a strong sustained
attention factor, but also measures divided attention, and it is likely that the
former is an important factor in dual task performance, i.e. remembering to
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attend to the second task while engrossed in the first. This test is highly
sensitive to the ability to handle the complex demands of everyday life. For
example, making a meal and holding a conversation simultaneously. The
elevator counting with reversal and elevator counting with distraction subtests
involve the manipulation and sequencing of auditory-verbal information in
working memory and also measure auditory selective attention. Subjects who
have difficulties with these tests may have problems with complex mental
arithmetic, or working out other problems mentally.
The tests were carried out in a quiet, well-lit area with a flat surface on which
visual test materials could be placed. Verbatim instructions were given for all
subtests, as well as background information for each subtest. The maps and
telephone directory materials were encased in clear plastic which the subjects
could mark with water-based colour pens. After scoring at the end of the test
session, the plastic could be wiped with a damp sponge to make it ready for the
next subject.
Table 5.1 TEA subtests and their attentional correlates. Reproduced from Diabetic Med














Telephone Search While Counting
Telephone Search While Counting
Elevator Counting With Reversal
Elevator Counting With Distraction
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During the scoring of the TEA, account had to be taken of age when interpreting
each subtest score. This was done by looking up a subject's score in one of four
separate age categories. The role of verbal intelligence in scoring is sufficiently
low as to be relatively unimportant in interpreting scores and there are no sex
differences or adjustments required for gender in any of the subtests.
5.2.3 Raven's Progressive Matrices (RPM)
Within the psychometric study of intelligence, general fluid intelligence reflects
adaptive, problem-solving ability, and is largely non-verbal in nature. Raven's
Progressive Matrices [Raven's Progressive Matrices, SPM, 1958] is a test of
non-verbal reasoning that involves rule induction and application in abstract
patterns. It is closely associated with general fluid intelligence [Marshalek et al,
1983]. General intelligence is a key finding and theoretical construct in the
psychometric structure of human abilities [Carroll, 1993], and is an important
influence on the quality of performance of many everyday activities
[Gottredson, 1997]. The RPM are considered to be the single best test of
general fluid intelligence [Marshalek et al, 1983].
When the RPM were designed, Raven set out to develop tests that would be easy
to administer and to interpret in a clear, theoretical way [Raven, 2000]. The
Matrices' items are diagrammatic puzzles exhibiting serial change in two
dimensions simultaneously. Each puzzle has a part missing which the subject
has to find among the answer options provided. The correct answer is found by
discovering and correctly applying the rules governing the changes in each
item's pattern. The test consists of 60 items divided into five sets (A, B, C, D,
E), each consisting of 12 items. In each set the first puzzle is very easy. The
puzzles that follow build on the argument of those that have gone before and
become progressively more difficult. Therefore, each problem in the set is
really the source of a system of thought. The order of the items provides the
standard training in the method of working and the five sets provide ample
opportunity to grasp the method of thought required to solve the problems. All
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of the problems are boldly presented and accurately drawn to ensure sustained
interest and freedom from fatigue. It is generally not possible to solve the more
difficult problems of the RPM if the capacities to solve the easier problems are
not present. Evidence for this is derived from the Item Characteristic Curves
plotted when the test was being developed and re-run in the course of a number
of subsequent standardisations. As a result, three facts were derived from this
data. Firstly, that all the items were measuring a common factor. Secondly, that
the abilities that are required to solve the more difficult problems form part of a
range which starts with the easiest items. Finally, although the abilities that are
required to solve the more difficult problems may appear to be qualitatively
different from those required to solve the easier ones, these apparently different
abilities shade imperceptibly one into the other [Raven et al, 1996].
Subjects were assigned two scores for this test; the number correct at 20 minutes
and the number correct at completion (no time limit). By doing this, the speed
of accurate intellectual work and the total capacity for orderly thinking of each
subject could be assessed. However, subjects were instructed to work at their
own pace and not to be concerned with a time limit. This was important
because as the five sets of items forming the test each begins with easy problems
and end with difficult ones, the scores would not be reliable if a single time limit
was used which did not allow everyone to finish. This is because a subject's
score would be very different if time ran out while they were working on the
difficult problems of an early set, rather than a few moments later, when they
would be moving quickly through the easier items of the next set. It is
important to note the strengths and weaknesses of the RPM. Strengths include
that it can be used with respondents of all ages from early childhood to the
elderly and it is of a duration that it can be applied in many different situations,
such as home, school or the laboratory. However, it does have limited
discrimination at the upper and lower levels of ability [Raven et al, 1996].
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5.2.4 Dundee Stress State Questionnaire (DSSQ)
The application of the DSSQ to the study of hypoglycemia is novel. It aims to
be a comprehensive, multi-dimensional assessment instrument for transient
mental states associated with stress, arousal and fatigue [Matthews et al, 1999].
The DSSQ seeks to measure state dimensions within the three traditional
psychological domains of affect (mood), motivation (conation), and cognition.
It consists of 10 factor analytically determined scales, which load onto three
secondary factors that reflect the individual's stress state. Three of the scales
reflect Task-Engagement (energetic arousal, motivation, and concentration),
three scales constitute the dimensions of Distress (tense arousal, confidence and
control, and hedonic tone), and four scales define the dimension ofWorry (self-
focused attention, self-esteem, task relevant cognitive interference, and task-
irrelevant interference). There are two versions of the test: Annexe A is
administered prior to task performance, and Annexe B is completed after the
task. In the pre-task assessment, subjects are informed that the questionnaire
will assess their feelings and thoughts at that moment in time. In Study 3,
Annexe A of the DSSQ was administered before the TEA. After the task,
subjects are given a further questionnaire that asks them about the thoughts and
feelings they experienced while they were performing the task. In Study 3,
Annexe B was given after the RPM. Instructions for the DSSQ emphasise
rating immediate rather than typical subjective experience, to ensure reporting of
short-term states rather than enduring traits. The latter is a personality
disposition that shows much greater temporal stability [Matthews et al, 2003].
The mood dimensions of the DSSQ are subdivided into energetic arousal, tense
arousal and hedonic tone. The motivation dimension relates to intrinsic
motivation, i.e. the extent to which the person is motivated by interest and
engagement in task content. Cognitive dimensions assess self-referent beliefs
and styles of thought including task-related and task-irrelevant interference, self-
focus of attention, which refers to a state of self-preoccupation and reflection, or
private self-consciousness, and self-esteem, which refers to sets of beliefs about
117
self-worth, especially as evaluated by others. Concentration items refer to
attention to the task being undertaken, and resisting distraction whereas
confidence refers to beliefs about personal control and success in task
performance.
The DSSQ comprises a compendium of existing scales and items for important
stress-related constructs that are not adequately accommodated by other
questionnaires. Subjects were given a series of four DSSQ questionnaires under
the following headings:
1. Uwist Mood Adjective Checklist (UMACL)
2. Motivation and Workload
3. Thinking Style
4. Thinking Content.
Each questionnaire tested a particular domain through a specific series of
questions or items. No more than 8 items were selected for each scale.
DSSQ Affect
Part 1 of the DSSQ questionnaires is the UWIST Mood Adjective Checklist
[Matthews et al, 1990a], which is used to index three dimensions of energy,
tension and hedonic tone. The checklist has been validated in both experimental
studies [Matthews et al, 1990b] and in field studies of real world stressors
[Matthews et al, 1991]. The adjectives used to characterise the mood
dimensions which were included in this questionnaire were graded by intensity
on a scale of 1 to 4 and were classified into three groups: hedonic tone, tense
arousal and energetic arousal. Higher scores indicate a higher happiness rating
for hedonic tone, a high anxiety rating for tense arousal, and a high energy
rating for energetic arousal. Using this questionnaire, the maximum score that
can be obtained for each of the three mood components is 32, and the minimum
score is 8.
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DSSQ Motivation and Workload
Part 2 of the DSSQ questionnaires deals with motivation and workload. The
items in this task represent two major aspects of motivation in performance
settings; task interest and aspiration to achieve successful performance. In the
pre-task questionnaire, subjects were asked 8 questions about their attitude to
the task that they were about to undertake e.g. "How eager are you to do well at
the task". They graded their answers on a Likert scale ranging from zero (Not at
all) to 9 (A great deal). In the post-task questionnaire, they were asked a similar
series of questions to assess attitude to the task just completed. The maximum
score that can be obtained is 72 and the minimum score possible is 0. The
subjects then proceeded to complete an additional six questions to rate the
mental, physical and temporal demand of the task completed, the effort put into
the task, and their perceived rating of performance and frustration with the task.
These are rating scales derived from the NASA-TLX [Hart & Staveland, 1988],
each assessing a different aspect of the workload imposed by the task. The
maximum score that can be obtained for workload is 60 and the minimum score
possible is 0.
DSSQ Cognition
Part 3 of the DSSQ questionnaires ('Thinking Style') assesses the person's
general style of thinking and beliefs about the task. It is important to note that
this is not cognitive performance; rather, it is self-reported beliefs about one's
cognitive performance. Existing, validated measures were used to assess
cognitive interference from the task itself and from personal concerns [Sarason
et al, 1986], performance and social self-esteem [Heatherton & Polivy, 1991],
and self-focus of attention [Fenigstein et al, 1975]. This aspect of the
questionnaire assessed self-focused attention (8 items), self-esteem (7 items),
concentration (7 items), and control and confidence (6 items) by a series of 28
questions. Subjects were asked a series of statements about their thoughts at
that moment (pre-task questionnaire) and during the task (post-task
questionnaire). For example, a question relating to self-esteem would be "I am
119
worried about whether I am regarded as a success or failure" and answers were
graded on a Likert scale from zero (Not at all) to 4 (Extremely).
Part 4 of the DSSQ questionnaires examined 'Thinking Content' and comprised
items from the Cognitive Interference Questionnaire [Sarason et al, 1986],
which evaluates task-related interference (8 items) and task-irrelevant
interference (8 items). For example, a question from the former would be "I
thought about how much time I had left" and from the latter "I thought about
personal worries". Scores were graded on a Likert scale from 1 (Never) to 5
(Very often).
5.3 Symptoms of hypoglycaemia
A subjective self-rating system (The Edinburgh Hypoglycemia Scale) [Deary et
al, 1993a] was used at four time points; baseline, before and after the TEA, and
after the RPM. The symptoms of hypoglycaemia were classified as autonomic
(palpitations, sweating, shaking and hunger), neuroglycopenic (confusion,
drowsiness, inability to concentrate, speech difficulty and blurred vision) and
non-specific (nausea and headache). Each symptom was graded on a Likert
scale of 1 to 7 (1 = not present, 7 = very intense). The total for each subgroup of
hypoglycaemic symptoms was calculated.
5.4 Statistical analysis
The statistical methods used in each of the studies are described in the individual
chapters. A p value of less than 0.05 was considered to be significant. In the
glucose clamp studies, with 16 subjects and a repeated measures design, the
power of the study in detecting a 0.5 standard deviation change (medium effect
size) in any test (assuming a=0.05, reliability of test=0.8) was 94%. Using the
same assumptions, the power of detecting a 0.33 standard deviation change
(small-medium effect size) was 63%.
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Effect size was calculated using Eta squared (r|2). r\2 is the proportion of the
variance in the test scores accounted for by study condition (euglycaemia vs.
hypoglycaemia). A r|2 score of 0.25-0.5 was considered a moderate effect size












As discussed in Chapter 2, the human brain is dependent on glucose for its
oxidative metabolism, and hypoglycaemia rapidly causes impairment in brain
functioning through the effects of acute neuroglycopenia [Deary, 1993b]. This
has been demonstrated in numerous studies using a variety of
neuropsychological [Holmes et al, 1983, 1984, Pramming et al, 1986, Heller et
al, 1987, Hoffman et al, 1989, Stevens et al, 1989, Widom & Simonson, 1990,
Mitrakou et al, 1991, Cox et al, 1993b, Mellman et al, 1994] and
neurophysiological tests [Pramming et al, 1988, Tamburrano et al, 1988,
Blackman et al, 1990, Jones et al, 1990, Tallroth et al, 1990, Zeigler et al, 1992].
Tasks which involve higher cognitive processes are thought to be more sensitive
to neuroglycopenia than motor tasks [Cox et al, 1993b]. In addition, tasks that
involve rapid responses and those which are more cognitively complex and
attention demanding tend to show substantial impairment during
neuroglycopenia whereas simple motor tasks and cognitive tasks such as digit
span, finger tapping and simple reaction times are relatively well preserved
[Deary, 1993b]. Although it is recognised that cognitive function is impaired
during hypoglycaemia, it is not clear which basic brain processes are affected by
neuroglycopenia, nor is it known to what extent neuropsychological tests, which
typically engage several putative mental processes, index abilities of cognitive
functioning that are important in everyday life. Because cognitive abilities are
important for work and leisure activities, this information is of considerable
practical as well as theoretical importance.
Attention is a complex mental ability involving multiple subcomponent
processes [Posner & Peterson, 1990], and several independent attention systems
in the brain serve different functions. Although no dominant theory can
integrate all of these components within a unifying framework, several models
have been proposed that support the concept of fractionation of attention into
different supramodal systems each of which has a distinct neuroanatomical basis
[Posner & Peterson, 1990].
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Because attention is a fundamental cognitive process that is integral to many
neuropsychological tests, the examination of attentional dysfunction is difficult
to study in isolation. The attentional processes that have been studied most
frequently involve focusing, selecting, dividing, sustaining, suppressing, and
inhibiting attention. Classical neuropsychological tests purporting to assess
attention have deteriorated during controlled hypoglycaemia in non-diabetic
subjects [Mitrakou et al, 1991, Stevens et al, 1989], and in adults with type 1
diabetes [Holmes et al, 1984, Pramming et al, 1986, Widom & Simonson,
1990]. However, little detailed information is available on the effects of
controlled hypoglycaemia upon the brain's specific information processing
abilities, and further research needs to demonstrate that impairments in
laboratory cognitive tasks have a bearing on mental performance in real life.
Furthermore, we need a study using a validated batch of attention tests during
hypoglycaemia.
As a major construct within the psychometric study of intelligence, fluid
intelligence reflects adaptive, problem-solving ability, and is largely non-verbal
in nature. The Raven's Progressive Matrices [Raven's Progressive Matrices,
SPM, 1958] are an acknowledged key test of this ability. General intelligence is
a key finding and theoretical construct in the psychometric structure of human
abilities [Carrol, 1993], and is an important influence on many everyday
activities [Gottffedson, 1997]. Few previous studies of acute hypoglycaemia
have included subtests that were designed specifically to measure aspects of
intelligence and it is surprising that such a test has not been utilised previously
in the study of hypoglycaemia in humans. In a previous study, mathematical
computations were impaired at a venous blood glucose level of 3.3 mmol/1 in 12
patients with type 1 diabetes, but reading comprehension was not affected
[Holmes et al, 1983], The Digit Symbol Task, a subtest of the Weschler battery
of intelligence tests (WAIS-R) [Weschler and Stone, 1981] was impaired at
arterialised blood glucose concentrations ranging from 2.5 mmol/1 to 3.4 mmol/1
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[Stevens et al, 1989, McCrimmon et al, 1996] in non-diabetic human volunteers,
and at 2.8 mmol/1 in subjects with diabetes [Kerr et al, 1991b].
Therefore, the aim of the present study was to examine the effects of acute
controlled, insulin-induced hypoglycaemia on general fluid intelligence and on
different aspects of attention using validated tests.
6.2 Research Design and Methods
Subjects
Twenty (9 male) healthy volunteers were studied. Their mean (SD) age was
28.7 (5.3) years with a mean (SD) Body Mass Index of 23.7 (1.9) kg/m2. The
mean (SD) National Adult Reading Test (NART) number correct score was 28.9
(5.8). The subjects did not have a previous medical history or a family history
of diabetes, previous head injury or psychiatric disorder. They had no
intercurrent illness and none were taking medications (other than the combined
oral contraceptive pill). Subjects were not paid to participate in the study other
than travel expenses. The protocol was approved by the Healthy Volunteer
Studies Medical Research Ethics Sub-Committee of the Lothian Medicine and
Oncology Ethical Advisory Committee. All subjects gave written informed
consent for study.
Study Design
The study design is shown in figure 6.1. Subjects were studied on two
occasions, separated by at least one week, in a counterbalanced order, i.e. halfof
the subjects underwent the euglycaemia session first, followed by the
hypoglycaemia study, and the other halfwere studied in the reverse order. A
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modified hyperinsulinaemic glucose clamp technique was used [De Fronzo et al,
1979] to set the blood glucose at a predetermined level. In one condition,
hypoglycaemia was induced (blood glucose 2.6 mmol/1), and in the other
condition, euglycaemia, the blood glucose concentration was maintained at 4.5
mmol/1. During the two study conditions (euglycaemia and hypoglycaemia) the
subjects were asked to complete tests of cognitive function and a questionnaire
of the symptoms of hypoglycaemia. Subjects were blinded to the order of the
studies and to their prevailing blood glucose concentration at all times
throughout the procedure.
Procedure
A modified hyperinsulinaemic glucose clamp technique was used, in which
insulin was infused, in supraphysiological concentrations, at a constant rate into
a peripheral vein to lower the blood glucose progressively, as detailed in section
5.1.4.
Cognitive Function Tests
During the euglycaemia and hypoglycaemia arms of the study subjects were
administered the Test of Everyday Attention (TEA) [Robertson et al, 1994]
followed by the Raven's Progressive Matrices (RPM) [Raven's Progressive
Matrices, SPM, 1958]. The order of the tests was identical during each study
condition.
Test of Everyday Attention (TEA)
The TEA has been described in detail in section 5.2.2. Briefly, the TEA is
divided into eight subtests that aim to assess selective, sustained and attentional
switching. In the present study, the subjects were asked to pretend that they
were visiting Philadelphia in the USA, and were told that they would be asked to
perform various tasks such as looking for symbols on maps and consulting
telephone directories.
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Raven's Progressive Matrices (RPM)
The RPM was used to examine fluid intelligence and is detailed in section 5.2.3.
The Standard and Parallel forms of the Matrices were administered after the
TEA was completed. Subjects were assigned two scores for this test; they were
asked to circle the number of the question they were attempting at 20 minutes
and then allowed to continue with the test until completion, so introducing a
time component.
Symptoms of hypoglycaemia
The Edinburgh Hypoglycaemia Scale [Deary et al, 1993a] was administered at
four time points; baseline, before and after the TEA, and after the RPM (figure
6.1). The symptoms of hypoglycaemia were classified as autonomic
(palpitations, sweating, shaking and hunger), neuroglycopenic (confusion,
drowsiness, inability to concentrate and blurred vision) or non-specific (nausea
and headache). Each symptom was graded on a Likert scale of 1 to 7 (1 = not
present, 7 = very intense). The total for each subgroup of hypoglycaemic
symptoms was calculated.
Statistical analysis
The results were analysed independently for each subtest of the TEA and the
RPM. A general linear model repeated measures analysis of variance was used
with order of session as a "between-subjects" factor with two levels
(euglycaemia-hypoglycaemia or hypoglycaemia-euglycaemia), and condition as
a "within subjects" factor with two levels (euglycaemia versus hypoglycaemia).
A similar model was used to analyse the symptoms of hypoglycaemia, with the
addition of time as a "within-subjects" factor with four levels. During the
symptoms analysis, the principal outcome statistic was any (experimental versus
time) interaction as this indicated the effects of hypoglycaemia on symptoms
controlled for day-to-day variation by including baseline scores. A p value of
less than 0.05 was considered to be significant. All analyses were performed
using SPSS version 10.0 for Windows.
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6.3 Results
The mean (SD) fasting venous blood glucose was 4.3 (0.3) mmol/1 and did not
differ between the two study days. Stable blood glucose plateaux were achieved
during both conditions (figure 6.2). The mean (SD) blood glucose concentration
during the hypoglycaemia clamp was 2.6 (0.2) mmol/1, and during euglycaemia
was 4.5 (0.2) mmol/1. The initial statistical analysis revealed that no significant
order effects (asymmetrical transfer effects) had occurred for any of the outcome
variables in this study, other than the "elevator counting with reversal" task.
Symptoms
Significant increments were observed in the autonomic (p=0.001) and
neuroglycopenic (p=0.02) scores during hypoglycaemia (table 6.1). There were
no significant changes on malaise scores (p=0.1). The significant increments in
neuroglycopenic and autonomic symptom reports confirmed that the subject
group had symptomatic awareness of hypoglycaemia at the predetermined low
blood glucose concentration and, more specifically, were experiencing
neuroglycopenia.
Table 6.1 Symptom scores during hypoglycaemia in 20 non-diabetic volunteers
Euglycaemia Hypoglycaemia p value
Baseline End study Baseline End study
Autonomic 5.4(1.6) 5.3 (1.6) 5.5(1.6) 13.3 (5.0) 0.001
Neuroglycopenic 4.9(1.6) 5.3 (2.0) 5.5(1.8) 9.9 (4.9) 0.02
General malaise 2.3 (0.6) 2.4 (0.6) 2.1 (0.52) 3.3 (1.6) 0.1
Values are means (SD)
P value refers to the interaction of'experimental condition versus time' in ANOVA
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Tests ofAttention
The results of the visual selective attention and auditory selective attention tests
are summarised in table 6.2. Table 6.3 contains the results for attentional
switching, sustained attention and divided attention.
Visual Selective Attention
Acute hypoglycaemia caused a significant deterioration in tests sensitive to a
visual selective attention deficit. The mean number (SD) of map symbols
circled during euglycaemia in one minute was 46.1 (10.0) versus 39.9 (10.2)
during hypoglycaemia (p=0.009, r|2=0.32). The mean number (SD) of symbols
circled in two minutes was also lower at 68.1 (11.3) during hypoglycaemia,
compared with 71.8 (6.9) in the euglycaemia condition, but did not achieve
statistical significance (p=0.1). In the telephone search task, no difference was
demonstrated between euglycaemia and hypoglycaemia in the number of
symbols located. However, the mean (SD) time taken to complete the task
increased from 51.7 (7.3) seconds during euglycaemia, to 57.0 (11.2) seconds
during hypoglycaemia (p=0.005, r|2=0.32). Furthermore, the telephone search
raw score, or the number of symbols located per second, increased from 2.7
(0.4) during euglycaemia, to 3.1 (0.7) during hypoglycaemia (p=0.005,
r|2=0.36) (figure 6.3). The results demonstrate that a visual selective attention
decrement had developed during hypoglycaemia.
Auditory Selective Attention/Auditory Verbal Working Memory
With the auditory elevator test with distraction, the achieved score declined
from a mean (SD) of 9.2 (1.2) during euglycaemia to 7.8 (2.0) during
hypoglycaemia (p=0.003, r|2=0.40). By contrast, the score attained on the
elevator test with reversal, did not deteriorate during hypoglycaemia, with a
mean (SD) score of 7.3 (2.6) during euglycaemia compared to 7.1 (2.3); p=0.7
during hypoglycaemia. A significant order effect occurred with this test
(p=0.01, r|2=0.28). When subjects went through the euglycaemia arm of the
study first, the score increased from 5.8 (euglycaemia study day) to 6.4
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(hypoglycaemia study day). By contrast, an initial hypoglycaemia study day
demonstrated a decrease in scores from 8.8 to 7.9 (euglycaemia study day).
Sustained Attention
Sustained attention did not deteriorate during hypoglycaemia using either the
lottery ticket test (p=0.2) or the elevator counting test (p=0.1).
Attentional Switching
In the visual elevator task, no difference was observed in the raw score between
the two study conditions. The mean (SD) raw score during euglycaemia was 9.1
(1.3) compared with 8.8 (1.6) during hypoglycaemia (p=0.4). However, during
hypoglycaemia a longer time was required to complete the visual elevator task
with a mean (SD) time of 136.9 (22.2) seconds, compared to 112.7 (15.0)
seconds during euglycaemia (p<0.0001, ri2=0.76), which was a highly
significant difference (figure 6.3).
Divided attention
In the task that involved search of a telephone directory while counting, no
significant difference was observed in the number of symbols that were located
during either study condition. The time taken to complete the task was higher
during hypoglycaemia with a mean (SD) of 60.0 (14.6) seconds compared to
55.9 (9.5) seconds during euglycaemia, but this difference was not significant
(p=0.1). The time per target score, which is the ratio of the number of circled
symbols divided by the time taken for the task, was higher with a mean (SD) of
3.4 (0.6) targets/second during hypoglycaemia compared to 3.1 (0.8)
targets/second during euglycaemia (p=0.02, r|2=0.26). The dual task decrement
was not significantly different between the two conditions (p=0.2).
Fluid intelligence
Using Raven's Progressive Matrices, no significant differences were observed
between euglycaemia and hypoglycaemia in the scores achieved either at 20
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minutes or upon completion of the test (figure 6.4). The mean (SD) RPM score
at 20 minutes was 48.4 (5.7) during euglycaemia and 47.2 (5.1) in the
hypoglycaemia condition (p=0.1). Upon completion, the mean (SD) score was
49.5 (5.6) in the euglycaemia condition and 48.7 (4.9) during hypoglycaemia
(p=0.3). No significant differences were found between the two study
conditions in the times taken to complete the test.
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6.4 Discussion
The present study has demonstrated that controlled hypoglycaemia in non-
diabetic humans causes attentional dysfunction. A decline in the rate of
information processing was demonstrable in visual and auditory selective
attention, and in attentional switching. By contrast, fluid intelligence was not
affected by hypoglycaemia. An arterialised blood glucose concentration of 2.6
mmol/1 was chosen for the degree of hypoglycaemia to be tested as several
previous studies have demonstrated that this level of blood glucose is associated
with significant impairment of cognitive functions [Deary, 1993b].
Although previous investigators have attempted to demonstrate attentional
problems during acute hypoglycaemia using psychological tests, to our
knowledge the present study is the first to confirm dysfunction of subdivisions
of attention during hypoglycaemia using a test battery designed specifically to
measure attention. The TEA was devised from the evidence on separable
attention systems in the brain [Posner & Peterson, 1990]. Using the concept that
attention is fractionated into different supramodal systems, it has been proposed
that attention consists of at least three separate systems [Posner & Peterson,
1990]. A selection system is responsible for selecting relevant stimuli/processes
and inhibiting irrelevant ones, a vigilance system maintains readiness to respond
in the absence of external cues and an orientation system is responsible for
engaging, moving and disengaging attention in space. The TEA attempts to
measure aspects of the selection and vigilance systems and correlates
significantly with existing measures of attention. For example, using factor
analysis, the map search and telephone search load on the selective attention
factor along with the Stroop Test and the Trail Making B test [Reitan &
Davison, 1974].
In the present study, a significant deterioration was demonstrated during
hypoglycaemia in tests of visual selective attention. These tests have shown an
inability to ignore irrelevant information and to select specific targets from
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complex visual arrays. Accuracy was preserved at the expense of speed in both
the telephone search and visual elevator test (which assesses cognitive
flexibility). This feature has been observed previously in studies of
hypoglycaemia, and may indicate either that the speed of response is slower
during hypoglycaemia or that individuals adopt a more cautious approach to
avoid errors [Holmes et al, 1983, 1984]. However, it is important to note that in
two previous studies by Holmes and her colleagues, verbal fluency and math
recall were the variables from which this conclusion was derived [Holmes et al,
1983, 1984], These are a measure of "crystallised ability", i.e. abilities that are
concerned with stored information and knowledge, and demonstrated that access
to previously acquired information was not inaccessible during hypoglycaemia,
but the rate of retrieval of this information was much slower. The present study
demonstrates that this principle holds true for the acquisition of unfamiliar
everyday tasks.
In the present study, the ability to manipulate information in auditory-verbal
working memory deteriorated during hypoglycaemia as measured by the test of
elevator counting with distraction. Using factor analysis, this test loads on the
same factor as PASAT and Backward Digit Span tests, and may be sensitive to
abilities such as complex mental arithmetic or mental computation of other
problems [Robertson et al, 1994], This test may also be sensitive to auditory
selective attention although further research is required to confirm this
possibility.
In the Elevator Counting with Reversal test, a significant order effect was
apparent. This was an unexpected result because the relative complexity of this
task was expected to be severely affected by moderate hypoglycaemia.
Furthermore, no order effects were noted on this test during the standardisation
and validation of the TEA [Robertson et al, 1994], This order effect was most
likely a type 1 statistical error and will need replication in future studies.
Sustained attention using the lottery and elevator counting tasks was unaffected
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by hypoglycaemia. These two subtests involve the ability to sustain attention to
repetitive stimuli in the absence of external stimuli. This concords with a
previous study where sustained attention to detail did not deteriorate with
hypoglycaemia [Holmes et al, 1983], but is at variance with a more recent study
where sustained attention to detail over a period of time was observed to be
profoundly affected by hypoglycaemia [Draelos et al, 1995]. In the present
study, significant ceiling effects for these tasks were observed with most
subjects achieving the highest score possible during both study conditions.
However, the task of conducting a telephone directory search while counting
also involves a strong, sustained attention element, in that a counting task
similar to the elevator counting must be done simultaneously with a visual
search task. It is noticeable that the time per target score of this test increased
significantly during hypoglycaemia. This test is analogous to assessing the
ability to handle complex tasks that are a common requirement of everyday life
- for example, writing a note from a telephone message while simultaneously
speaking to the person giving the message. It is possible that these tests would
have become impaired if the tasks had been of longer duration. The degree of
impairment may also have been greater in other tests if the duration of testing
had been prolonged. Following our study of attention during hypoglycemia,
future studies should examine tests that are more demanding and of longer
duration. Finally, it should be noted that the degree of attentional impairment
found in this study might underestimate the real life scenario of hypoglycemia
where the blood glucose may fall more rapidly from a higher starting point.
In the present study, fluid intelligence was not affected by hypoglycaemia.
Various reasons may be proposed to explain this. The standard RPM were
designed originally to cover the widest possible range ofmental ability and to be
applicable to persons of all age groups. As it was designed for children as well
as adults, the first and second sets in the test, and the introductory problems in
the third and fourth sets provide little more than training in the method of
working. The test may, therefore, have been too elementary for most adult
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subjects. However, the RPM were designed to provide a reliable estimate of a
person's capacity to think clearly when allowed to work steadily at their own
speed from the beginning to the end of a task without interruption. It covers the
entire range of intellectual development from the time a child is able to grasp the
idea of identifying a missing shape to complete a simple jigsaw or pattern, to the
levels of ability required to form comparisons and reason by analogy. Although
it is sufficiently short not to be unduly exhausting or unwieldy, there are an
adequate number of difficult problems to discriminate between adults.
However, in the present study, even when subjects were allowed to complete the
test in their own time, no significant differences were observed in the scores
achieved or the times taken to complete the task during both study conditions.
The hierarchical model of intelligence provides a parsimonious way to think
about mental ability factors, and may also help explain our results. At the top of
the hierarchy is general ability or g - a broad general factor that accounts for
performance in a great variety of intellectual tasks. Tests that correlate highly
with this factor are "complex" tests requiring abstract problem-solving analysis
and rule inferring such as the RPM. Previous studies of hypoglycaemia looking
at reading comprehension showed no deterioration in this complex cognitive
skill [Holmes et al, 1983], This suggests that higher level or associative
cognitive skills may be less detectable or show no impairment during
hypoglycaemia, in contrast to brain functioning that involves less complex
informational analysis.
The RPM were administered towards the end of the hypoglycaemia session and
it may be suggested that by this time the brains of the subjects had adapted to
hypoglycaemia. This proposal is unlikely because the subjects were overtly
neuroglycopenic before commencing the RPM test and also immediately
afterwards, as demonstrated by their symptom scores. A previous study of non-
diabetic subjects has demonstrated that hypoglycaemia of a similar degree and
duration (60 minutes) was not associated with any evidence of cerebral
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adaptation either in cognitive function or in symptom scores [Gold et al, 1995d].
In the present study, although no significant difference was demonstrated
between the two study conditions, 50% of the subjects did show a deterioration
in the RPM during hypoglycaemia. The present study had sufficient power to
detect differences in cognitive function during acute hypoglycaemia compared
to euglycaemia. Moreover, because subjects acted as their own controls the
sample size provided approximately 94% power to detect a 0.5 standard
deviation change (medium effect size) with a p value set at 0.05. It is possible
that these differences would have become statistically significant with a larger
cohort.
In summary, a deterioration in attention occurs during acute insulin-induced
hypoglycaemia in non-diabetic humans, but fluid intelligence is preserved.
Based on these results it can be surmised that many complex attention tasks
relevant to everyday life are likely to be impaired during moderate
hypoglycaemia. In the context of hypoglycaemia developing during everyday
activities, examples of practical problems may include difficulty in filling out
forms, looking up transport timetables, or finding items on supermarket shelves.
The finding that accuracy was preserved at the expense of speed in tests of
visual selective attention and attentional switching is of practical importance.
Specifically, the tests of visual selective attention are pertinent to many of the
activities that people encounter on a daily basis. It is reassuring that higher level
constructs do not seem to become impaired during this acute metabolic insult. It
is likely that people with type 1 diabetes, who are often exposed to
hypoglycaemia, will be subject to a similar deterioration in attention, which
could have important practical implications in everyday life. The results of a




ACUTE HYPOGLYCAEMIA IN SUBJECTS WITH TYPE 1
DIABETES CAUSES ATTENTIONAL DYSFUNCTION WHILE
NON-VERBAL INTELLIGENCE IS PRESERVED
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7.1 Introduction
As previously discussed, moderate hypoglycaemia occurs frequently in people
with type 1 diabetes, and some mental functions deteriorate during this state
[Deary et al, 1993b, Deary et al, 1999, Ryan et al, 1997]. The performance of
tests that require attention, concentration, psychomotor skill, the accessing of
longterm memory and the ability to ignore distracting information deteriorates
when arterialised blood glucose falls below about 3.0 mmol/1 [Hoffman et al,
1989, Widom & Simonson, 1990, Kerr et al, 1991b, Mitrakou et al, 1991,
Wirsen et al, 1992]. Several studies have demonstrated a substantial degree of
variability in individual responses to the effects of acute hypoglycaemia, and
numerous moderators of cognitive function have been examined, including
intelligence [Gold et al, 1995a], the presence or absence of diabetes [Herold et
al, 1985, Heller et al, 1987, Widom & Simonson, 1990, Wirsen et al, 1992], and
glycaemic control [Widom & Simonson, 1990, Ziegler et al, 1992], However,
few individual cognitive domains have received detailed examination. To fill
this gap in our understanding, recent studies have attempted to address which
specific aspects of these cognitive domains are disrupted by neuroglycopenia.
They have also ascertained how abnormalities of cognitive function that are
demonstrable by neuropsychological tests, are related to everyday mental tasks
[McAulay et al, 2001, Sommerfield et al, 2003a, 2003b, Deary et al 2003,
Warren et al, 2004],
Attention is a complex cognitive domain involving multiple subcomponent
processes [Posner & Peterson, 1990, Pashler, 1998]. Because it comprises
fundamental cognitive processes that are integral to many neuropsychological
tests, it is difficult to examine attentional dysfunction in isolation. Standard
neuropsychological tests purporting to assess attention deteriorate during
controlled hypoglycaemia in non-diabetic adult humans [Mitrakou et al, 1991,
Stevens et al, 1996], and in adults with type 1 diabetes [Widom & Simonson,
1990, Holmes et al, 1984, Pramming et al, 1986]. A previous study performed
in Edinburgh, was the first to examine individual validated attentional processes
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during hypoglycaemia in non-diabetic subjects, and demonstrated deterioration
in attentional flexibility and speed of information processing, while sustained
attention was preserved [McAulay et al, 2001],
Within the psychometric study of intelligence, general fluid intelligence reflects
adaptive, problem-solving ability, and is largely non-verbal in nature. Raven's
Progressive Matrices [Raven's Progressive Matrices, SPM, 1958] is a test of
non-verbal reasoning that involves rule induction and application in abstract
patterns. It is closely associated with general fluid intelligence [Marshalek et al,
1983], General intelligence is a key finding and theoretical construct in the
psychometric structure of human abilities [Carroll, 1993], and is an important
influence on the quality of performance of many everyday activities
[Gottredson, 1997], Although a deterioration in aspects of intelligence has been
observed during acute hypoglycaemia both in non-diabetic subjects [Stevens et
al, 1989, McCrimmon et al, 1996], and in people with diabetes [Holmes et al,
1983, Kerr et al, 1991b, Ewing et al, 1998], to our knowledge few studies of
non-diabetic or diabetic adults have included subtests that were designed
specifically to measure aspects of non-verbal intelligence [McAulay et al, 2001,
Warren et al, 2004],
It is not known whether the results of the previous study in non-diabetic subjects
can be applied to subjects with type 1 diabetes. Thus, the aim of the present
study was to examine the effects of acute, controlled, insulin-induced
hypoglycaemia on attention and on general non-verbal intelligence in adults
with type 1 diabetes, and to establish whether any variation exists with those
observed in non-diabetic subjects.
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7.2 Subjects and Methods
Subjects
Sixteen adults with type 1 diabetes were recruited from the diabetes outpatient
clinics at the Royal Infirmary of Edinburgh to participate in the present study.
The median (range) age was 25.5 (18-39) years and duration of diabetes was 8.0
(2.5-15) years with a mean (SD) Body Mass Index of 24.1 (1.8) kg/m2. The
mean (SD) National Adult Reading Test (NART) number correct score was 27
(7.8). Thus, the group comprised people whose mean was just above average
intelligence, with an overall predicted full scale intelligence quotient of around
109. Their mean (SD) HbAlc, measured by high-performance liquid
chromatography (Variant II Hemoglobin Testing System; Biorad Diagnostics,
Hercules, CA) was 7.7 (1.0)% (local DCCT-aligned, non-diabetic reference
range: 4.3-6.5%). None of the participants had a history of chronic disease,
hypertension, previous head injury, seizure or blackouts, alcohol or drug abuse,
or psychiatric disorder. None had any intercurrent illness, nor was taking
medication (other than insulin and the combined oral contraceptive pill) and
none of the subjects had any evidence of microvascular disease. The absence of
retinopathy was confirmed by direct ophthalmoscopy and digital retinal
imaging. Peripheral neuropathy was excluded by clinical examination, and none
of the participants had microalbuminuria. No subjects had a history of impaired
awareness of hypoglycaemia. Care was taken to avoid hypoglycaemia in the 48
hours prior to the cognitive testing, with regular blood glucose monitoring,
including bedtime measurements on the night before each study. The study was
deferred for one week if there was evidence at that time of biochemical
hypoglycaemia (blood glucose <4.0 mmol/1). Ethical permission for the study
was given by the Lothian Medical Ethical Advisory Committee, and all subjects
gave their written informed consent.
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Study Design
The subjects were studied on two occasions, separated by at least one week.
The experiment had a repeated measures, counterbalanced design, i.e. half of the
subjects underwent the euglycaemia session first, followed by the
hypoglycaemia study, and the other half were studied in the reverse order. A
modified hyperinsulinaemic glucose clamp technique [DeFronzo et al, 1979]
was used to adjust the blood glucose to a predetermined level. In one condition,
hypoglycaemia was induced (blood glucose 2.6 mmol/1) and maintained at this
level, and in the other condition the blood glucose concentration was maintained
at 4.5 mmol/1 (euglycaemia). During the two study conditions (euglycaemia and
hypoglycaemia) tests of cognitive function were administered and the subjects
completed a questionnaire on the symptoms of hypoglycaemia. Subjects were
blinded as to the order of the studies and to their prevailing blood glucose
concentration at all times throughout the procedure.
Procedure
Each session commenced at 0800 hrs after an overnight fast, and the subjects
omitted their morning dose of insulin. The procedure was as detailed in section
5.1.4.
Cognitive Function Tests
The Test of Everyday Attention (TEA) [Robertson et al, 1994] and the Raven's
Standard Progressive Matrices (RPM) [Raven's Progressive Matrices, SPM,
1958] were used to measure attention and intelligence respectively. The order
of the tests was identical during each study condition.
Test of Everyday Attention (TEA)
The TEA was devised from the evidence on separable attention systems in the
brain [Posner and Peterson, 1990]. Using the concept that attention is
fractionated into different supramodal systems, it has been proposed that
attention consists of at least three separate systems [Posner & Peterson, 1990].
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A selection system is responsible for selecting relevant stimuli/processes and
inhibiting irrelevant ones, a vigilance system maintains readiness to respond in
the absence of external cues and an orientation system is responsible for
engaging, moving and disengaging attention in space. The Test of Everyday
Attention attempts to measure aspects of the selection and vigilance systems and
correlates significantly with existing measures of attention. The TEA is
described in detail in section 5.2.2.
Briefly, the TEA is divided into eight subtests and has parallel forms. Subjects
were asked to pretend that they were on holiday in Philadelphia in the USA, and
were told that they would be asked to perform various tasks such as looking for
symbols on maps, consulting telephone directories, attending to lottery numbers,
and going up and down in elevators. The attention processes examined and their
corresponding test(s) are shown in table 7.1.
Raven's Progressive Matrices (RPM)
The RPM examine general non-verbal intelligence and specifically measure the
inductive ability to find and apply rules that make it easier to bring order to
complex situations and events [Carpenter et al, 2000]. The RPM are considered
to be the single best measure of general fluid intelligence [Marshalek et al,
1983], The Matrices' items are diagrammatical puzzles exhibiting serial change
in two dimensions simultaneously. Each puzzle has a part missing which the
subject has to find among the answer options provided. The correct answer is
found by discovering and correctly applying the rules governing the changes in
each item's pattern. The test consists of 60 items divided into five sets, each
consisting of 12 items. Subjects were assigned two scores for this test; the
number correct at 20 minutes and the number correct at completion (no time
limit). By doing this, the speed of accurate intellectual work and the total
capacity for orderly thinking of the subjects could be assessed.
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Table 7.1 The subtests and attention processes of the TEA
Attentional Process Test
Selective Attention
Speed Of Information Processing
Map Search
Telephone Search
Attentional Switching Visual Elevator
Sustained Attention Lottery Counting
Elevator Counting
Telephone Search While Counting
Divided Attention Telephone Search While Counting
Attentional Switching Elevator Counting With Reversal
Elevator Counting With Distraction
Symptoms of hypoglycaemia
A subjective self-rating system (The Edinburgh Hypoglycemia Scale) [Deary et
al, 1993a] was applied at four time points: baseline, before and after the TEA,
and after the RPM. The symptoms of hypoglycaemia were classified as
autonomic (palpitations, sweating, shaking and hunger), neuroglycopenic
(drowsiness, confusion, inability to concentrate, speech difficulty and blurred
vision) and non-specific (headache and nausea). Each symptom was graded on
a Likert scale of 1 to 7 (1 = not present, 7 = very intense). The total for each
subgroup of hypoglycaemic symptoms was calculated. A validated 7-point
scale was used to assess impaired awareness of hypoglycaemia [Gold et al,
1994],
Statistical analysis
The results were analysed independently for each subtest of the TEA and the
RPM. A general linear model (repeated measures analysis of variance) was
used with order of session as a 'between-subjects' factor with two levels
(euglycaemia-hypoglycaemia or hypoglycaemia-euglycaemia), and condition as
a 'within-subjects' factor with two levels (euglycaemia versus hypoglycaemia).
A similar model was used to analyse the symptoms of hypoglycaemia, with the
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addition of time as a 'within-subjects' factor with four levels. During the
symptoms analysis, the principal outcome statistic was any (experimental versus
time) interaction as this indicated the effects of hypoglycaemia on symptoms
controlled for day-to-day variation by including baseline scores. A p value of
lees than 0.05 was considered to be significant. Effect size was calculated using
Eta squared (ri2). r|2 is the proportion of the variance in the test scores
accounted for by study condition (euglycaemia versus hypoglycaemia). A r|2
score of 0.25-0.5 was considered a moderate effect size [Cohen, 1992]. All
analyses were performed using SPSS version 11.0 for Windows.
7.3 Results
A stable blood glucose plateau was achieved during each condition (figure 7.1).
The mean (SD) blood glucose concentration during the hypoglycaemia clamp
was 2.6 (0.2) mmol/1, and during euglycaemia was 4.5 (0.2) mmol/1. The initial
statistical analysis revealed that no significant order effects had occurred.
Symptoms
During the hypoglycaemia study arm, autonomic symptom scores increased
from a mean (SD) of 5.1 (1.2) at baseline to 7.9 (2.8) during hypoglycaemia
(p=0.005). The neuroglycopenic symptom score increased from a mean (SD) of
6.0 (1.9) at baseline to 11.1 (5.4) during hypoglycaemia (p=0.01). No
significant increment was observed in the general malaise symptom scores,
which increased from 2.1 (0.3) at baseline to 3.3 (1.8) during hypoglycaemia
(p=0.04). There were no significant changes in symptom scores during the
euglycaemia study arm. The symptom reports confirmed that all subjects had
intact symptomatic awareness of hypoglycaemia at the predetermined low blood
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Tests ofAttention
The results of the attention tests are summarised in tables 7.2 and 7.3.
Visual Selective Attention
Acute hypoglycemia caused a significant deterioration in tests sensitive to a
visual selective attention deficit. The mean number ofmap symbols circled was
lower during hypoglycaemia at both one minute (p=0.032, r|2=0.29) and at two
minutes (p=0.042, p2=0.26). By contrast, in the telephone search task, no
difference was demonstrated between euglycaemia and hypoglycaemia in the
number of symbols located (p=0.46). However, the mean time taken to
complete the task increased significantly during hypoglycaemia (p=0.022,
r)2=0.32). The results demonstrate that a visual selective attention decrement
had developed during hypoglycaemia.
Auditory Selective Attention/Auditory Verbal Working Memory
With the auditory elevator test with distraction, the achieved score declined
during hypoglycaemia with a large effect size (p=0.001, r)2=0.59) (figure 7.2).
Furthermore, the score attained on the elevator test with reversal deteriorated
during hypoglycaemia (p=0.013, r|2=0.39).
Sustained Attention
Sustained attention did not deteriorate during hypoglycaemia using either the
lottery ticket test (p=0.26) or the elevator counting test (p=0.15).
Attentional Switching
In the visual elevator task, no difference was observed in the raw score between
the two study conditions (p=0.21). However, a significantly longer time was
required to complete the visual elevator task during hypoglycaemia with a large
effect size (pO.OOOl, r|2=0.78).
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Divided attention
In the task that involved search of a telephone directory while counting, no
significant difference was observed in the number of symbols that were located
during either study condition (p=0.67). However, the time taken to complete the
task was higher during hypoglycaemia (p=0.001, r|2=0.58). The time per target
score, which is the ratio of the number of circled symbols divided by the time
taken for the task, was higher during hypoglycaemia with a moderate effect size
(p=0.036, r|2=0.28). The dual task decrement was not significantly different
between the two conditions (p=0.95).
Non-verbal intelligence
Using Raven's Progressive Matrices, no significant differences were observed
between euglycaemia and hypoglycaemia in the scores achieved either at 20
minutes or upon completion of the test. The mean (SD) RPM score at 20
minutes was 50.1 (5.6) during euglycaemia and 49.0 (6.4) in the hypoglycaemia
condition (p=0.24, r|2=0.12). Upon completion, the mean (SD) score was 51.7
(6.1) in the euglycaemia condition and 50.6 (6.0) during hypoglycaemia
(p=0.11, r)2=0.22) (figure 7.3). No significant differences were found between
the two study conditions in the times taken to complete the test.
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7.4 Discussion
In the present study, impairment of function in the subdivisions of attention was
demonstrated to occur during hypoglycaemia in adults with type 1 diabetes. A
cognitive test battery was employed that was designed specifically to measure
multiple facets of attention. Visual selective attention deteriorated during
hypoglycaemia with a moderate effect size, whereas auditory selective attention
was exquisitely sensitive to hypoglycaemia with a large effect size. Mean
scores on the test of divided attention were significantly poorer during
hypoglycaemia. By contrast, no significant effect was evident on sustained
attention or nonverbal intelligence. The subjects had good glycaemic control
and had no evidence of microvascular disease or co-morbidities that might
influence cognitive performance.
A previous study in Edinburgh which used an identical study design and
cognitive function tests, examined the effects of acute hypoglycaemia in non-
diabetic adults of similar age and observed a broadly similar distribution of
cognitive dysfunction during hypoglycaemia [McAulay et al, 2001]. In that
study, a decline in the rate of information processing was demonstrable in visual
and auditory selective attention and in attentional switching. Although the data
from both of theses studies are congruent with the received wisdom that acute
hypoglycaemia slows the speed of processing, the TEA measures other
cognitive processes. Furthermore, important differences between these two
studies provide further insights on whether diabetes is a factor that moderates an
individual's susceptibility to cognitive dysfunction during hypoglycaemia
[Herold et al, 1985, Widom & Simonson, 1990, Wirsen et al, 1992],
In the present study, significant decrements occurred during hypoglycaemia in
the test scores for auditory selective attention (figure 2 and table 2). Unlike the
other subtests in the TEA, these are not timed, so the decrements noted are not
accounted for by slowing of speeded processing. These two subtests measure
the ability to manipulate and sequence information in auditory-verbal working
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memory [Robertson et al, 1994]. Using principal components analysis, they
share the same factor structure as the Paced Auditory Serial Addition Test
(PASAT) and Backward Digit Span tests [Robertson et al, 1994]. In the study
of non-diabetic volunteers, who were of a similar age (mean (SD) 28.7 (5.3)
years) and premorbid IQ (mean (SD) correct for NART 28.9 (5.8)) as the
subjects with diabetes in the present study (see results), acute hypoglycaemia led
to a deterioration in the elevator counting with distraction test, but not elevator
counting with reversal [McAulay et al, 2001]. Indeed, the effect size during
hypoglycaemia was smaller (r|2=0.40) for elevator counting with distraction in
non-diabetic volunteers, compared with the present study of subjects with
diabetes (r|2=0.59), suggesting a greater cognitive decline in subjects with
diabetes (table 7.2). An example of a clinical correlate for these tests of
auditory verbal working memory is the ability to work out complex mental
arithmetic, an activity that is used by most people on a daily basis.
Important differences in visual selective attention deficits during hypoglycaemia
were also observed. Although hypoglycaemia led to a similar reduction in the
number of map search symbols found in one minute during both studies, only
the subjects with diabetes showed a significant deterioration in the score for the
number ofmap symbols circled at two minutes (table 2). While the map search
subtest is a timed test, and to an extent will measure speed of processing, it also
evaluates the ability to select target stimuli, while ignoring powerfully
competing distractors, and hence also involves a considerable degree of
selective attention. Supporting evidence for this can be found using principal
components analysis, in which the map search shares the factor structure of
visual selective attention, in common with tests such as Trails B [Reitan, 1958]
and the d2 visual search task [Brickenkamp, 1962]. Therefore, because the
effects of the other tests of speeded processing administered during
hypoglycaemia were similar both in the non-diabetic and diabetic subjects, it is
possible that acute hypoglycaemia has a greater impact on visual selective
attention in subjects with type 1 diabetes, especially when the test is prolonged.
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This argument is supported by a further study where acute hypoglycaemia
caused a significant and marked deterioration in visual information processing
[McCrimmon et al, 1996], An alternative explanation is that the cognitive
'reserve' for speeded tests, or visual selection tests, is diminished in people with
type 1 diabetes.
In the present study, sustained attention, as assessed by the lottery and elevator
counting tasks, was not impaired during hypoglycaemia. This is consistent with
a previous study of non-diabetic subjects [McAulay et al, 2001], and since most
subjects achieved the highest score possible during both study conditions,
suggests that significant ceiling effects had occurred. These results are at
variance with a different study in which sustained attention to detail was
profoundly affected by hypoglycaemia [Draelos et al, 1995]. However, in that
study the digit vigilance test [Lewis & Rennick, 1979] was used as a measure of
sustained attention. In this test, subjects are given a page containing rows of
digits and instructed to cancel target digits (either the number 6 or 9). The
number of targets located in 2 minutes as well as the percentage of targets
erroneously missed are scored, providing measures of speed and accuracy. It is
highly likely that this test is measuring speeded processing, and this may
account for the significant deterioration in this subtest in the study by Draelos et
al [1995]. In the present study, although it is possible that a test of longer
duration may have increased the sensitivity of detecting a deterioration, it
appears that sustained attention to detail over a short period of time (10 minutes)
is unaffected by hypoglycaemia. Finally, the degree of attentional impairment
observed in the present study may underestimate the severity of the effect when
it is experienced during a "real life" episode of hypoglycaemia when the rate of
fall of blood glucose may be more rapid.
In the present study, non-verbal intelligence did not diminish significantly
during hypoglycaemia, as was observed in a previous study of non-diabetic
volunteers [McAulay et al, 2001] (figure 3). This outcome was unexpected
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because so many aspects of cognition are adversely affected during
hypoglycaemia [Deary et al, 1999]. Furthermore, the RPM is known to have a
substantial correlation with working memory [Ackerman et al, 2002], which is
very sensitive to hypoglycaemia [Deary et al, 2003, Sommerfield et al, 2003b].
It is conceivable that the cognitive abilities required for activities such as those
tested by the RPM are resistant to the effects of hypoglycaemia, but this
hypothesis contravenes the received wisdom that complex tasks are more
susceptible than simple tasks to disruption during acute hypoglycaemia [Deary
et al, 1999]. It is unlikely that the brain would have adapted to cope with the
effects of hypoglycaemia during a study of this relatively short duration [Gold et
al, 1995d],
A more likely explanation is that the standard matrices that were used here were
too easy for this particular group of adults. These matrices were designed
originally to cover the widest possible range of mental ability and to be
applicable to persons of all ability levels. At the beginning of each set in the
RPM most of the problems are simple. This hypothesis about the difficulty
level of the standard RPM was tested in non-diabetic adults by using a more
difficult test of general fluid intelligence, the Raven's Advanced Progressive
Matrices (RAPM) [Warren et al, 2004]. In that study, acute hypoglycaemia
caused a significant deterioration in the RAPM, suggesting that a ceiling effect
had occurred using the standard RPM. However, it is relevant that in the study
by Warren et al [2004] the mean number correct score of the subjects, using the
National Adult Reading Test, was higher (at 40) compared to the present study
of people with type 1 diabetes and to the previous study of non-diabetic subjects
[McAulay et al, 2001] in both of which it was 28. People with a higher
intelligence may be more susceptible to cognitive dysfunction during
hypoglycaemia [Gold et al, 1995a], which may explain, in part, the observations
of the study by Warren et al [2004], In addition, the RAPM provides a means of
examining high-level inductive reasoning ability, spreading the distribution of
scores in the top 25% of the population and assessing more accurately a person's
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speed of intellectual work; timed tests such as the RAPM discriminate against
those who work more slowly and carefully. When the diabetic subjects in the
present study were allowed to complete the test in their own time, no significant
differences were observed in the scores achieved, or the times taken, to
complete the task during both study conditions, which is consistent to observed
responses in the previous study of non-diabetic adults [McAulay et al, 2001].
The present study has demonstrated that acute controlled hypoglycaemia causes
attentional dysfunction in adults with type 1 diabetes, while there was a non¬
significant decline in non-verbal reasoning. The tests of attention that were used
in the present study are plausible, realistic and relevant to everyday activities,
thus tasks utilising complex intellectual activity that are relevant to everyday life
activities, such as procedures at work or the process of driving a car, are likely
to be impaired during the moderate insulin-induced hypoglycaemia that is
experienced frequently by people with insulin-treated diabetes. The severity of
the attentional deficit during acute moderate hypoglycaemia was dependent
upon which attentional system was being examined. The degree of
hypoglycaemia examined in this study is common in people with type 1
diabetes, and does not affect conscious level, so a similar deterioration during
hypoglycemia is likely to have important practical implications for many tasks
in the everyday lives of people with type 1 diabetes. The differential
deterioration observed in subtests of visual selective attention and auditory
verbal working memory in subjects with type 1 diabetes compared to non-
diabetic subjects, raises a potentially contentious issue and implies that a





IMPACT OF ACUTE HYPOGLYCAEMIA ON MOOD,
MOTIVATION, THINKING CONTENT AND THINKING STYLE IN
SUBJECTS WITH TYPE 1 DIABETES
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8.1 Introduction
Insulin is an essential hormone for normal metabolism and cell function, and is
required to drive glucose into cells. Since the human brain is almost totally
dependent on the oxidation of glucose supplied by the circulation for its energy
requirements, a reduction of blood glucose supply will usually result in
impairment of cognitive function. In healthy people, physiological mechanisms,
including the release of counterregulatory hormones to promote a return to
normal blood glucose, have evolved that are designed to protect the brain
against hypoglycaemia and, therefore, this is a rare event. However, people
with type 1 diabetes, who need to inject subcutaneous insulin to control blood
glucose, frequently experience blood glucose levels low enough to result in
cognitive disruption [Deary, 1993b], and more rarely seizures [MacLeod et al,
1993], and even coma [Hart & Frier, 1998].
The development of the hyperinsulinaemic glucose clamp technique [DeFronzo
et al, 1979] has enabled the effects of hypoglycaemia in humans to be studied
under steady-state conditions. It allows investigators to 'clamp' the blood
glucose at a predetermined level for a prolonged period, allowing detailed
examination of the physiological and cognitive changes that occur during
hypoglycaemia. Over the last two decades, a considerable body of research has
accumulated on the effects of acute hypoglycaemia on brain function. This has
been done in various ways; in addition to administering tests of cognitive
function [Holmes et al, 1983, 1984, Hoffman et al, 1989, Widom & Simonson,
1990, Kerr et al, 1991a, Mitrakou et al, 1991, Wirsen et al, 1992, Cox et al,
1993b, Pramming et al, 1986], some have examined the neuroglycopenic
symptoms generated during hypoglycaemia [Hepburn et al, 1991]. At an even
more basic level, others have applied electrophysiological measures such as
brain-evoked potentials [Amiel et al, 1991] and functional brain imaging
[Rosenthal et al, 2001]. It has been shown that cerebral blood flow increases
globally during hypoglycaemia, and that the pattern of regional cerebral blood
flow alters during hypoglycaemia in people with diabetes, with increases to the
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superior frontal regions and right thalamus, and decreases to the right posterior
cingulate cortex and putamen [MacLeod et al, 1994].
Controlled studies of hypoglycaemia have demonstrated that a wide range of
mental functions deteriorate when the arterialised blood glucose concentration
declines below 3.0 mmol/1. Abnormalities occur in several domains, including
verbal function, attention and concentration, memory, executive and motor
function [Deary et al, 1993b, Deary et al, 1999, Ryan et al, 1997]. Furthermore,
a hierarchy exists in the sensitivity of different aspects of cognition, with
complex tasks being more severely impaired than simpler cognitive tasks
[Hoffman et al, 1989, Widom & Simonson, 1990, Kerr et al, 1991b, Mitrakou et
al, 1991, Wirsen et al, 1992, Cox et al, 1993b, Pramming et al, 1986]. Until
recently, few individual cognitive domains had received detailed examination.
However, studies are now attempting to address which particular aspects of
these domains are disrupted by neuroglycopenia, and how the abnormalities of
cognitive function that are demonstrable by neuropsychological tests, relate to
everyday mental tasks. For example, the aspects of memory and attention that
are most affected by hypoglycaemia have recently been described [McAulay et
al, 2001, McAulay et al, 2006, Sommerfield et al, 2003a, 2003b, Deary et al
2003, Warren et al, 2004],
Although many aspects of cognitive function have been examined during acute
hypoglycaemia, other important areas have been neglected. Performance
challenges, such as attaining proficiency in the workplace and passing
examinations, have high importance for people in Westernised societies, so that
comprehension of the nature of subjective experience in these settings is of both
theoretical and practical relevance. In particular, little information is available
concerning the subjective feelings that are generated by acute hypoglycaemia.
Much of psychology is shaped by a 'trilogy of mind', dividing psychological
functioning into the three domains of affect (mood), conation (motivation) and
cognition [Hilgard, 1980]. Demanding tasks readily elicit a variety of 'stress'
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responses that impinge on these domains, such as fatigue, anxiety, worry and
loss of motivation (Hockey, 1997). According to cognitive theories of stress,
how a person appraises and then copes with a given situation may drive
individual differences both in subjective stress responses and in objective
behaviour [Matthews & Wells, 1996]. Thus, substantial disturbance of
subjective state may provide at least an indirect marker for potential behavioural
impairments. Participants undergoing laboratory experiments, such as a
hyperinsulinaemic glucose clamp, probably have concerns about whether they
will cope adequately with task requirements.
Few studies have examined the non-cognitive changes in cerebral function that
occur during acute hypoglycaemia including the influence on emotions (affect,
mood). The emotional consequences of living with the ever-present risk of
hypoglycaemia can affect the personal lives of both the individual with diabetes
and other members of the family. Therefore, it is not surprising that most
individuals with recurrent exposure to severe hypoglycaemia develop an
aversion to it. In general, hypoglycaemia promotes expression of negative mood
states including diminished energetic arousal, decreased happiness, increased
anxiety and increased anger [Gold et al, 1995c, Hepburn et al, 1995,
McCrimmon et al, 1999a, 1999b]. However, to our knowledge, no studies have
examined either the role of motivation on the performance and outcomes of
controlled studies of hypoglycaemia, or the perception of workload during the
tasks administered. The conative aspect of mind has not been explored during
hypoglycaemia. Furthermore, the subjective component of subjects' style of
thinking and beliefs, such as self-esteem, concentration, and control and
confidence, in relation to the tasks that they are asked to perform during
hypoglycaemia has not been examined (i.e. subjective cognition). The
subjective factors that may index potential interference with cognitive task
performance have also been neglected.
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The present study examined the three aspects of mental function during acute,
controlled, insulin-induced hypoglycaemia. Thus, mood, motivation and
cognition were examined in adults with type 1 diabetes using a validated
measure, the Dundee Stress State Questionnaire (DSSQ) [Matthews et al, 1999].
Workload was also assessed.
8.2 Materials and Methods
Subjects
Sixteen adults with type 1 diabetes were recruited from the diabetes outpatient
clinics at the Royal Infirmary of Edinburgh. Their clinical characteristics are
shown in table 8.1. The median (range) age was 25.5 (18-39) years and the
duration of diabetes was 8.0 (2.5-15) years with a mean (SD) Body Mass Index
of 24.1 (1.8) kg/m2. The mean (SD) National Adult Reading Test (NART)
number correct score was 27 (7.8). Thus, the group comprised people whose
mean was above average intelligence, with an overall predicted full scale
intelligence quotient of around 109. Their mean (SD) HbAlc, measured by
high-performance liquid chromatography (Variant II Hemoglobin Testing
System; Biorad Diagnostics, Hercules, CA) was 7.7 (1.0)% (local Diabetes
Control and Complications Trial-aligned, non-diabetic reference range: 4.3-
6.5%). None of the participants had a history of chronic disease, hypertension,
previous head injury, seizure, blackout, alcohol or drug abuse, or psychiatric
disorder. None had any intercurrent illness, nor was taking any medication
(other than insulin or the combined oral contraceptive pill), and none of the
subjects had any evidence of microvascular disease. The absence of retinopathy
was confirmed by direct ophthalmoscopy and digital retinal imaging. Peripheral
neuropathy was excluded by clinical examination, and none of the participants
had microalbuminuria. No subjects had a history of impaired awareness of
hypoglycaemia. Care was taken to avoid hypoglycaemia in the 48 hours prior to
the cognitive testing, by performing frequent blood glucose monitoring,
including bedtime measurements on the night before each study. The study was
deferred for one week if there was evidence at that time of biochemical
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hypoglycaemia (blood glucose<4.0 mmol/1). Ethical permission for the study
was given by the Lothian Medical Ethical Advisory Committee, and all subjects
gave their written informed consent.
Table 8.1 Clinical characteristics of sample
Age (years) 25 (18-39)
Male (%) 62.5
Duration of diabetes (years) 8.0(2.5-15)
BMI (kg/m2) 24.1 (1.8)#
HbAlc (%) 7.7(1.0)#
Data are median (range), unless otherwise indicated
# mean (SD)
Study Design
The subjects were studied on two occasions, separated by at least one week.
The experiment had a repeated measures, counterbalanced design, i.e. half of the
subjects underwent the euglycaemia condition first, followed by the
hypoglycaemia condition, and the other half were studied in the reverse order.
A modified hyperinsulinaemic glucose clamp technique [DeFronzo et al, 1979]
was used to adjust the blood glucose to a predetermined level. In one condition,
hypoglycaemia was induced (blood glucose 2.6 mmol/1) and maintained at this
level, and in the other condition the blood glucose concentration was maintained
at 4.5 mmol/1 (euglycaemia). During these two study conditions
(hypoglycaemia and euglycaemia, respectively) tests of cognitive function were
administered and the subjects completed a questionnaire on the symptoms of
hypoglycaemia. The cognitive tests that were administered were the Test of
Everyday Attention (TEA) [Robertson et al, 1994] and the Raven's Progressive
Matrices (RPM) [Raven's Progressive Matrices, SPM, 1958]. The DSSQ was
administered before, and after, the cognitive function tests during both arms of
the study. Subjects were unaware of the order in which the studies were
performed and were not informed about their prevailing blood glucose
concentration at all times throughout the procedure.
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Procedure
Each session commenced at 0800 hrs after an overnight fast, and the subjects
omitted their morning dose of insulin. The procedure was as detailed in section
5.1.4.
The Dundee Stress State Questionnaire
The DSSQ has been described in detail in section 5.2.4. In the present study,
Annexe A was administered prior to the TEA and RPM, and Annexe B was
completed after these tests. Briefly, the TEA [Robertson et al, 1994] is a
validated batch of attention tests that measure aspects of the selection and
vigilance systems of attention (section 5.2.2), and the RPM [Raven's
Progressive Matrices, SPM, 1958] examine general non-verbal intelligence
(section 5.2.3). These two tests were administered over approximately 90
minutes. Instructions for the DSSQ emphasise rating immediate rather than
typical subjective experience, to ensure reporting of short-term states rather than
enduring traits (i.e. personality dispositions that show much greater temporal
stability [Matthews et al, 2003]. The scales show adequate internal
consistencies with Matthews et al (2002) reporting Cronbach alpha coefficients
ranging from 0.77-0.89. The DSSQ has been validated as a state index in
studies showing that it is sensitive to external stress factors, appropriately
correlated with cognitive stress factors, and predictive of objective performance
indices [Matthews et al, 1999, 2001, 2002].
Test of Everyday Attention (TEA)
The TEA was devised from the evidence on separable attention systems in the
brain [Robertson et al, 1994]; it attempts to measure aspects of the selection and
vigilance systems. Briefly, the TEA is divided into eight subtests and has
parallel forms (table 5.1). Subjects were asked to pretend that they were visiting
Philadelphia in the USA, and were told that they would be asked to perform
various tasks such as looking for symbols on maps, consulting telephone
directories, and travelling in an elevator. The results of the TEA and RPM used
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in this study have been reported elsewhere [McAulay et al, 2006], Briefly,
visual selective attention deteriorated during hypoglycaemia with a moderate
effect size (p=0.03), whereas auditory selective attention was exquisitely
sensitive to hypoglycaemia with a large effect size (p=0.001). Mean scores on
the test of divided attention were poorer during hypoglycaemia (p=0.001),
whereas no significant effect was evident on sustained attention (p=0.15) or
nonverbal reasoning (p=0.24) [McAulay et al, 2006],
Symptoms of hypoglycaemia
A validated self-rating system for subjective symptoms of hypoglycaemia (The
Edinburgh Hypoglycemia Scale) [Deary et al, 1993a] was applied at four time
points: baseline, before and after the TEA, and after the RPM. The symptoms of
hypoglycaemia were classified as autonomic (palpitations, sweating, shaking
and hunger), neuroglycopenic (confusion, drowsiness, inability to concentrate,
speech difficulty and blurred vision) and non-specific (nausea and headache).
Each symptom was graded on a Likert scale of 1 to 7 (1 = not present, 7 = very
intense). The total for each subgroup of hypoglycaemic symptoms was
calculated.
Statistical analysis
The results were analysed independently for each subtest of the DSSQ. A
general linear model (repeated measures analysis of variance) was used, with
order of glycaemic condition as a 'between-subjects' factor with two levels
(euglycaemia-hypoglycaemia or hypoglycaemia-euglycaemia). There were two
'within-subjects' factors, each with two levels; experimental condition
(euglycaemia versus hypoglycaemia) and time (baseline versus experimental).
A similar model was used to analyse the symptoms of hypoglycaemia; however
time was a 'within-subjects' factor with four levels. During the symptoms
analysis, the principal outcome statistic was any (experimental versus time)
interaction as this indicated the effects of hypoglycaemia on symptoms
controlled for day-to-day variation by including baseline scores. A p value of
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less than 0.05 was considered to be significant. Effect size was calculated using
Eta squared (r|2). r\2 is the proportion of the variance in the test scores
accounted for by the relevant study effect. A r|2 score of 0.25-0.5 is considered
a moderate effect size [Cohen, 1992]. All analyses were performed using SPSS
version 11.0 for Windows.
8.3 Results
A stable blood glucose plateau was achieved during each condition (figure 8.1).
The mean (SD) blood glucose concentration during the hypoglycaemia clamp
was 2.6 (0.2) mmol/1, and during euglycaemia was 4.5 (0.2) mmol/1. The initial
statistical analysis revealed that no significant order effects had occurred.
Symptoms
During the hypoglycaemia study arm, significant increments occurred in the
scores for autonomic (p=0.005) and neuroglycopenic symptoms (p=0.01), but no
significant change was observed in the symptoms of general malaise (p=0.4).
There were no significant changes in symptom scores during the euglycaemia
study arm. The symptom reports confirmed that all subjects had intact
symptomatic awareness of hypoglycaemia at the predetermined low blood
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DSSQ results
The results are summarised in tables 8.2 and 8.3.
Mood
Acute hypoglycaemia caused a significant increase in anxiety with a
concomitant reduction in energy levels. The mean score for energetic arousal
decreased significantly during hypoglycaemia (p=0.03, p2=0.48) with a
moderate effect size. A significant increase occurred in scores for tense arousal
during hypoglycaemia (p=0.05, r|2=0.25). No significant changes were
observed in the scores for hedonic tone (p=0.11) during hypoglycaemia, and a
trend to higher anger/frustration scores (p=0.09, rj2=0.19) was noted. No
significant differences were noted before and after cognitive testing, and the
time by condition interaction was not significant for any mood scale.
Motivation and workload
A trend towards reduced motivation was observed during the hypoglycaemia
arm of the study (p=0.07, r|2=0.21). During both arms, a significant decrease
occurred in motivation over the period of cognitive function testing, with a
• 9
moderate to large effect size (p=0.01, r\ =0.35). Subjects reported less
motivation afterwards. Perception of workload was higher during
• • • • • 2
hypoglycaemia, but did not achieve statistical significance (p=0.11, r\ =0.17).
Thinking style
A significant time by study condition interaction for self-focus was observed,
with a moderately large effect size (p=0.02, r| =0.32). Inspection of the mean
values in table 8.3 reveals that, although self-focus is similar at baseline during
hypoglycaemia and euglycaemia, the subjects' mean levels of self-focus were
very high when reported at post-test. That is, their reports indicate that self-
focus was especially high during hypoglycaemia. The main effect of
hypoglycaemia did not result in a significant change in self-focus (p=0.14) or
self-esteem (p=0.44). Similarly, no significant pre- and post-task changes on
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self-esteem (p=0.15) or self-focus (p=0.65) were demonstrable during each arm
of the study. Concentration, and control and confidence did not alter
significantly during hypoglycaemia (p=0.14 and p=0.19 respectively).
Similarly, no significant pre-and post-task changes developed in concentration
(p=0.22) or control and confidence (p=0.10). There were no further time by
condition interactions.
Thinking content
Significant main effects of acute hypoglycaemia were observed both in task-
relevant and -irrelevant interference. Task-relevant interference decreased
during hypoglycaemia (p=0.03, r\ -0.29). By contrast, for task-irrelevant
interference, a large increment in scores was observed during hypoglycaemia
(p=0.02, r|2=0.32). No main effects of time and no significant time by condition
interactions were found.
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8.4 Discussion
To our knowledge this study is the first to examine comprehensively the
subjective cognitive and conative aspects of mental function during controlled
hypoglycaemia. This complements previous research which demonstrates the
disruptive effects of hypoglycaemia on cognitive and emotional mental states
[Deary, 1999]. Prior to completing cognitive tests, hypoglycaemia and
euglycaemia did not differ with respect to reported self-focus of attention.
However, when subjects reported on their mental state during task performance,
self-focus of attention was much higher during hypoglycaemia. Self-focus of
attention refers to a state of self-preoccupation and reflection, or private self-
consciousness. During the hypoglycaemia condition as a whole, task-relevant
interference decreased whereas task-irrelevant interference increased, i.e. there
was an increase in thoughts that were irrelevant to the cognitive tasks
performed. We replicated previous findings that a less energetic and more tense
mood develops during hypoglycaemia [Gold et al, 1995c, Hepburn et al, 1995,
McCrimmon et al, 1999a, 1999b]. Thus, viewed as a 'stressor', hypoglycaemia
conforms to the typical finding that stressors produce patterned changes in
multiple psychological state indices, rather than some global change in stress or
anxiety [Hockey, 1997, Matthews et al, 2002]. That is to say, some elements of
state are more sensitive to hypoglycaemia than others.
The features of the multifaceted state changes associated with hypoglycaemia
will now be addressed in more detail, and their potential impact on behaviour
and performance is assessed. These new findings about how cognition is
affected during hypoglycaemia provide information about the effect of a low
blood glucose on the brain. The subjects have extra thoughts, irrelevant to the
task, in their minds, even before performance of the tasks. This might be caused
by an awareness of cognitive impairment during hypoglycaemia. However,
such extra content in consciousness is likely to drain processing resources and
limit performance in its own right. Extensive evidence from studies of
evaluative anxiety has demonstrated detrimental effects of cognitive interference
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on information processing and performance [Zeidner, 1998]. Thus, performance
of the hypoglycaemic person is doubly compromised in that the mood changes
of reduced energy and (to a lesser degree) increased tension are also associated
with impairments on demanding attentional tasks [Matthews et al, 2001].
These effects of hypoglycaemia were main effects, and appeared during both
pre- and post-test, indicating a general state difference. In addition, the time by
study condition interaction for self-focus indicated an effect in which
hypoglycaemia moderated the subjective response to performing the tasks.
Interestingly, the increase in self-focused attention appeared in awareness after
the participants had performed a cognitive task, suggesting that the challenge of
this cognitive effort and engagement elicited additional self-referent processing
that might also impair mental performance. The state change seen in
hypoglycaemia is unusual, in that self-focused attention typically declines
during task performance, as subjects orient attention away from the self and
towards the task [Matthews et al, 2002]. Previous research suggests that the
combination of self-focused attention and high tension or anxiety is often
detrimental to performance [Carver, 1996, Wells & Matthews, 1994], In
summary, it would appear that the brain is not only less cognitively competent
and more dysphoric during hypoglycaemia, it is also more self-aware and
distracted when required to perform effortful processing. More time is occupied
by thinking about the task, the self, and other things, possibly leaving fewer
processing resources for successful completion of the cognitive tasks, whether in
the laboratory or during everyday life. It could be argued that the effects of
acute hypoglycaemia on self-focus represent a type 1 error. Of course, this is a
possibility, and in such a new area of study these results will require replication
in future studies.
The tests of cognitive function utilised during studies of hypoglycaemia have
been criticised as being imperfect because of the perceived practice effect that
may take place, i.e. repetition of the test will improve performance. The
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resulting improvement results from practice and will diminish the impairment
caused by hypoglycaemia, leading to the incorrect conclusion that cognitive
function is unaffected or only modestly impaired. Furthermore, fatigue may
increase the sensitivity of cognitive tests, in that those tests attempted at the end
of a test period may be more sensitive to the effects of hypoglycaemia [Heller &
Macdonald, 1996]. It may also be difficult to discriminate the effects of affect,
or mood, from those of its cognitive and motivational concomitants (although
the multidimensional assessment provided by the DSSQ may allow such
discriminations to be made). For example, the effects of anxiety on behaviour
might be mediated by affect (e.g. tension) or by cognitions (e.g. intrusive
thoughts and worries), or by motivations, such as the urge to withdraw from the
threatening situation. Another variable is that the motivation to perform a task
may decline over the cognitive function testing period and between test days,
thereby influencing the results. Effort reduction is a common response to tasks
that have little perceived value [Hockey, 1997]. Vigilance tasks are often lower
in workload but require the performer to cope with the monotony of the task
[Scerbo, 1998]. Thus reduced motivation, energy and concentration may all be
expressions of the fatigue control mode.
In this context, two broad modes have been suggested. In an 'overload' mode,
the person maintains effort to compensate for processing inefficiency,
generating emotional strain, loss of performance on low-priority tasks
components, and provoking physiological responses such as catecholamine
secretion. With the 'fatigue' mode, the person reduces the target level of
performance, so that less effort is required, and the person primarily experiences
loss of motivation and energy rather than strain [Hockey, 1997]. In the present
study, motivation declined to a similar extent during both the euglycaemia and
hypoglycaemia arms of the glucose clamp, thus reassuring and supporting the
results and conclusions of previous studies of hypoglycaemia. Although
workload scores did increase during hypoglycaemia, they did not achieve
statistical significance, suggesting that despite moderate hypoglycaemia, the
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neuroglycopenia induced may conceal the workload of the task being
undertaken.
Within the affective domain, mood states provide a background context for
psychological functioning, and impinge on different functions such as attention,
judgement, and memory [Matthews, 1992], In the present study, hypoglycaemia
produced a negative mood state with a significant fall in energy levels and a
concomitant rise in anxiety levels. These findings concur with previous
observations in Edinburgh [Hepburn et al, 1995] in a study utilising an insulin
infusion to induce hypoglycaemia in 12 subjects without diabetes and 15
subjects with type 1 diabetes. They are also broadly similar to the results of
another study, in which a hyperinsulinaemic glucose clamp was used to induce
hypoglycaemia in 24 non-diabetic adults [Gold et al 1995c]. In that study,
hypoglycaemia induced significant increments in the scores for tense arousal
with a decrement in that for energetic arousal. Furthermore, in another study of
healthy adult volunteers [McCrimmon et al 1999a], which also used the
hyperinsulinaemic glucose clamp technique, a rise in anxiety levels was
demonstrated during hypoglycaemia. However, in these previous studies of
non-diabetic subjects [Gold et al, 1995c, McCrimmon et al, 1999a], subjects
became less happy (hedonic tone) during hypoglycaemia in contrast to the
present findings. This is perhaps not surprising since non-diabetic volunteers
are unaccustomed to hypoglycaemia, whereas this state is experienced on a
frequent basis by people with type 1 diabetes. Finally, the small rise in anger
scores during hypoglycaemia in the present study is consistent with previous
data [McCrimmon et al, 1999b] and is compatible with the symptom of
aggression, or even frustration, that is occasionally manifest as an expression of
hypoglycaemia in some individuals.
Despite the wide-ranging effects of acute hypoglycaemia on the various
subcomponents of attention [McAulay et al, 2001, McAulay et al, 2006], in the
present study, the subjects' perception of their concentration abilities was
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unaffected during prolonged moderate hypoglycaemia. Similar results were
observed for control and confidence, with no decline in the scores for these tasks
during hypoglycaemia. These data are congruent and extend that found in
ambulant subjects with type 1 diabetes who were asked to evaluate their
decision to drive based on their perception of what their blood glucose
concentration was at that time [Clarke et al, 1999]. In that study, approximately
half of subjects decided that it was safe to drive at least 50% of the time when
their blood glucose level was less than 3.9 mmol/1. However, self-focus of
attention did increase significantly between euglycaemia and hypoglycaemia
signifying an increase in sensitivity to criticism from others, implying that
significant worry occurs during hypoglycaemia in addition to the elevated level
of anxiety demonstrated earlier.
A high level of interference may be generated by many different specific
thoughts about personal concerns [Carver, 1996, Sarason et al, 1986]. The state
is defined by the overall level of intrusive thoughts, not by the specific contents
of the thoughts. Acute hypoglycaemia increased task-irrelevant interference
demonstrating that the state of hypoglycaemia is characterised by intrusive
thoughts which are unconnected to the task that is currently being undertaken. It
is also possible that this state may persist across a change of context. For
example, worries experienced during an episode of acute hypoglycaemia may
transfer to state at the workplace or at home, thus affecting quality of life.
Although we controlled for the recognised moderators of cognitive dysfunction
during hypoglycemia such as glycaemic control, antecedent hypoglycemia, age,
pre-morbid intelligence and impaired awareness of hypoglycemia, there were
important individual differences between subjects in this study. The mechanism
underlying this phenomenon remains elusive but there may be a potential
association with serum angiotensin-converting enzyme (s-ACE) activity. The
frequency of severe hypoglycemia varies greatly between people with diabetes,
and is positively correlated with s-ACE activity [Pedersen-Bjorgaard U et al,
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2001, Pedersen-Bjorgaard U et al, 2003, Nordfeldt et al, 2003]. Low s-ACE
activity confers greater ability to function during physical stress [Montgomery et
al, 1998, Gayagay et al, 1998], and people with diabetes with low s-ACE
activity may be better able to maintain cognitive function during acute
hypoglycemia. However, the mechanism through which such an effect might be
mediated is unknown.
The present study has demonstrated that the motivation to perform the tasks of
the TEA and RPM becomes impaired during acute controlled hypoglycemia.
Therefore, it is reasonable to assume that with an appropriate study design
(counter-balanced design and euglycemia control arm) and suitable
methodology (appropriate tests to reduce practice effects for cognitive tests), the
effects of workload, fatigue and motivation are unlikely to be modifying the
results of studies of hypoglycemia. Acute hypoglycemia induces a state of
significant worry and anxiety which is likely to have an impact on our patients'
social, personal and work activities. It is disconcerting that during
hypoglycemia, subjects with type 1 diabetes seem to be relatively unconcerned
about their potential danger and predicament, and continue to feel in control of,
and confident about their abilities. This has obvious implications for performing







OPTIMAL TIME OF ADMINISTRATION OF INSULIN LISPRO IN
THE SETTING OF A HIGH FAT MEAL
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9.1 Introduction
The advent of fast-acting analogues of human insulin (insulin lispro and insulin
aspart) which are more rapidly absorbed following subcutaneous injection, and
have a faster onset and shorter duration of action than human soluble insulin
[Howey et al, 1994], has allowed greater flexibility in their time of
administration. Although they are usually injected immediately before meals to
avoid inducing preprandial hypoglycaemia [Anderson et al, 1997, Garg et al,
1996], a delayed rise in postprandial blood glucose or a reduced magnitude of
the glycaemic response to food may increase the risk of early postprandial
hypoglycaemia.
The rate of gastric emptying is an important determinant of the temporal
response ofpostprandial blood glucose [Horowitz et al, 1993], and is influenced
by the composition of a meal [Kong et al, 1996, Macdonald, 1996]. Liquids
leave the stomach more rapidly than solids [Kelly, 1980, Collins et al, 1991,
Lyrenas et al, 1997], and gastric emptying is slower when the composition of a
meal is high in fat [Hunt et al, 1968, Houghton et al, 1990, Sidery et al, 1994].
Studies using insulin lispro have shown that administration a few minutes before
a meal is the optimal time of injection in most clinical situations. However, in
people with type 1 diabetes the absorption of nutrients is slower when a meal is
high in fat (particularly in the solid-phase) because gastric emptying is slower
[Horowitz et al, 1991]. In this situation, postprandial administration of insulin
lispro may be necessary to provide a closer match between the time action
profile of the fast-acting insulin and the postprandial rise in blood glucose, and
so reduce the risk ofpostprandial hypoglycaemia [Burge et al, 1997a,
Schernthaner et al, 1998, Strachan & Frier, 1998], These previous studies used
test meals characterised by their composition of carbohydrate and fat, and some
had a relatively high liquid content [Burge et al, 1997b, Strachan & Frier, 1998],
While these test meals were chosen to investigate particular aspects of the
composition of food in relation to insulin action, most were absorbed more
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rapidly than the usual high fat, solid-phase meals that are typical of the average
Western diet.
The aim of the present study was to examine the effect of either pre- or post¬
prandial administration of insulin lispro on the pharmacodynamics of blood
glucose following the consumption of a high fat, solid-phase meal, which is
popular in the UK and is often consumed by many people with type 1 diabetes.
The principal objective was to determine which time of administration of insulin
was less likely to allow the development of early post-prandial hypoglycaemia.
9.2 Research design and methods
Subjects
Twelve subjects with Type 1 (insulin-dependent) diabetes were recruited from
the diabetes outpatient clinic of the Royal Infirmary of Edinburgh. All had type
1 diabetes, diagnosed according to World Health Organization criteria, for more
than two years and had a HbAlc concentration below 9.3% [non-diabetic range
4.3-6.5%]. All subjects were using insulin lispro [Eli Lilly & Co., Basingstoke,
UK] as part of a basal bolus regimen (all subjects administered isophane insulin
once daily at bedtime). No subjects were overweight or had significant
microvascular complications of diabetes (other than background retinopathy) or
other medical disorders, and none had a history of dyspepsia or gastric fullness
after meals. Autonomic neural function was assessed using standard tests of
cardiovascular reflexes [Ewing & Clarke, 1985] and none had evidence of
autonomic dysfunction. Table 9.1 shows the clinical characteristics of the
subjects with type 1 diabetes. The study was approved by the local medical
ethics advisory committee, and all subjects gave written informed consent
before taking part.
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Table 9.1 Clinical characteristics of 12 subjects with type 1 diabetes
Group characteristic Median (range)
Gender (M/F)
Age (years)
Duration of diabetes (years)
BMI (kg/m2)
w








The subjects attended on three separate occasions separated by at least one
week. Lunchtime was chosen for the time of the test meal as this was
considered to provide the most stable pre-meal blood glucose concentration,
which was less likely to be affected by fasting hyperglycaemia or asymptomatic
nocturnal hypoglycaemia, and fluctuations in glycaemic control affecting blood
glucose later in the day. The test meal consisted of a pre-weighed portion of
fried fish and ffench fried (chipped) potatoes (170 gms fish, 85 gms fried
potatoes). The fish was coated in batter (a mixture of flour, eggs and milk, used
to coat certain foods before frying) and with the chipped potatoes was deep-fried
in cooking oil. This was freshly prepared in a local commercial outlet. An
allowance of 150 ml ofwater was administered with each test meal. At the first
visit, subjects attended for a preliminary assessment of the insulin dose that
would be required for the test meal. The subjects estimated, from their previous
experience, the dose of pre-prandial insulin lispro that they would require to
achieve satisfactory control of blood glucose for the study meal. The estimated
dose of insulin lispro was self-administered subcutaneously using an injection
site on the anterior abdominal wall, five minutes before ingestion of the study
meal. The insulin dose used for the subsequent study days was determined on
the basis of these preliminary results in which the target capillary blood glucose
concentration was to be between 7 and 10 mmol/1 5 hours after ingestion of the
meal. The same dose of insulin lispro was used in the two subsequent studies.
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The insulin regimen for each subject remained unchanged throughout the study
period.
On the two study days, the subject injected the pre-determined dose of insulin
lispro either 5 minutes before (time zero minus five minutes) the test meal
(started at time zero), or 20 minutes after the meal had been commenced. The
order of the time of administration was randomised and the pre-determined
insulin dose and the abdominal site of injection of insulin remained constant for
both studies. To assess the glucodynamic response, serial venous blood samples
for glucose estimation were obtained, via an in-dwelling cannula before the
meal and at 30-minute intervals for a period of five hours. The study was
discontinued immediately if at any time venous blood glucose concentrations
fell to less than 2.5 mmol/1, or if symptoms of hypoglycaemia developed with a
venous blood glucose below 3.0 mmol/1.
On each study day, the pre-meal glucose concentration was required to be within
the range of 4.0-12.0 mmol/1. A capillary blood glucose value that was outside
this range required the study to be rescheduled on another day. This was
necessary to ensure that the blood glucose concentrations for individuals at the
commencement of each study were comparable on both study days as the
prevailing level of glycaemia is known to influence the rate of gastric emptying;
hyperglycaemia delays gastric emptying [MacGregor et al, 1976, Fraser et al,
1990, Oster-Jorgensen et al, 1990], while hypoglycaemia accelerates gastric
emptying [Schvarcz et al, 1993].
Assay methods
Whole venous blood glucose was determined using the glucose oxidase method
(Yellow Springs Instruments 2300 stat). Glycated haemoglobin (HbAlc) was
determined using high speed liquid chromatography based on an ion-exchange
reverse-partition method (Variant II Hemoglobin Testing System; Biorad
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Diagnostics, Hercules, CA) (local DCCT-aligned non-diabetic reference range:
4.3-6.5%).
Statistical analyses
Baseline blood glucose concentrations were compared using Student's t test for
paired data. Postprandial blood glucose excursions were compared using a
repeated measures analysis of variance (ANOVA). Post hoc analyses were
performed using Student's t test for paired data. A p value of less than 0.05 was
considered significant for the ANOVA; a p value less than 0.01 was considered
significant for the paired t test analyses, to reduce the risk of a type 1 statistical
error occurring in view of the multiple analyses that were performed. All
analyses were performed using SPSS version 10.0 for Windows.
9.3 Results
The baseline fasting blood glucose concentration [mean (SD)] before each test
meal was similar when insulin lispro was administered pre- or postprandially
[7.3 (2.6) mmol/1 versus 6.3 (1.9) mmol/1, p=0.3]. Between-subjects ANOVA
showed that the order of the timing of the injection of insulin lispro had no
effect on the resulting glycaemic excursions.
Preprandial administration of lispro
Administration of insulin lispro before the high fat, solid-phase meal produced a
cumulative decline in postprandial blood glucose, with a mean (SD) maximal
decrement of 1.7 (2.4) mmol/1 below baseline at 150 minutes (figure 9.1). When
insulin lispro was administered before the test meal, hypoglycaemia developed
in three subjects. In one subject, the premeal blood glucose was 5.9 mmol/1 and
fell progressively to 2.9 mmol/1 at 150 minutes. In the second subject, the blood
glucose fell from a premeal value of 6.8 to 2.7 mmol/1 at 150 minutes. In the
third subject, the premeal blood glucose was 5.1 mmol/1 and fell progressively
to 2.8 mmol/1 at 240 minutes. Data from these subjects were included in the
repeated measures analysis of variance over time as it is accepted practice to
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employ a 'missing value' rule for the purpose of such an analysis [Burge,
1997b]. However, the mean plasma glucose concentrations for the post hoc
analyses include values for only those subjects who remained in the study and
do not include the derived data.
Postprandial administration of lispro
The glycaemic excursion over time was significantly greater when insulin lispro
was administered after the test meal compared to before the meal (p=0.006).
Postprandial administration of insulin lispro permitted a rise in blood glucose
after the meal with a mean (SD) maximal increment of 2.2 (1.3) mmol/1 above
baseline at 60 minutes (see figure 9.1). Hypoglycaemia did not occur in any
subject when insulin lispro was administered postprandially. When insulin
lispro was administered postprandially, the blood glucose excursions were
significantly higher (p<0.01) at the time points of 60 minutes and 150 minutes,
compared with preprandial administration.
9.4 Discussion
When the rise in blood glucose after a meal is delayed, the rapid onset of action
of insulin lispro may promote the risk of early postprandial hypoglycaemia
[Burge et al, 1997a]. The principal aims of the present study were to identify
the optimal time of administration of insulin lispro before or after a high fat,
solid-phase meal and assess the risk of developing postprandial hypoglycaemia
over an extended period of 5 hours. It was surmised that the consumption of a
high fat meal would delay the postprandial rise in blood glucose, and that
greater synchronisation of the peak action of insulin with the postprandial rise in
blood glucose would be achieved by administration of insulin lispro after the
meal. Fried fish and french fried (chipped) potatoes was chosen as a test meal
as it is high in saturated fat and is a popular dish in the UK.
The timing of the administration of insulin lispro in relation to the composition
of a meal has been examined previously [Burge et al, 1997a, Strachan & Frier,
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1998, Schernthaner et al, 1998]. Schernthaner et al [1998] used a test meal
consisting of beef stroganoff and demonstrated that the postprandial injection of
insulin lispro produced a glucodynamic pattern over two hours that was
comparable to the effect of human soluble insulin given either 20 minutes
before, or immediately before the meal. Burge et al [1997a] gave subjects a
low-carbohydrate, high-fat breakfast coincident with the injection of insulin
lispro and demonstrated that early postprandial hypoglycaemia occurred more
frequently than when they were given soluble insulin 30 minutes before the
meal. Strachan & Frier [1998] showed that when insulin lispro was
administered after a high fat breakfast, either in solid or liquid form,
postprandial blood glucose rose in most subjects and the risk of postprandial
hypoglycaemia was minimal. The increments in postprandial blood glucose
were relatively high, with a peak excursion of 3.6 mmol/1 at 45 minutes when
the meal was solid, and a peak excursion of 4.2 mmol/1 at 45 minutes when the
meal was liquid [Strachan & Frier, 1998], However, the preprandial
administration of insulin lispro before the high fat, solid-phase breakfast meal
provoked a decline in blood glucose, so that by 120 minutes, mean blood
glucose was 3.4 mmol/1 below baseline concentrations, and three subjects
developed overt hypoglycaemia.
In the present study, when insulin lispro was administered 20 minutes after a
high fat meal, no evidence of a postprandial fall in blood glucose was obtained,
congruent with previous observations [Strachan & Frier, 1998, Schernthaner et
al, 1998], However, the postprandial administration of insulin lispro did not
compromise glycaemic control by producing postprandial hyperglycaemia; the
mean rise of blood glucose was 2.2 mmol/1 at 60 minutes after the start of the
meal. This is probably related to the composition of the test meal which has a
high fat component in solid phase, and contrasts with the relatively high liquid
content of the test meal used in the study performed by Strachan & Frier [1998].
The postprandial injection of insulin lispro neither provoked unrestrained
hyperglycaemia nor caused postprandial hypoglycaemia with this type of meal,
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which is reassuring from a practical viewpoint. Thus, in the present study,
administration of insulin lispro after the high fat meal resulted in a satisfactory
glycaemic excursion over the subsequent five hours (figure 9.1) with no
evidence of pronounced hyperglycaemia before the evening meal.
The preprandial administration of insulin lispro before this typical high fat meal
provoked progressive hypoglycaemia in three subjects. The preprandial blood
glucose concentration in these three subjects was between 5.1 and 6.8 mmol/1
indicating good preprandial glycaemic control. In these individuals the
presumed delay in gastric emptying associated with the high fat meal would
result in a delayed rise in postprandial blood glucose and so exacerbate a
mismatch between blood glucose concentration and insulin activity, thus
promoting postprandial hypoglycaemia.
Gastric emptying is influenced by many factors other than the composition of a
meal and, as noted earlier, the prevailing level of blood glucose influences the
rate of gastric emptying [MacGregor et al, 1976, Fraser et al, 1990, Oster-
Jorgensen et al, 1990, Schvarcz et al, 1993] and abnormalities of gastric
emptying are common in people with diabetes of long duration [Keshavarzian et
al, 1987, Wegener et al, 1990, Kong et al, 1996, Samsom et al, 1996, Lyrenas et
al, 1997, Merio et al, 1997]. An attempt was made to control for these two
factors by selecting subjects with relatively short duration of diabetes and with
no symptoms of gastric stasis, and by ensuring that the blood glucose
concentration before the commencement of study was within a narrow range (4-
12 mmol/1).
In conclusion, when a meal contains a high content of fat in the solid-phase,
administration of insulin lispro after the meal may reduce the risk of early







CONCLUSIONS AND FUTURE RESEARCH
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10.1 DETERMINING THE RELEVANCE AND VALIDITY OF COGNITIVE
DYSFUNCTION IMPOSED BY ACUTE HYPOGLYCAEMIA
The initial chapters of this thesis gave a comprehensive overview of the research
that has accumulated over the last two decades on acute hypoglycaemia. It is
clearly evident that acute hypoglycaemia causes an acute, reversible decline in
mental capacity and that this can have a deleterious effect on the quality of life
of people with diabetes [Deary, 1999], However, previous studies have used
cognitive tests and measures that were general in nature. Therefore, a major aim
of this thesis was to try and determine the importance of these effects on a
practical basis using a set ofwell-validated tests.
10.2 ACUTE HYPOGLYCAEMIA, ATTENTION AND INTELLIGENCE
Studies 1 and 2 provided further insight into two areas that have previously been
difficult to study. A validated test of attention that was designed specifically to
measure multiple facets of attention, based largely on everyday materials and
the use of real-life circumstances, was used to determine whether acute
hypoglycaemia disrupts attentional functioning in both people with and without
type 1 diabetes. There was a significant decline in tests of selective attention,
both visual and auditory, and in attentional switching, in keeping with the
received wisdom that psychological tests that involve rapid responses, and those
which are more cognitively complex, are more likely to be affected by
hypoglycaemia. However, contrary to previous work, it was shown that
sustained attention to a repetitive, relatively boring stimulus was unaffected by a
short duration of hypoglycaemia (ten minutes), although future efforts should
look at tests of sustained vigilance. Crucially, it was shown that acute
hypoglycaemia significantly impairs practical everyday activities such as
reading a map, or determining which floor to stop in a lift.
An unexpected finding was the lack of a deleterious effect of acute
hypoglycaemia on non-verbal reasoning. After considering the various
possibilities that could have accounted for this result, the most likely conclusion
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was that the Standard RPM were too easy for the chosen subjects, who
comprised people whose mean was just above average intelligence, and thus a
ceiling effect had been reached. This problem is occasionally encountered when
using psychological tests during hypoglycaemia [Deary, 1993b]. As discussed
in Chapter 7, this hypothesis has now been tested by Warren et al [2004] who
repeated the study using the Ravens Advanced Progressive Matrices. Although
they demonstrated a decline in non-verbal reasoning during hypoglycaemia with
the more difficult test, the subjects in the study by Warren et al [2004] were of a
higher premorbid intelligence (mean number correct score on NART was 40)
compared with a mean number correct score of 27 in the study by McAulay et al
[2006], thus introducing a possible confounder.
It would have been interesting to correlate symptoms of hypoglycaemia with
cognitive performance but, given the low power (and likelihood of a type 2
statistical error) for this type of analysis, it was not performed. Similarly, a
gender analysis would also have required a larger sample size. In keeping with
this thesis, future research could examine the effects of acute hypoglycaemia on
other basic brain processes. For example, this could be based on cognitive
studies, such as memory and language function, psychophysics including
sensory processing, or brain imaging, using positron emission tomography
(PET), single photon emission tomography (SPET) or MRI. A study involving
functional MRI has been published with a key finding that cortical activity was
increased during a choice reaction task, raising the possibility of a compensatory
mechanism to reduce higher cognitive dysfunction induced by hypoglycaemia
[Rosenthal et al, 2001].
As discussed in Chapter 2, there are numerous proposed moderators of cognitive
dysfunction during acute hypoglycaemia. The evidence derived from the
present studies suggests that a diagnosis of diabetes may act as a susceptibility
factor to cognitive disruption during hypoglycaemia. Further research to
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understand the individual differences in the mental disruption caused by
hypoglycaemia is welcome.
10.3 MOTIVATION AND SUBJECTIVE COGNITION DURING ACUTE
HYPOGLYCAEMIA
The perceived practice effect that may take place with tests of cognitive function
during studies of hypoglycaemia has been a concern [Heller & Macdonald,
1996]. Furthermore, fatigue may increase the sensitivity of cognitive tests, in
that those tests attempted at the end of a test period may be more sensitive to the
effects of hypoglycaemia. Therefore, Study 3 is a useful addition to current
understanding by demonstrating that motivation declined to a similar extent
during both the euglycaemia and hypoglycaemia arms of the glucose clamp,
thus supporting the results and conclusions of previous studies of
hypoglycaemia. However, the main motivation dimension assessed by the
DSSQ relates to intrinsic motivation, which reflects the extent to which the
person is motivated by interest and engagement in task content. Therefore,
further work could investigate additional dimensions, such as extrinsic
motivation.
Research on the measurement of subjective states has been limited, focusing on
one or two dimensions only, because cognition is a difficult aspect of state to
assess due to the multiplicity of constructs that may be relevant, and Study 3
appears to be the first to examine subjective cognition in the setting of
hypoglycaemia. Although the adverse effects of recurrent severe
hypoglycaemia on cognitive function in people with diabetes has generated
much debate [Deary & Frier, 1996], the issue of whether subjective aspects of
cognition deteriorate has not been examined. While the present study was not
intended to address this, given that there might be some slight long-term
cognitive decrements on average among people with diabetes [Perros & Deary,
1999], it would be interesting to ascertain whether subjective aspects of
cognition are also affected.
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Although the cognitive tests in Study 3 were chosen because they engaged
effortful cognitive processing (TEA) and had a relation to the person's general
ability (RPM), little is known about the external validity of this study in terms of
the real-life impact of hypoglycaemia on motivation and cognitive interference.
Therefore, multimethod in-field assessment, such as experience sampling
combined with continuous glucose monitoring would be worth further study.
Future work could examine the associations between mood, symptoms,
motivation and cognition, and the addition of data derived from
counterregulatory hormone measurement, especially epinephrine data, would
add interest. Moreover, it would be of value to correlate the symptoms of
hypoglycaemia with many of the state measures, including the interference
scales, but for reasons previously stated, our study sample of 16 subjects would
not allow this.
10.4 REDUCING THE FREQUENCY OF HYPOGLYCAEIWIIA WITH INSULIN
ANALOGUES
Although the flexibility in time of injection of insulin lispro may be of benefit
during intercurrent illness and in situations where the quantity of food to be
ingested may be unpredictable, because of the rapid onset of action of insulin
lispro, the risk of early postprandial hypoglycaemia is increased in certain
situations. This includes the ingestion of certain meal types, especially high fat,
solid meals that are slowly absorbed. Study 4 demonstrated that the optimal
time of administration of insulin lispro with a high fat meal (fried fish and chips)
was after the meal in order to reduce the risk of hypoglycaemia, without
compromising the postprandial control of blood glucose. This is of practical
interest to those with type 1 diabetes who may be using insulin lispro and who
eat such a meal, although current dietary recommendations would not encourage
ingestion of this particular meal on a regular basis. Further study would be
enhanced by controlling for antecedent glycaemia by use of an insulin infusion,
thus ensuring that all subjects start with the same blood glucose value.
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10.5 CONCLUSIONS
Hypoglycaemia will remain a major barrier to the management of insulin-treated
diabetes for the likely future, as long as insulin delivery systems remain
imperfect. Therefore, the measurement of cognitive function is relevant to
diabetes management. In addition to those already mentioned, important areas
for research include unraveling the mechanisms and finding treatments for
impaired awareness of hypoglycaemia, and determining the moderators of
cognitive change and its threshold during acute hypoglycaemia. The arrival of
novel treatments such as islet cell replacement [Shapiro et al, 2000], human
amylin analogues [Buse et al, 2002], GLP 1 analogues [Dupre et al, 1995] and
immunotherapies [Bach 2001] will signal improvements for those who can
access these treatments. However, for the majority of people with diabetes, the
absence of a plasma glucose regulated insulin delivery system will mean that the
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